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Nomenclature 
 
Amino acids are given in the one-letter code (e.g. K). 
The positions of amino acids within a protein are indicated by numbers. The numbering 
starts with “1” at the first methionine/valine of the wild-type protein. 
Amino acid substitutions are termed as follows: The native amino acid is designated in 
one letter code first, followed by its position in the protein, and the one-letter code for 
the amino acid substitution introduced. (Example: EF-P K34R, here, lysine at position 
34 of EF-P is replaced by an arginine). 
Deletions are marked with “Δ”. 
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AcKRS    acetyl lysyl-tRNA synthetase 
A-site     aminoacyl-site 
BTH     bacterial two-hybrid 
β3Ωβ4    loop between beta-strands β3/β4 
CAT     chloramphenicol acetyltransferase 
EF-P     elongation factor P 
eIF5A     eukaryotic translation initiation factor 5A 
E-site     exit-site 
fMet-tRNAifMet   initiator transfer RNA N-formyl-methionyl-tRNAi 
GFP     green fluorescent protein 
LysRS    lysyl-tRNA synthetase 
mRNA    messenger RNA 
ncAA     non-canonical amino acid 
ORF     open reading frame 
PTM     post-translational modification 
PylRS     pyrrolysyl-tRNA synthetase 
P-site     peptidyl-site 
tRNACUA    pyrrolysyl-transfer RNA 
tRNALys    lysyl-transfer RNA 
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Summary 
 
During the synthesis of two or more consecutive prolines, translation comes to a halt. 
To resolve this arrest, bacteria have evolved a specialized translation elongation 
factor P (EF-P), being orthologous and functionally equivalent to the 
archaeal/eukaryotic initiation factor a/eIF5A. EF-P binds to the stalled ribosome in 
order to stabilize and orient the P-site prolyl-tRNA in a way that translation can resume. 
In this regard, a seven amino acids long loop between beta-strands β3/β4 (β3Ωβ4) is 
crucial for EF-P function and modified at its tip. In the Gram-negative model organism 
Escherichia coli and around 25% of all bacteria, the ligase EpmA catalyzes formation 
of an unusual peptide bond between the α-carboxyl group of (R)-β-lysine and the 
ε-amino group of EF-P lysine at position 34 (K34). Another 10% including 
Pseudomonads have evolved a glycosyltransferase termed EarP, which 
rhamnosylates an arginine at position 32 (R32) in the K34 equivalent position. As the 
requirements allowing these two chemically distinct modifications to fulfil the same 
function are unknown, this thesis was intended to shed a light on this so far neglected 
aspect. To do so, the following translational and post-translational strategies were 
developed and applied to modify EF-P synthetically:   
With the first strategy, we aimed to incorporate (R)-β-lysyl-lysine in a single 
translational step directly, using the pyrrolysyl-tRNA synthetase (PylRS)/tRNACUA pair 
dependent amber suppression system from Methanosarcina mazei. Therefore, E. coli 
EF-P would be synthetically functionalised in a post-translational independent manner. 
For this purpose, a screening system was initially developed, allowing to select for 
PylRS mutants which accept (R)-β-lysyl-lysine as a substrate (Chapter 2). In parallel 
and based on the acquired expertise regarding the amber suppression system, a 
toolbox to control bacterial protein levels was developed during this thesis (Chapter 3). 
This toolbox allows to control protein levels translationally, and when combined with 
transcriptional control, to gradually adjust the protein output in diverse Gram-negative 
bacteria. Furthermore, the potential of this system to regulate even essential gene 
products was demonstrated.  
In the second strategy, we employed the modification system EarP from Pseudomonas 
putida to synthetically switch the post-translational modification of E. coli EF-P from 
(R)-β-lysylation to rhamnosylation (Chapter 4). We could show that a single amino acid 
exchange from lysine to arginine in the post-translational modification site is sufficient 
to switch the modification. Since the resulting E. coli EF-P variant is rhamnosylated but 
not functional, we furthermore investigated the influence of the amino acid composition 
of the β3Ωβ4 surrounding the modification site with respect to functionality. Based on 
these analyses we identified a conserved proline in E. coli EF-P located two amino 
acids upstream of the modification site which, when removed, restores functionality of 
rhamnosylated E. coli EF-P and therefore synthetically activates it. 
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Zusammenfassung 
 
Bei der Synthese von zwei oder mehr aufeinanderfolgenden Prolinen kommt die 
Translation zum Stillstand. Um diesen Arrest aufzulösen, haben Bakterien einen 
speziellen Translationselongationsfaktor P (EF-P) entwickelt, welcher ortholog zu dem 
archaealen/eukaryotischen Initiationsfaktor a/eIF5A ist. EF-P bindet an das blockierte 
Ribosom und stabilisiert bzw. orientiert die P-site Prolyl-tRNA so, dass die Translation 
wiederaufgenommen werden kann. In diesem Zusammenhang ist eine sieben 
Aminosäuren lange Schleife entscheidend für die EF-P-Funktion. Sie liegt zwischen 
den Beta-Strängen β3/β4 (β3Ωβ4) und wird an deren Spitze modifiziert. Im 
Gram-negativen Modellorganismus Escherichia coli und rund 25% aller Bakterien 
katalysiert die Ligase EpmA die Bildung einer ungewöhnlichen Peptidbindung 
zwischen der α-Carboxylgruppe von (R)-β-Lysin und der ε-Aminogruppe von 
EF-P-Lysin in Position 34 (K34). Weitere 10% der Bakterien, einschließlich 
Pseudomonaden, haben eine Glykosyltransferase namens EarP entwickelt, die ein 
Arginin in Position 32 (R32) in der äquivalenten Position zu K34 rhamnosyliert. Da die 
Anforderungen unbekannt sind die es diesen beiden chemisch unterschiedlichen 
Modifikationen erlauben die gleiche Funktion zu erfüllen, war die vorliegende Arbeit 
dazu gedacht diesen bisher vernachlässigten Aspekt zu untersuchen. Zu diesem 
Zweck wurden folgende translationale und posttranslationale Strategien entwickelt 
und angewendet um EF-P synthetisch zu modifizieren:  
In der ersten Strategie wurde versucht (R)-β-Lysyl-Lysin unter Verwendung des 
Pyrrolysyl-tRNA Synthetase (PylRS)/tRNACUA Paar abhängigen Amber-Suppressions-
Systems von Methanosarcina mazei translational einzubauen. Somit würde E. coli 
EF-P in einem einzigen posttranslational unabhängigen Schritt synthetisch 
funktionalisiert werden. Um dies zu erreichen wurde initial ein Screening-System 
entwickelt welches es ermöglicht PylRS-Mutanten zu identifizieren welche 
(R)-β-Lysyl-Lysin als Substrat akzeptieren (Kapitel 2). Parallel hierzu, und auf 
Grundlage der erworbenen Expertise bezüglich des Amber-Suppressions-Systems, 
wurde im Rahmen dieser Arbeit ein Werkzeug entwickelt mit dessen Hilfe sich 
Proteinlevel in diversen Gram-negativen Bakterien steuern lassen (Kapitel 3). Dieses 
Werkzeug erlaubt, wenn kombiniert mit transkriptionaler Kontrolle, Proteinlevel 
graduell zu steuern und kann selbst auf essentielle Gene angewendet werden. 
In der zweiten Strategie verwendeten wir das Modifikationssystem EarP von 
Pseudomonas putida, um posttranslational die Modifikation von E. coli EF-P von 
(R)-β-Lysylierung auf Rhamnosylierung umzustellen (Kapitel 4). Wir konnten zeigen, 
dass ein einzelner Aminosäureaustausch von Lysin zu Arginin an der 
posttranslationalen Modifikationsstelle ausreicht, um die Modifikation zu wechseln. Da 
jedoch die resultierende E. coli EF P-Variante rhamnosyliert aber nicht funktional war, 
wurde in einem nächsten Schritt der Einfluss der Aminosäurezusammensetzung der 
β3Ωβ4 auf die Funktionalität untersucht. Mit Hilfe dieser Analysen konnte ein 
konserviertes Prolin in E. coli EF-P identifiziert werden, welches sich zwei Positionen 
stromaufwärts bezogen auf die Modifikationsstelle befindet. Abschließend konnten wir 
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zeigen, dass durch den Austausch dieses Prolins rhamnosyliertes E. coli EF-P 
funktionalisiert und somit synthetisch aktiviert werden kann. 
  
 Introduction 
1 
1. Introduction 
 
1.1 The non-uniformity of translation 
In all domains of life mRNAs are translated on the ribosomes into polypeptide chains 
in a highly conserved four step process. This process consists of: initiation, elongation, 
termination and ribosome recycling. During elongation individual amino acids are 
connected in the ribosomal peptidyl transferase center via peptide bonds to a 
polypeptide chain. To achieve this, the ribosome moves along the mRNA during 
elongation and this was initially seen as a uniform process. However, already in the 
late 1970s, early 1980s it became evident that this movement takes place rather in a 
non-uniform manner (Protzel and Morris, 1974; Chaney and Morris, 1978; Lizardi et 
al., 1979; Abraham and Pihl, 1980; Randall et al., 1980; Varenne et al., 1981; 
Yanofsky, 1981; Varenne et al., 1982; Varenne et al., 1984). One reason for this 
resides in the sequence composition (Wohlgemuth et al., 2008). This is not surprising 
when considering that peptide bond formation has to be achieved between 20 
chemically diverse amino acids which allow for 400 different combinations. A peculiar 
case here represents peptidyl transferase reactions involving proline, due to its unique 
chemical properties among the proteinogenic amino acids. Its integral pyrrolidine ring 
gives proline an exceptional rigidity in structure which in turn makes it a poor substrate 
for peptide bond formation, as acceptor substrate in the ribosomal aminoacyl-site (A-
site) (Pavlov et al., 2009) as well as donor substrate in the peptidyl-site (P-site) (Muto 
and Ito, 2008). In both cases this results in slow peptide bond formation (Wohlgemuth 
et al., 2008; Johansson et al., 2011; Doerfel et al., 2013; Chevance et al., 2014; Doerfel 
et al., 2015). This effect becomes particularly apparent when proline acts as acceptor 
and donor substrate at the same time, resulting in translational arrest of the ribosome 
during the synthesis of stretches of two or more consecutive prolines. (Tanner et al., 
2009; Doerfel et al., 2013; Hersch et al., 2013; Peil et al., 2013; Ude et al., 2013; 
Woolstenhulme et al., 2013; Elgamal et al., 2014; Starosta et al., 2014; Woolstenhulme 
et al., 2015). However, despite this translational arrest, polyproline motifs are found 
extensively in the genomes throughout all domains of life (Mandal et al., 2014; Qi et 
al., 2018). The reason for this is presumably that the translational drawbacks of 
consecutive prolines are outweighed by prolines capability to endow proteins with 
unique structural properties not least exemplified by polyproline helices. Accordingly, 
life had to find a way to overcome this barrier, and in 2013 the molecular mechanism 
that made this possible was discovered. In this year, two parallel studies demonstrated 
independently that in bacteria the specialized translation elongation factor P (EF-P) is 
responsible for the relief of the translational ribosomal arrest caused by polyproline 
motifs (Doerfel et al., 2013; Ude et al., 2013). This finding was shortly afterwards also 
reported for the eukaryotic EF-P homolog, eIF5A (Gutierrez et al., 2013). 
1.2 The discovery of EF-P and its molecular function 
EF-P itself was already discovered in 1975 by Bernard Glick and Clelia Ganoza (Glick 
and Ganoza, 1975). In their work they were able to identify a soluble protein fraction 
containing an extraribosomal factor with the ability to stimulate peptide bond formation 
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between the initiator transfer RNA N-formyl-methionyl-tRNAi (fMet-tRNAifMet) and the 
aminoacyl-tRNA analog, puromycin. Since puromycin represents a special case as 
aminoacyl acceptor, the team around Glick and Ganoza was curious if EF-P can also 
stimulate peptide bond formation between fMet-tRNAifMet and other aminoacyl 
acceptors mimicking more the natural aminoacyl tRNAs. To do so, they investigated 
1979 the influence of EF-P on peptide bond formation between fMet-tRNAifMet and 
diverse other aminoacyl acceptors (Glick et al., 1979). In this work they could show in 
vitro, that small amino acids like glycine and leucine depend more on EF-P to form the 
first peptide bond with fMet-tRNAifMet than others. Based on these finding they 
suggested that EF-P stimulates the first peptide bond formation not in general but 
specifically when aminoacyl acceptors have a smaller and/or less hydrophobic side 
chain. However, the confirmation of this suggestion in vivo did not take place at that 
time, most likely because efp was described as essential (Aoki et al., 1997), which 
turned out to be incorrect later on. Correct is, that efp can be deleted in the majority of 
the model organisms used in the laboratory, including Escherichia coli (Baba et al., 
2006), Pseudomonas aeruginosa (Balibar et al., 2013) Salmonella enterica (Zou et al., 
2012), Shewanella oneidensis (Lassak et al., 2015), Agrobacterium tumefaciens (Peng 
et al., 2001), Brucella abortus (Iannino et al., 2012) and Bacillus subtilis (Ohashi et al., 
2003) and only in rare cases like Neisseria meningitides or Mycobacterium 
tuberculosis deletion of efp is lethal (Sassetti et al., 2003; Yanagisawa et al., 2016). 
Based on the first structural data (Hanawa-Suetsugu et al., 2004), it became evident 
that the overall structure of EF-P consists of three β-barrel domains which resemble 
the L-shape of tRNAs (Figure 1).  
 
Figure 1: Structure comparison between EF-P and tRNA. (Left) Crystal structure of EF-P from 
Thermus thermophiles (Hanawa-Suetsugu et al., 2004) (PDB: 1UEB). The different colors represent the 
different β-barrel domains I (blue), II (green) and III (brown) (Right) Crystal structure of tRNAPhe from 
Saccharomyces cerevisiae (Jovine et al., 2000) (PDB: 1EVV). For visualization, UCSF Chimera was 
used (Pettersen et al., 2004). 
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Then, in 2009, Steitz and colleagues were able to solve the crystal structure of EF-P 
in complex with the Thermus thermophilus 70S ribosome, the ribosomal protein L1, 
fMet-tRNAifMet and the messenger RNA (mRNA) (Blaha et al., 2009). Based on this 
co-crystal structure they assumed, like Glick and Ganoza 30 years ago, that EF-P is 
needed in the cell for the correct positioning of the fMet-tRNAifMet in the P site, and by 
that allowing the formation of the first peptide bond during translation elongation. 
1.3 EF-P resolves polyproline (PPP) mediated ribosome stalling 
In 2013, two independent research groups showed that EF-Ps main task is to stimulate 
peptide bond formation between prolines (Doerfel et al., 2013; Ude et al., 2013). This 
discovery arose from in vivo experiments in which the polyproline containing pH-sensor 
CadC of E. coli could be identified as a protein whose synthesis is directly dependent 
on EF-P (Ude et al., 2013). Based on this finding, further in vivo analysis of diverse 
polyproline containing proteins in combination with in vitro translation experiments 
could show that EF-P is required to resolve ribosome stalling caused by three or more 
consecutive prolines. Independently of this study, the group lead by Marina Rodnina 
came to the same conclusion (Doerfel et al., 2013). They determined the kinetics of 
peptide bond formation between the 20 proteinogenic amino acids and puromycin. 
Here they showed that the addition of EF-P leads to a strong acceleration of the peptide 
bond formation between proline and puromycin, an affect which could not be observed 
between the 19 other proteinogenic amino acids and puromycin. Furthermore, in vitro 
translation experiments showed that the synthesis of peptides containing three 
consecutive prolines was only possible in the presence of EF-P. Shortly afterwards, 
also a third laboratory supported these results. They showed that eIF5A, the eukaryotic 
homolog of EF-P, is also required for the translation of polyproline sequences 
(Gutierrez et al., 2013). 
Taken together, these studies prove that EF-P/eIF5A are universal translation factors 
needed for the effective translation of polyproline sequences on the ribosome. 
Additionally, and since polyproline motifs are widespread in proteins (Morgan and 
Rubenstein, 2013; Ude et al., 2013), it provides also a conclusive explanation for 
properties associated with EF-P, such as its influence on cell growth, motility, viability, 
virulence, sensitivity to low molarity and susceptibility to certain antibiotics (Kearns et 
al., 2004; Navarre et al., 2010; Zou et al., 2011; Zou et al., 2012). 
1.4 EF-P resolves diprolyl (PP) mediated ribosome stalling 
Having shown that EF-P stimulates the peptide bond formation between stretches of 
three consecutive prolines (PPP), a more differentiated image of this effect was 
obtained shortly afterwards by our group in a joined work with Daniel Wilson and 
colleagues (Peil et al., 2013). In this study it could be shown that certain diprolyl motifs 
can also lead to a ribosomal arrest (Figure 2). The strength of this arrest depends 
strongly on the sequence context of the diprolyl motif, whereby the amino acid 
upstream (XPP) and downstream (PPX) of the diprolyl motif has a decisive role here. 
Based on these data, a hierarchy of arrest motifs was generated, ranging from strong 
stalling (PPP, DPP and PPN) to weak stalling motifs (CPP, PPR and PPH). These data 
were confirmed in 2015 by Buskirk and colleagues using ribosome profiling to 
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characterize pausing at proline motifs in the absence of EF-P (Woolstenhulme et al., 
2015), and also by von Heijne and colleagues by using a mechanical pulling force 
sensor applied to different diprolyl arrest peptides (Cymer et al., 2015).   
Figure 2: EF-P mediated release of ribosome stalling. (Left) Diprolyl paused ribosome. Red circles 
with P indicate proline, yellow circles with X indicate any of the 20 proteinogenic amino acids flanking 
the diprolyl motif and having influence on ribosome stalling. (Middle) EF-P enters the stalled ribosome 
through the vacant E-site and binds to the P-tRNA/ribosome to stimulate peptide bond formation. (Right) 
Afterwards, EF-P dissociates, leaves through the vacant E-site and protein synthesis continues. 
1.5 The larger upstream amino acid context of the arrest motif also 
influences its stalling strength 
Interestingly, the absence of EF-P does not lead in all cases to a reduced abundancy 
of polyproline (PPP) containing proteins in the cell, and in some cases leads even to 
increased levels (Peil et al., 2013; Starosta et al., 2014). The reason for this 
unexpected fact was found in 2014 by an in-depth analysis of the amino acids 
preceding the stall site performed by our group, again in cooperation with Daniel Wilson 
and colleagues (Starosta et al., 2014). This analysis revealed that not only the first 
amino acid preceding the stall site strongly influence the strength of the arrest motif, 
but that this effect extends further up to five amino acids upstream of the stall site. 
Although this effect is strongest for the amino acid directly preceding the arrest motif it 
is still measurable, although with decreasing strength, till the fifth amino acid upstream. 
This observation was supported by a parallel study which came to comparable results 
(Elgamal et al., 2014). Based on these results we assumed that the conformation of 
the nascent polypeptide chain located within the ribosomal tunnel upstream of the 
stalling site is responsible for the stalling effect. However, to clarify this question further 
structural studies are needed. 
1.6 Additional factors influencing the translation of proteins containing 
consecutive prolines 
Besides the already mentioned factors (arrest motif strength, context and larger 
upstream amino acid composition), two other factors strongly affect diprolyl/polyproline 
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translation. This is on the one hand the translation initiation rate and, on the other hand, 
the position of the arrest motif within the open reading frame (ORF) (Hersch et al., 
2014; Woolstenhulme et al., 2015). The following applies to these two properties: 
 High rates of translation initiation result in an increase in EF-P dependence. 
 The earlier the arrest motif is embedded in the ORF, the higher is the EF-P 
dependence. 
The theory behind the described dependencies is the following: When having a stalling 
motif in combination with a high translation initiation rate, a ribosome queue emerges 
that extends back to the start codon and prevents further binding of new ribosomes. 
This happens the faster, the nearer the stalling motif is located within the ORF (Hersch 
et al., 2014; Woolstenhulme et al., 2015). 
1.7 Post-translational modifications of EF-P 
In order to improve its molecular function, EF-P is post-translationally modified. To 
date, three different strategies have been discovered in bacteria, which are discussed 
in detail in the following three sections. 
1.7.1 β-Lysylation of lysine type EF-P by the EpmABC pathway 
Already in 1991, the first suspicions arose that EF-P from E. coli owns a 
post-translational modification (PTM) (Aoki et al., 1991), but experimental proof 
regarding this aspect was only presented 17 years later by Ganoza and coworkers 
(Aoki et al., 2008). Their study actually investigated the interaction between E. coli 
EF-P and its ribosome. Within the scope of this work, however, the mass of EF-P was 
determined by means of mass spectrometry, whereby a mass shift of 144 Da could be 
detected on lysine at position 34 (K34). Nonetheless, the type of post-translational 
modification involved remained unclear until 2010 the first hypothesis regarding this 
was presented (Bailly and de Crecy-Lagard, 2010). Bailly and Crécy-Lagard 
postulated, on the basis of bioinformatic analyses, that K34 is (R)-β-lysylated. This 
happens in a two-step process under the participation of EpmA (also known as YjeA, 
PoxA or GenX) and EpmB (also known as YjeK) as follows: The lysine 
2,3-aminomutase EpmB converts (S)-α-lysine into (R)-β-lysine (Figure 3, Step 1) 
(Behshad et al., 2006), which is then transferred onto K34 of EF-P by EpmA (Figure 3, 
Step 2). This results in a (R)-β-lysylation of K34. This hypothesis was confirmed in the 
following years by mutational analyses, in vitro experiments and the crystal structure 
of EF-P in complex with EpmA (Navarre et al., 2010; Sumida et al., 2010; Yanagisawa 
et al., 2010; Roy et al., 2011). 
However, after the PTM pathway responsible for the full functionalisation of EF-P was 
elucidated, it remained unclear why in vitro (R)-β-lysylated EF-P has a 128 Da 
modification (Navarre et al., 2010; Yanagisawa et al., 2010) whereas endogenous 
EF-P has a 144 Da modification (Aoki et al., 2008; Park et al., 2012). The mass shift 
already indicated a hydroxylation (Yanagisawa et al., 2010), but how this hydroxylation 
is achieved was not clarified until 2012. There, Wilson and colleagues showed that 
EpmC (also known as YfcM) hydroxylates PTM EF-P in a final step, and that this 
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hydroxylation takes most likely place at the C5 atom of K34 (Peil et al., 2012) (Figure 
3, Step 3). 
 
Figure 3: β-Lysylation of EF-P with conserved lysine at position 34 (K34) by EpmABC. (Step 1) 
The aminomutase EpmB shifts the α amino group of (S)-α-lysine in the β position, resulting in 
(R)-β-lysine. (Step 2) (R)-β-Lysine is attached onto K34 of EF-P by the protein ligase EpmA, resulting 
in (R)-β-lysyl-lysine. (Step 3) (R)-β-Lysyl-lysine is hydroxylated most likely on the C5 atom by EpmC, 
resulting in (R)-β-lysyl-hydroxylysine. 
In the following years, the catalytic mechanism of EpmC could be clarified to a large 
extent (Kobayashi et al., 2014a; Kobayashi et al., 2014b), but the biological function 
behind this hydroxylation remains unclear, since deletions of epmC seemed to have 
no effect in vivo and in vitro on the functionality of EF-P (Peil et al., 2012; Doerfel et 
al., 2013; Ude et al., 2013). Furthermore, genome analyses show that EpmC is 
restricted however to some phyla encoding the EpmAB pathway (Lassak et al., 2015) 
(among them E. coli and Salmonella). This suggests that EpmC possesses only a 
minor molecular function, such as stabilization of the PTM by hydroxylation. 
1.7.2 5-Amino-pentanolylation of lysine type EF-P by an unknown 
pathway 
The so far described modification pathway from E. coli could only be identified in about 
25% of all bacteria (Bailly and de Crecy-Lagard, 2010; Lassak et al., 2015), and 
notably, among them are no Gram-positive. Motivated by this this lack of information, 
Ibba and co-worker investigated the Gram-positive model organism B. subtilis 
regarding this aspect. There they found that the deletion of efp only impairs swarming 
motility but has no effect on growth or swimming motility (Kearns et al., 2004; Rajkovic 
et al., 2016). In comparison to that, the deletion of efp in Gram-negative bacteria 
exhibits a severe pleiotropic phenotype. With this knowledge in hand, Ibba and 
colleagues investigated the importance of EF-P in B. subtilis (Rajkovic et al., 2016) and 
mutated the lysine of the potential PTM site at position 32 (K32) of B. subtilis EF-P 
(equivalent to the PTM site K34 in E. coli / Salmonella). The result was that swarming 
motility of these mutants was impaired to the same amount as in the ∆efp mutants, 
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indicating a PTM at this position. To verify this, mass spectrometry experiments were 
performed and revealed a 5-amino-pentanolylation on K32. 
In subsequent studies, Ibba and colleagues have now begun to clarify the modification 
pathway which leads to this 5-amino-pentanolylation of K32 (Hummels et al., 2017; 
Witzky et al., 2018). These studies indicate that the PTM is directly assembled on EF-P 
itself in a four step process (Figure 4, Step 1 to Step 4), but the involved enzymes 
remain unclear with exception of the enzyme involved in the last step (Witzky et al., 
2018). In this step, YmfI (a homolog to the reductase FabG) catalyzes the reduction 
from 5-aminopentanone to 5-aminopentanol (Figure 4, Step 4) (Hummels et al., 2017). 
However, the PTM described here is rather an exceptional case and probably limited 
to Firmicutes (Hummels et al., 2017). 
 
Figure 4: 5-Aminopentanolylation of EF-P with conserved lysine at position 32 (K32). (Step 1 to 
Step 3) Recent studies suggest, based on tandem mass spectrometry, that 5-aminopentanone is 
assembled directly on K32 of EF-P from B. subtilis (Witzky et al., 2018). The involved modification 
enzymes remain unknown to date. (Step 4) In a final step 5-aminopentanone is converted into 
5-aminopentanol by YmfI (Hummels et al., 2017). 
1.7.3 Rhamnosylation of arginine type EF-P by the RmlABCD/EarP 
pathway 
So far, the two PTMs mentioned, (R)-β-lysylation and 5-amino-pentanolylation, are 
structurally and chemically reminiscent. In 2015, however, a chemically distinct PTM 
was discovered which is present in about 10% of all bacteria (Lassak et al., 2015). The 
basis for this discovery was again provided by bioinformatic analyses, which helped to 
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identify a subfamily of unusual EF-Ps in genomes lacking the β-lysylation pathway 
EpmABC. These EF-Ps have a strictly conserved arginine R32, which is the equivalent 
position to the PTM site K34 in E. coli. However, even more interesting, they encode a 
conserved protein in the direct genomic neighbourhood which has now been referred 
to as EarP (Lassak et al., 2015). To elucidate whether there is a functional connection 
between EarP and EF-P, the corresponding genes were individually deleted both in 
S. oneidensis and in P. aeruginosa. The deletion of earP led to the same mutant 
phenotype as the deletion of efp, which is reflected by a strong growth defect. (Lassak 
et al., 2015; Rajkovic et al., 2015). Furthermore, reporter assays showed that EF-P 
can only rescue polyproline stalled ribosomes in the concomitant presence of EarP 
(Lassak et al., 2015). 
Having shown a functional connection between EarP and EF-P, it had to be clarified 
whether this connection is related to an unknown PTM at R32. Therefore, mass 
spectroscopy experiments were performed and identified a deoxyhexose moiety on 
the R32 residue of EF-P (Lassak et al., 2015; Rajkovic et al., 2015). This moiety was 
not present when earP was chromosomally deleted, providing first evidence that EarP 
modifies EF-P post-translationally. Subsequent in vitro experiments identified 
dTDP-rhamnose as the substrate for EarP, a result which was further supported by in 
vitro glycosylation reactions with purified components (Lassak et al., 2015; Rajkovic et 
al., 2015). dTDP-β-L-rhamnose is the product of the well characterized RmlABCD 
pathway which is strictly conserved in bacteria encoding EarP. In an inverting 
glycosyltransferase reaction (Li et al., 2016; Krafczyk et al., 2017; Sengoku et al., 2018) 
EarP uses this precursor and attaches rhamnose to EF-P (Lassak et al., 2015; Rajkovic 
et al., 2015) establishing now the full modification pathway of EF-Ps with conserved 
arginine at position 32 (Figure 5). 
   
Figure 5: Rhamnosylation of EF-P with conserved arginine at position 32 (R32) by the 
RmlABCD/EarP pathway. (Step 1) α-D-glucose-1-phosphate is converted in a multistep process to 
dTDP-β-L-rhamnose by the RmlABCD pathway. (Step 2) EarP uses dTDP-β-L-rhamnose as donor 
substrate to attach rhamnose to arginine at position 32 of EF-P. 
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1.8 Motivation and strategies for the synthetic activation of EF-P 
As the molecular function of EF-P is well understood, the mechanism of how EF-P 
stimulates the peptide bond formation between prolines on the ribosome and the 
involvement of the chemically distinct PTMs remains elusive. Although the first 
cryo-electron microscopy structure of EF-P with (R)-β-lysyl-hydroxylysine modification 
in complex with the translating ribosome stalled at polyproline stretches sheds some 
light on the exact role of the PTM (Huter et al., 2017), it remains unclear to date how 
chemically distinct PTMs can have the same stimulating effect on the ribosome. To 
understand this so far neglected aspect, this thesis was intended to investigate this by 
the synthetic functionalisation of E. coli EF-P. To achieve this, two different strategies 
were pursued in parallel, one translational and one post-translational based approach. 
1.8.1 Strategy one: Translational activation of E. coli EF-P using the 
amber suppression system  
With this strategy we aimed to replace the natural occurring lysine at position 34 (K34) 
in EF-P from E. coli by (R)-β-lysyl-lysine and related derivatives by using the amber 
suppression system (Wang et al., 2001). With this system non-canonical amino acids 
(ncAA) can be incorporated site specifically into proteins, after mutating the desired 
site to an amber stop codon (TAG). The incorporation of the ncAA then takes place 
through an orthogonal translation system, in our case the pyrrolysyl-tRNA synthetase 
(PylRS)/tRNACUA pair from the archaeum Methanosarcina mazei (Figure 6) (Crnkovic 
et al., 2016). 
  
Figure 6: The amber suppression system for the site specific incorporation of ncAAs into 
proteins. (Left) In a first step, cells are transformed with plasmids harboring the orthogonal translation 
system (PylRS/tRNACUA pair) and the efp gene were at position 34 the natural codon is replaced by an 
amber stop codon. (Right) In the next step, these cells are cultured in a medium that contains the ncAA 
for incorporation. As a result, the ncAA is incorporated at the amber stop codon position 34 into the 
growing polypeptide chain by the PylRS/tRNACUA pair. 
 Introduction 
10 
Due to the high PylRS substrate promiscuity paired with engineering efforts of the 
catalytic pocket, it is nowadays possible to incorporate more than 150 different ncAAs 
with this system (Wan et al., 2014; Dumas et al., 2015). Among them are also 
numerous lysine derivatives which resemble the naturally occurring post-translational 
modified lysine variant (R)-β-lysyl-lysine of E. coli. As part of my master's thesis, 
several of these lysine derivatives (e.g. Nε-propionyl-, Nε-butyryl-, and Nε-crotonyl-
lysine) were already incorporated into E. coli EF-P. However, all of these EF-P variants 
lost their translational activity. 
Therefore, we asked whether (R)-β-lysyl-lysine can be incorporated directly into EF-P 
by means of orthogonal translation using an engineered PylRS (Chapter 2). If this 
would work, subsequent rational design of the catalytic pocket of this PylRS variant 
might even enable the incorporation of derivatives closely related to (R)-β-lysyl-lysine. 
Ultimately this would allow to draw conclusions regarding the chemical prerequisites 
of the EF-P modification that stimulates peptide bond formation between prolines. 
In addition, the expertise acquired during the master's thesis on the amber suppression 
system led to the idea of developing a toolbox which allows to control bacterial protein 
levels of even essential genes in vivo based on orthogonal translation. (Chapter 3). 
1.8.2 Strategy two: Non-cognate post-translational activation of E. coli 
EF-P 
As already mentioned, only two EF-P modification pathways in bacteria are completely 
understood. These pathways post-translationally modify EF-P, and thus fully 
functionalise it. This functionalisation is achieved in γ-proteobacteria like E. coli by 
(R)-β-lysylation and in β-proteobacteria like P. aeruginosa by rhamnosylation. Since 
the two modification strategies differ significantly from each other but the EF-Ps to be 
modified are structurally similar (Katz et al., 2014; Krafczyk et al., 2017) (Figure 7), we 
assumed that it might be possible to switch the EarP acceptor substrate specificity from 
P. aeruginosa EF-P to the non-cognate E. coli EF-P. This cross-modification of E. coli 
EF-P would then allow to draw conclusions about the chemical and structural 
requirements to rescue polyproline mediated ribosome stalling (Chapter 4). 
 
Figure 7: Comparison of EF-P structures from different bacteria. (Left) Crystal structure of E. coli 
EF-P (Yanagisawa et al., 2010) (PDB: 3A5Z). (Right) Crystal structure of P. aeruginosa EF-P (Choi and 
Choe, 2011) (PDB: 3OYY). For visualization, UCSF Chimera was used (Pettersen et al., 2004).
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Introduction 
Ribosome stalling occurs during the synthesis of proteins containing consecutive 
prolines, and is resolved in bacterial cells by the translation elongation factor EF-P 
(Doerfel et al., 2013; Ude et al., 2013). EF-P binds between the P- and E-sites of the 
ribosome and interacts from there with the CAA end of the peptidyl-tRNA. This 
interaction leads to a conformation of the polyproline-containing nascent peptide chain 
that promotes the formation of peptide bonds between prolines (Huter et al., 2017). 
However, in order to fully fulfil its function on the ribosome, EF-P has to be 
post-translationally modified. In bacteria like Escherichia coli, this modification is 
achieved by the attachment of a (R)-β-lysine moiety to a conserved lysine (K34) at the 
tip of domain I of EF-P, resulting in a (R)-β-lysylation of K34. ((Behshad et al., 2006; 
Bailly and de Crecy-Lagard, 2010; Navarre et al., 2010; Sumida et al., 2010; 
Yanagisawa et al., 2010)).  
Interestingly, the pyrrolysyl-tRNA synthetase (PylRS) allows to charge its cognate 
amber codon recognizing tRNACUA with numerous lysine derivatives (Dumas et al., 
2015) due to its high substrate promiscuity (Wan et al., 2014) and allowing thereby the 
incorporation of these derivatives into proteins. Based on this fact the idea arose to 
use the amber suppression system to incorporate site specifically (R)-β-lysyl-lysine 
into E. coli EF-P (EF-PEco) at position 34, and by that, activate EF-P in a 
post-translational independent manner. For this purpose (R)-β-lysyl-lysine was 
chemical synthesized and subsequently, the wild-type (wt) PylRS was tested for its 
ability to incorporate (R)-β-lysyl-lysine site specifically at position 34 into EF-PEco. 
In parallel, a screening system based on the swimming ability of E. coli was developed. 
This system allows to select for PylRS mutants capable of incorporating the lysine 
derivative of interest in a cheap and simple way. 
Results 
Incorporation of (R)-β-lysyl-lysine into EF-PEco 
Since the PylRS is known for its high substrate promiscuity (Yanagisawa et al., 2008b; 
Wan et al., 2014), we hypothesized that the amber suppression system based on the 
wt PylRS/tRNACUA pair might also be capable of incorporating (R)-β-lysyl-lysine into 
EF-PEco. To test this, we replaced the original lysine codon at position 34 of efpEco by 
an amber stop codon leading to the variant EF-PEco K34(Am). As a result, only 
wt PylRS/tRNACUA pair mediated incorporation of (R)-β-lysyl-lysine into this variant 
leads to the production of full-length EF-PEco. Furthermore, and since this synthetic 
variant harbor a C-terminal His6-tag, (R)-β-lysyl-lysine incorporation can be verified 
indirectly by Western Blot analysis using an Anti His6 antibody afterwards. 
In order to determine if the synthetic EF-PEco K34(Am) variant with incorporated 
(R)-β-lysyl-lysine is functional, experiments were performed in an E. coli reporter strain 
(Figure 8A). In this reporter strain, efp is chromosomally deleted (Δefp) and possesses 
an EF-P dependent lacZ activity. As a result, only EF-P in its post-translationally 
modified form leads to β-galactosidase activity whereas unmodified EF-P does not (for 
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more details see also (Ude et al., 2013)). Furthermore, not only (R)-β-lysyl-lysine was 
used for wt PylRS/tRNACUA pair mediated incorporation but also Nε-butyryl-lysine 
(Figure 8B). Nε-Butyryl-lysine is a substrate known to be accepted by the 
wt PylRS/tRNACUA pair (Gattner et al., 2013) and therefore served as a positive control 
for successful incorporation. 
  
Figure 8: Reporter strain for the detection of EF-P functionality and chemical structures of 
(R)-β-lysyl-lysine and Nε-butyryl-lysine. (A) Schematic illustration of the E. coli reporter strain used 
to detect EF-P functionality: The membrane integrated polyproline/diproline containing pH sensor CadC 
can only be produced in the presence of active (post-translationally modified) EF-P. If CadC is produced 
- and the cells were grown under mild acidic pH and in the presence of lysine - CadC binds to its promoter 
cadBA, which is fused to lacZ in this reporter strain. As a result, the lacZ expression and thereby 
β-galactosidase activity in this strain is dependent on post-translationally modified EF-P. (B) Chemical 
structures of (R)-β-lysyl-lysine and Nε-butyryl-lysine which are used in this study as substrates for the 
wt PylRS/tRNACUA pair. 
Our results show that, however, the wt PylRS/tRNACUA pair is not capable of 
incorporating (R)-β-lysyl-lysine into EF-PEco K34(Am) (Figure 9A). Furthermore, the 
functionality of post-translationally modified EF-PEco (Figure 9A and B, dark grey 
EF-PEco bars) was compared to that of other EF-PEco variants (Figure 9A and B) 
including unmodified EF-PEco (Figure 9B, light grey EF-PEco bar). In line with previous 
reports (Volkwein et al., 2019) the replacement of lysine by alanine (EF-PEco K34A) 
leads to a loss of functionality, while the replacement of lysine by arginine (EF-PEco 
K34R) restores functionality to a certain degree (Figure 9A and B). Interestingly, the 
EF-PEco K34(Am) Nε-butyryl-lysine variant shows also functionality in the Δefp reporter 
strain (Figure 9A). One possible explanation for this functionality could be that the 
butyryl moiety is cleaved of by sirtuins like CobB (Ringel et al., 2014), resulting in lysine 
at position 34 (K34) which can then be lysylated by EpmA again. To exclude this, 
experiments were additionally performed in the reporter strain background where efp 
and the modification enzyme epmA were deleted (Figure 9B, light grey bars). 
Additionally, this reporter strain allows to produce unmodified EF-PEco since epmA is 
deleted, and to compare its functionality with the EF-PEco K34(Am) Nε-butyryl-lysine 
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variant. The result was that the EF-PEco K34(Am) Nε-butyryl-lysine variant is indeed 
functional, but that its functionality is below the functionality of unmodified EF-PEco 
(Figure 9B, light grey EF-PEco bar), hence a synthetic translational activation with 
Nε-butyryl-lysine is not possible. Furthermore, these results show that unmodified 
EF-PEco, when overproduced, can rescue polyproline mediated ribosome stalling to a 
certain degree (Figure 9B) which is in line with previous reports (Volkwein et al., 2019).  
Figure 9: Translational activity of synthetic EF-PEco variants. (A) In vivo expression of different 
His6-tagged EF-PEco variants (EF-PEco, EF-PEco K34A, EF-PEco K34R, EF-PEco K34(Am)) in combination 
with the wt PylRS/tRNACUA pair in the reporter strain where efp is deleted (MG-CR-efp-KanS, Δefp). 
Cells were grown under cadBA-inducing conditions (LB, pH 5.8). Where indicated, 1 mM 
(R)-β-lysyl-lysine or 1 mM Nε-butyryl-lysine was added to the medium. EF-P production was verified by 
Western Blot analysis. β-Galactosidase activities are given in relative Miller units with EF-PEco in the 
Δefp background set to 100%. (B) In vivo expression of different EF-P variants (EF-PEco, EF-PEco K34A, 
EF-PEco K34R, EF-PEco K34(Am)) in combination with wt PylRS/tRNACUA pair in the described reporter 
strain. In the reporter strain, either efp (MG-CR-efp-KanS, dark grey bars, Δefp) or efp in combination 
with epmA (MG-CR-efp-epmA-KanR, light grey bars, Δefp ΔepmA) is deleted. Cells were grown under 
cadBA-inducing conditions (LB, pH 5.8). 1 mM Nε-Butyryl-lysine was added to the surrounding medium 
where indicated. EF-P production was verified by Western Blot analysis. β-Galactosidase activities are 
given in relative Miller units with EF-PEco in the Δefp background set to 100%. 
Development of a screening system based on E. coli FliC 
Based on the fact that the wt PylRS is not capable of incorporating (R)-β-lysyl-lysine 
into the growing polypeptide chain, the idea arose to evolve its substrate specificity 
towards (R)-β-lysyl-lysine. That it is indeed possible to evolve the PylRS towards a 
specific substrate has already been shown repeatedly (Wan et al., 2014). However, 
none of the described substrates so far resembled the chemical structure of 
(R)-β-lysyl-lysine. For this reason, a mutational screening was considered to be useful, 
and as a first step a new screening system should be developed and established based 
on the following idea: 
To swim, E. coli uses its peritrichous flagella on the cell surface, which are composed 
of many different proteins including the filament FliC (Berg, 2003). The replacement of 
a natural codon within the fliC gene by an amber stop codon would have the result that 
the protein production of FliC, and thereby the swimming motility, would depend on the 
amber suppression activity of the introduced PylRS mutant for a specific substrate. In 
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our case (R)-β-lysyl-lysine. As a consequence, only E. coli cells with the desired mutant 
capable of incorporating (R)-β-lysyl-lysine into FliC can produce FliC and are thereby 
able to swim while the others are not. These cells can then be easily identified and 
isolated on swimming plates. 
In a first step and in order to establish the described screening system in E. coli, fliC 
was interrupted in the E. coli MG1655 derivative C321.ΔA.exp (Lajoie et al., 2013). We 
decided to work with this strain because in its chromosome all 321 UAG (amber) stop 
codons have been replaced by UAA (ochre) stop codons. This permits the deletion of 
release factor 1, which in turn leads to improved properties for substrate incorporation 
mediated by the amber suppression system (Lajoie et al., 2013). 
Then, in a second step we used the generated strain with interrupted fliC (C321.ΔA.exp 
fliC::npt) in combination with a PylRS mutant which is capable of incorporating 
Nε-acetyl-lysine at the amber position into the growing polypeptide chain. This acetyl 
lysyl-tRNA synthetase (AcKRS) (Umehara et al., 2012) was chosen for the 
establishment of the screening system due to the following reasons: 
 First, it is capable of incorporating the commercially available and cheap 
substrate Nε-acetyl-lysine (Sigma-Aldrich) instead of the not commercially 
available substrate Nε-butyryl-lysine.  
 
 Second, the use of the AcKRS allows the production of unaltered FliC if a lysine 
codon is replaced by an amber stop codon. The reason for this is that after 
Nε-acetyl-lysine is incorporated, the acetyl group can be subject to cleavage by 
CobB (AbouElfetouh et al., 2015), resulting in unmodified native protein, which 
ensures in turn the full functionality of the produced FliC. 
To demonstrate the functionality of the screening system, the E. coli strains 
C321.ΔA.exp and C321.ΔA.exp fliC::npt were transformed with a plasmid encoding for 
the acetyl lysyl-tRNA synthetase/tRNACUA pair (AcKRST), FliC or FliC(Am), or a 
combination of these plasmids (Figure 10A). To determine the influence of these 
plasmid combinations on the swimming capability in response to Nε-acteyl-lysine, the 
cells were spotted on 0.3 % (w/v) swimming plates supplemented with (Figure 10B) or 
without (Figure 10C) Nε-acetyl-lysine. The swimming plates were then incubated for 24 
hours and subsequently pictures were taken. These pictures show that the swimming 
behavior of the stain C321.ΔA.exp is independent of the presence/absence of 
Nε-acetyl-lysine (Figure 10B and 10C, samples 1 to 6). The plates also show that the 
swimming capability is abolished when fliC is interrupted chromosomally in the strain 
C321.ΔA.exp fliC::npt (Figure 10B and 10C, samples 7). The plasmid encoding FliC(Am) 
alone has no influence on the swimming capability of the cells (Figure 10B and 10C 
samples 8 and 11). The swimming capability can be restored upon ectopic expression 
of FliC (Figure 10B and C, samples 9 and 10). Most interestingly, the expression of 
AcKRST in combination with FliC(Am) results in swimming capability only in the 
presence of Nε-acetyl-lysine (Figure 10B and C, samples 12 with red frame), proving 
the applied screening principle as correct. 
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Figure 10: Establishment of a screening system to detect successful substrate incorporation 
mediated by the amber suppression system. (A) Schematic overview of the different cultures spotted 
on the swimming plates. The cultures 1-6 correspond to E. coli C321.ΔA.exp, and the cultures 7-12 
correspond to E. coli C321.ΔA.exp fliC::npt cells, complemented where indicated with a plasmid 
encoding AcKRST, FliC, FliC(Am) or a combination of these plasmids. (B) Swimming capability of the in 
(A) described cultures on swimming plates supplemented with Nε-acetyl-lysine. (C) Swimming capability 
of the in (A) described cultures on swimming plates not supplemented with Nε-acetyl-lysine. The 
swimming capability was determined as described in the material and methods section. 
Concluding Remarks  
The here presented results demonstrate that the FliC-based screening system in 
principle can be used to identify new PylRS mutants with new substrate specificity. At 
this point, the next step would be to tested whether other components of the flagella 
are better suited for this purpose or not. Then, PylRS libraries have to be generated 
were residues of the binding pocket are randomized to change its substrate specificity 
towards (R)-β-lysyl-lysine. Which residues have to be mutated in order to achieve this 
remains speculation at this time point, because (R)-β-lysyl-lysine has a unique 
chemical structure compared to all other substrates accepted so far by the PylRS. A 
further aspect of uncertainty which has to be taken into account is the fact that it is not 
known if chemically synthesized (R)-β-lysyl-lysine is properly taken up into the cells or 
not. However, the here provided screening system can in principle also be applied to 
other substrates and provides a cheap and easy screening platform which can be used 
in nearly every lab. 
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Material and Methods 
All strains, plasmids and primers used in this study are listed in Tables 1 to 3. 
Strain construction 
The fliC gene in the E. coli strain C321.ΔA.exp (Lajoie et al., 2013) was deleted using 
pRed/ET recombination technology in accordance to the Quick & Easy E. coli Gene 
Deletion Kit (Gene Bridges, Germany), resulting in C321.ΔA.exp fliC::npt. The strain 
C321.ΔA.exp itself was a gift from George Church (Addgene plasmid # 49018). 
Plasmid construction 
The plasmid pBBR1MCS-5-NP-fliC was constructed as follows: The fliC gene was 
amplified from E. coli MG1655 using the primer pair P1/P2 and was ligated between 
the SacI and EcoRI restriction sites of pBBR1MCS-5 (Kovach et al., 1995). In a similar 
way the plasmid pBBR1MCS-5-NP-fliC K199(Amber) was generated, only with the 
difference that mismatched primer pairs (P1 to P4) were used for overlap extension 
PCR to replace the original lysine (K) codon of fliC at position 199 by an amber (TAG) 
codon.  
To replace the lysine codon at position 34 in efp in the construct pBBR1MCS-4-efpEco, 
a mismatched primer pair (P9/P10) in combination with primers for overlap-extension 
PCR (P11/P12) were used. The resulting fragment was then cloned into pBBR1MCS-4 
using the XbaI and BamHI restriction sites resulting in pBBR1MCS-4-efpEco 
K34(Amber). 
β-galactosidase assay 
β-Galactosidase activities in the E. coli Δefp (MG-CR-efp) and E. coli Δefp/ΔepmA 
(MG-CR-efp-epmA-KanR) reporter strain were determined as follows: Cells were 
grown over night at 37 °C under agitation and microaerobic conditions in 100 mM 
sodium-phosphate buffered Miller modified LB (pH 5.8) (Bertani, 1951; Miller, 1972). 
The next day, cells were harvested by centrifugation, and the β-galactosidase activities 
were determined as described (Tetsch et al., 2008) and are given in relative Miller units 
(MU) (Miller, 1992). 
SDS PAGE and Western Blot 
To visualize protein production of EF-P, proteins were separated by sodium dodecyl 
sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) according to Lämmli 
(Laemmli, 1970). Afterwards, proteins were transferred to a nitrocellulose membrane 
by vertical Western blotting. Fully produced EF-P was detected in a first step by a 
primary Anti-His6 antibody from rabbit (Abcam, Inc.). This primary antibody was then 
targeted by a secondary Anti-rabbit antibody with conjugated alkaline phosphatase 
(Rockland). To finally visualize EF-P presence on the nitrocellulose membrane, 0.01% 
(w/v) p-nitro blue tetrazolium chloride (NBT) and 0.045% (w/v) 5-bromo-4-chloro-3-
indolyl-phosphate disodium salt (BCIP) was dissolved in 50 mM sodium carbonate 
buffer (pH 9.5) and added to the membrane. 
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Swimming assay 
Cells were grown in Miller modified LB medium (Bertani, 1951; Miller, 1972) 
supplemented with 15 µg/mL gentamicin sulfate and 30 µg/mL chloramphenicol till an 
OD600 of 1.2. Then, 2 µL of these cultures were spotted on LB swimming plates 
containing 0.3% agar (w/v) supplemented with 15 µg/mL gentamicin sulfate, 30 μg/mL 
chloramphenicol and 5 mM Nε-acetyl-lysine where indicated. These plates were 
incubated over night at room temperature. The next day, the incubation temperature 
was shifted to 37°C, and the plates were incubated for additional 6 hours. Afterwards, 
pictures were taken. 
 
Synthesis of lysine derivatives 
(R)-β-Lysyl-lysine and Nε-butyryl-lysine were synthesized by the group of Thomas 
Carell from the Ludwig-Maximilians-Universität München.  
Table 1: Strains used in this study 
Strain Genotype Reference 
DH5αλpir  
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 ΔlacZYA-argF U169 ɸ80dlacZΔM15 λpir  
(Macinga et 
al., 1995) 
MG1655 F- λ- ilvG rfb50 rph-1 
(Blattner et al., 
1997) 
MG-CR-efp  
MG1655 ΔlacZ::tet rpsL150 efp::npt ΔcadBA 
PcadBA::lacZ  
(Lassak et al., 
2015) 
MG-CR-efp-epmA-
KanR  
MG1655 ΔlacZ::tet rpsL150 Δefp ΔcadBA 
epmA::npt PcadBA::lacZ  
(Volkwein et 
al., 2019) 
C321.ΔA.exp 
E. coli MG1655 Δ(ybhB-bioAB)::zeoR ΔprfA; all 
321 UAG codons changed to UAA 
(Lajoie et al., 
2013) 
C321.ΔA.exp fliC::npt 
E. coli MG1655 Δ(ybhB-bioAB)::zeoR ΔprfA; all 
321 UAG codons changed to UAA, fliC::npt 
this study 
 
Table 2: Plasmids used in this study 
Plasmid Feature Reference 
pRed/ET Amp  λ-RED recombinase in pBAD24; AmpR 
GeneBridges, 
Germany 
pBBR1MCS-4 Broad-host-range cloning vector, 5.0 kb, AmpR 
(Kovach et al., 
1995) 
pBBR1MCS-5 Broad-host-range cloning vector, 4.9 kb, GmR 
(Kovach et al., 
1995) 
pACYC-DUETTM-1 
Standard expression vector, ORI P15A, 4 kb, 
CamR 
Novagene 
pACYC-DUET-PylRST 
Contains the pyrrolysyl-tRNA synthetase 
(PylRS) / cognate amber suppressor tRNACUA 
(pylT) pair from M. mazei, 5.5 kb, CamR 
(Gattner et al., 
2013) 
pACYC-DUET-AcKRST 
Contains the acetyl lysyl-tRNA-synthetase 
(AcKRS), a mutated version of the PylRS from 
M. mazei towards Nε-acetyl-lysine specificity, 
according to (Umehara et al., 2012) and the 
cognate amber suppressor tRNACUA (pylT), 5.5 
kb, CamR 
(Volkwein et 
al., 2017) 
pBBR1MCS-5-NP-fliC 
Contains fliC from E. coli MG1655 fronted by 
its natural promoter, inserted into the SacI and 
EcoRI restriction sites of pBBR1MCS-5, GmR 
this study 
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pBBR1MCS-5-NP-fliC 
K199Amber 
Derivative from pBBR1MCS5-NP-fliC where 
additionally the lysine codon (AAA) at position 
199 was replaced by an amber stop codon 
(TAG), GmR 
this study 
pBBR1MCS-4-efpEco 
Contains efp from E. coli fronted by its natural 
promoter, AmpR 
Jürgen Lassak 
(unpublished) 
pBBR1MCS-4-efpEco 
K34A 
Derivative from pBBR1 MCS4-efpEco where 
additionally the lysine codon (AAA) at position 
34 was replaced by an alanine codon (GCG), 
AmpR 
Jürgen Lassak 
(unpublished) 
pBBR1MCS-4-efpEco 
K34R 
Derivative from pBBR1 MCS4-efpEco where 
additionally the lysine codon (AAA) at position 
34 was replaced by an arginine codon (AGG), 
AmpR 
Jürgen Lassak 
(unpublished) 
pBBR1MCS-4-efpEco 
K34(Amber) 
Derivative from pBBR1 MCS4-efpEco where 
additionally the lysine codon (AAA) at position 
34 was replaced by an amber stop codon 
(TAG), AmpR 
Wolfram 
Volkwein 
(unpublished) 
AmpR, CamR, and GmR are ampicillin, chloramphenicol and gentamycin resistance, respectively. 
Table 3: Primers used in this study 
Identifier Oligonucleotide Sequence (5' - 3')  Restriction 
site 
P1 SacI-NP-fliC 
CGC GAG CTC GCG ATT TCC TTT 
TAT CTT TCG ACA CG 
SacI 
P2 EcoRI-NP-fliC 
CGC TCG AAT TCT TAA CCC TGC 
AGC AGA GAC AGA AC 
EcoRI 
P3 fliC-K199Amber-Fw 
CCA CAA ACA ATA TTT AGC TTA 
CTG GAA TTA CC 
 
P4 fliC-K199Amber-Rev 
GGT AAT TCC AGT AAG CTA AAT 
ATT GTT TGT GG 
 
P5 fliC-ET-Fw 
GGT GGA AAC CCA ATA CGT AAT 
CAA CGA CTT GCA ATA TAG GAT 
AAC GAA TCA ATT AAC CCT CAC 
TAA AGG GCG 
 
P6 fliC-ET-Rev 
ATC AGG CAA TTT GGC GTT GCC 
GTC AGT CTC AGT TAA TCA GGT 
TAC AAC GAT AAT ACG ACT CAC 
TAT AGG GCT C 
 
P7 fliC-chk-Fw GAT AAC AGG GTT GAC GGC GAT TG  
P8 fliC-chk-Rev 
CTT ATC CGG CCT ACA AAA ATG 
TGC 
 
P9 
efp-K34(Amber)-OL-
Fw  
GTA AAA CCG GGT TAG GGC CAG 
GCA TTT 
 
P10 
efp-K34(Amber)-OL-
Rev 
AAA TGC CTG GCC CTA ACC CGG 
TTT TAC 
 
P11 XbaI-NP-efp-Fw 
AGT CTA GAA TGC GCA GCA ACA 
TAC TCA AGT G 
XbaI 
P12 
BamHI-efp-GS-His6-
Rev 
CAG CGG ATC CAC TAG TTC TAG 
ATT AGT GAT GGT GAT GGT GAT 
GGC TGC CCT TCA CGC GAG AGA 
CGT ATT CAC C 
BamHI 
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ABSTRACT: The analysis of the function of essential genes in
vivo depends on the ability to experimentally modulate levels of
their protein products. Current methods to address this are
based on transcriptional or post-transcriptional regulation of
mRNAs, but approaches based on the exploitation of translation
regulation have so far been neglected. Here we describe a
toolbox, based on amber suppression in the presence of Nε-
acetyl-L-lysine (AcK), for translational tuning of protein output.
We chose the highly sensitive luminescence system LuxCDABE
as a reporter and incorporated a UAG stop codon into the gene
for the reductase subunit LuxC. The system was used to
measure and compare the effects of AcK- and Nε-(tert-
butoxycarbonyl)-L-lysine (BocK) dependent amber suppression in Escherichia coli. We also demonstrate here that, in
combination with transcriptional regulation, the system allows protein production to be either totally repressed or gradually
adjusted. To identify sequence motifs that provide improved translational regulation, we varied the sequence context of the
amber codon and found that insertion of two preceding prolines drastically decreases luminescence. In addition, using LacZ as a
reporter, we demonstrated that a strain encoding a variant with a Pro-Pro amber motif can only grow on lactose when AcK is
supplied, thus confirming the tight translational regulation of protein output. In parallel, we constructed an E. coli strain that
carries an isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible version of the AcK-tRNA synthetase (AcKRS) gene on the
chromosome, thus preventing mischarging of noncognate substrates. Subsequently, a diaminopimelic acid auxotrophic mutant
(ΔdapA) was generated demonstrating the potential of this strain in regulating essential gene products. Furthermore, we
assembled a set of vectors based on the broad-host-range pBBR ori that enable the AcK-dependent amber suppression system to
control protein output not only in E. coli, but also in Salmonella enterica and Vibrio cholerae.
KEYWORDS: translational regulation, gene silencing, PylRS, Salmonella enterica, Vibrio cholerae, genetic screen
M ost gene silencing strategies target gene expression at thelevel of transcription by exploiting the activity of
transcriptional regulators, e.g., TetR,1 LacI2 or the CRISPRi
system.3 Alternatively, gene expression can be tightly regulated
post-transcriptionally by the use of, e.g., microRNAs or small
interfering RNAs.4 Here, we show that translational regulation
can also be employed to sensitively adjust protein levels.
Canonically, 20 different amino acids can be utilized for
polypeptide synthesis by the translational apparatus. However,
the genetic code can be translationally expanded to direct the
incorporation of two natural but noncanonical amino acids
(ncAAs), namely selenocysteine (Sec)8 and pyrrolysine (Pyl).9
Both Sec-tRNA and Pyl-tRNA recognize codonsUGA and
UAG, respectivelythat are usually reserved for translation
termination. Whereas Sec is found in a variety of proteins in all
domains of life,10,11 Pyl is restricted to a small number of
proteins in a few archaeal and bacterial species.12 In
methanogenic archaea such as Methanosarcina barkeri, the
pyrrolysyl tRNA-synthetase (PylRS) charges its cognate
tRNACUA (encoded by pylT) (Figure 1A) to suppress the
amber stop codon UAG.13 Due to its substrate promiscuity and
its narrow distribution, PylRS has become a powerful means of
expanding the genetic code to include synthetic ncAAs.14
Today, over 150 substrates can be incorporated into proteins
by means of amber suppression.15,16 This in turn has enabled
researchers not only to investigate post-translational modifica-
tions,17 but also to introduce fluorescent labels,18 and ultimately
allows one to engineer proteins with modified functions. In
2015 Rovner et al. introduced the orthogonal translation system
consisting of an aminoacyl-tRNA synthetase and its cognate
UAG-reading tRNA from Methanococcus janaschii, which is
optimized for the incorporation of p-acetyl-L-phenylalanine,
into an E. coliMG1655 derivative.19 With this strain, they found
that three amber mutations, one in each of the open reading
frames of the essential genes murG, dnaA and serS, can be
rescued by an external supply of 4-acetyl-L-phenylalanine.
Along the same line Yusuke Kato and co-workers demonstrated
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the tunable translational control using site-specific 3-iodo-L-
tyrosine incorporation in Escherichia coli.20,21 Thus, the amber
suppression system can be used to efficiently deplete essential
gene products at the translational level.
In the present study we describe the assembly of a versatile
toolbox for control of protein levels in diverse bacterial species
using Nε-acetyl-L-lysine (AcK)-dependent amber suppression.
■ RESULTS AND DISCUSSION
Selection of Nε-Acetyl-L-lysine for Amber Suppres-
sion. Our study began with the selection of a suitable substrate
to be incorporated by PylRS-mediated amber suppression. We
chose Nε-acetyl-L-lysine (AcK) for this purpose because an
evolved variant of PylRS has been reported to charge tRNACUA
with AcK,7,22 and AcK occurs frequently in bacterial proteins as
a product of the post-translational modification of the ε-amino
group of lysine residues.23−26 Lysine acetylation can be
catalyzed by protein acetylases such as YfiQ (PatZ) in
E. coli,27 but can also result from a nonenzymatic reaction
with acetyl phosphate.24,26 Note that protein acetylation is not a
permanent modification, but can be reversed by deacetylases,
e.g., CobB, in bacteria.27 This would allow the production of an
unaltered protein when a native lysine codon is replaced by
UAG and read by AcK-dependent amber suppression.22,28
Apart from the fact that AcK is found naturally in proteins, it
has no effect on bacterial growth (Supplementary Figure S1), is
commercially available and is relatively cheap. For example,
supplementing 1 L of culture medium with 1 mM AcK costs
around 5€, and is thus about as expensive as IPTG. Taken
together, these considerations make AcK an ideal substrate. We
used the previously described PylRST expression system from
Methanosarcina mazei29 and introduced the mutations reported
by Umehara et al.7 to render the enzyme specific for AcK,
resulting in the Nε-acetyl lysyl-tRNA synthetase/tRNACUA pair
(AcKRST) (Figure 1B).
Development of a Luminescence-Based Amber
Suppression Reporter. Amber suppression is conventionally
quantified using either green fluorescent protein (GFP)30 or β-
galactosidase (LacZ)7 as the reporter. We decided to use
luminescence as the readout, and chose the system based on
expression of the luxCDABE operon from Photorhabdus
luminescens (Lux) (Figure 2A, B). In this system luxA and
luxB encode the α- and β-subunits of the luciferase heterodimer
(Figure 2A), while the reductase, transferase and synthase
specified by LuxC, D and E, respectively, together form the
complex that synthesizes and regenerates the myristyl aldehyde
substrate required for the bioluminescent reaction (Figure
2A).31,32 The Lux system is highly sensitive and allows one to
quantify amber suppression in living cells in real time.33
To make luminescence development not only dependent on
amber suppression but also tunable at the transcriptional level
we cloned the luxCDABE cassette into pBAD/HisA, placing it
under the control of the L-arabinose (Ara)-inducible promoter
PBAD. The stop sequence TAG was inserted at position 3 in the
luxC gene (Figure 2B)
We note that alterations at the 5′ end of coding sequences
might affect translation efficiency due to changes in mRNA
folding34−36 and accordingly one should be careful when
inserting TAG here. On the other hand, the region close to the
protein start site often lacks structural features important for
protein function and therefore tolerates manipulation without
perturbation of functionality. In the case of LuxC, secondary
structure prediction did not identify any α-helix or β-sheet in
the first six amino acids and thus giving first hint for a tolerance
toward insertions. Furthermore, there is relative low sequence
conservation in this region and some LuxC homologues even
have N-terminal extensions, e.g., LuxC of Photobacterium
phosphoreum altogether indicating this region to be suitable
for TAG insertion.
We analyzed Lux-amber reporter (LuxAm) activity in E. coli
BW25113 which, in addition to pBAD/HisA-Lux(Am), harbors
the vector pACYCDuet-AcKRST that codes for AcKRS and its
cognate tRNACUA (Figure 1B, 2C, Table 1). We grew the cells
in LB and supplemented the medium with either 0.2% Ara, 1
Figure 1. PylRS and AcKRS based amber suppression. (A) The pyrrolysyl-tRNA synthetase (PylRS) of Methanosarcina mazei loads its natural
substrate pyrrolysine onto its cognate suppressor tRNACUA (encoded by pylT). The six amino acids that form the pyrrole ring binding pocket are
indicated.5,6 (B) Acetyl lysyl-tRNA synthetase (AcKRS), a PylRS variant bearing the highlighted amino acids at positions 301, 306, 309 and 348,
which enable it to interact specifically with Nε-acetyl-L-lysine (AcK).7
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mM AcK or both compounds together (Figure 2C). The Lux
reporter plasmid pBAD/HisA-Lux, in which the wildtype luxC
ORF was unchanged, served as a positive control (Lux+). The
maximal luminescence was determined and is given in relative
light units (RLU). As expected, cells harboring pBAD/HisA-
Lux produced light after induction with 0.2% Ara, irrespective
of the presence or absence of AcK (Figure 2C). In contrast, in
LuxAm-expressing E. coli cells, luminescence was best stimulated
by a combination of the two substances. However, under Ara-
inducing conditions, we detected significant light emission (1 ×
106 RLU) even in the absence of AcK. This result can be
explained by translational read-through mediated by binding of
near-cognate tRNAs37 or by misaminoacylation of tRNACUA.
38
Strikingly, while Lux+-harboring cells showed a certain degree
of light production in the absence of Ara, the LuxAm-containing
cells remained completely dark (Figure 2C). Thus, the
combination of transcriptional and translational control
completely abolishes protein output, in line with an earlier
report.19
In the next step we systematically varied both the
concentration of Ara and AcK and compared the luminescence
of LuxAm with Lux+ cells (Figure 2D, Supplementary Figure
S2). As before, light production by the Lux+ strain was
essentially unaffected by increasing concentrations of AcK
(Supplementary Figure S2), and reached a maximum when the
growth medium contained ≥0.02% Ara (Figure 2C, Supple-
mentary Figure S2). In contrast, luminescence in the LuxAm
strain responds to the increasing presence of AcK, which allows
for adjustment of the light output over a range that extends
from “below detection” (blue) to more than 3.8 × 106 RLUs
(green), corresponding to 41% of the maximal light intensity
that we could measure with Lux+ (Figure 2C, D, Supplementary
Figure S2).
Additionally, we used the LuxAm luminescence reporter to
investigate the potential of Nε-(tert-butoxycarbonyl)-L-lysine
(BocK) as alternative substrate for translational protein level
control. BocK can be incorporated into the genetic code
employing the wildtype PylRST.39 Like AcK, BocK is
commercially available and comparably cheap. In contrast to
AcKRS, PylRS is not promiscuous to charge tRNACUA with
natural amino acids,7,40 and thus we were curious to compare
the two aminoacyl-tRNA-synthetases in our test system with
respect to misacylation and amber suppression efficiency. To
this end we transformed E. coli BW25113 cells harboring
pBAD/HisA-Lux(Am) in combination with pACYCDuet-
PylRST,29 pACYCDuet-AcKRST or the empty vector
pACYCDuet-1, respectively, in order to discriminate between
misacylation and translational read through. Subsequently, light
production was analyzed in the resulting strains in the presence
of 0.2% Ara with and without the supplement of 10 mM BocK
and AcK, respectively (Supplementary Figure S3). Independent
of PylRS and AcKRS we measured a base level luminescence of
about 2.0 × 105 RLU. This value further increased in cells
harboring pACYCDuet-AcKRST to about 5.0 × 105 RLU
without the addition of AcK, indicating mischarging of
tRNACUA by endogenously available noncognate substrates.
By contrast, in cells bearing pACYCDuet-PylRST we did not
observe such an increase in luminescence clearly showing, that
natural amino acids are not recognized by PylRS. Therefore,
BocK might be a good alternative to AcKRS in order to control
protein output translationally. Note that the BocK supplement
resulted in an approximately 5-fold increase in luminescence in
cells expressing pylRS/pylT. This was slightly (1.0 × 106 RLU)
lower compared to the maximal value measured with AcKRST.
Thus, and similar to AcK dependent amber suppression, the
translational regulation with BocK/PylRST allows a tight
Figure 2. A luminescence-based amber suppression bioreporter (A) Basic principle of the luminescence system (Lux) from Photorhabdus luminescens.
The lux genes are organized in the luxCDABE operon, which encodes the multienzyme complex LuxCDE and the luciferase heterodimer LuxAB.
These two orchestrate substrate synthesis/regeneration of myristyl aldehyde and generate luminescence, respectively. (B) The LuxAm luminescence
reporter: The luxCDABE operon of P. luminescens was placed under the control of the Ara-inducible promoter PBAD, and the third codon of the open
reading frame of luxC was replaced by an amber stop codon, resulting in the Lux-amber reporter (LuxAm). (C) Luminescence production of LuxAm in
E. coli BW25113. A construct in which the wildtype luxC ORF was left unaltered was used as a positive control (Lux+): Cells harboring the
corresponding Lux reporter plasmid in combination with pACYCDuet-AcKRST, which codes for the AcKRS and its cognate tRNACUA, were grown
in LB overnight and luminescence production was monitored in response to Ara and/or AcK, and is given in relative light units (RLU). Error bars
represent the standard deviation of data from three different experiments. (D) Parameter optimization for Lux+- and LuxAm-encoding E. coli strains.
Ara and AcK concentrations were varied and maximal luminescence was determined. The resulting luminescence values ranged from “below
detection” (0) RLU (blue) to 9.0 × 106 RLU (yellow).
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protein output control when combined with inducible gene
expression.
Adjustment of the Amber Codon Context Permits
Modulation of Protein Output. In the preceding section we
showed that the LuxAm strain produces significant levels of
luminescence even in the absence of the cognate AcKRS
substrate AcK (Figure 2C), which prompted us to ask whether
an additional amber codon in the reporter gene might eliminate
this background signal. Indeed, the introduction of a second
TAG into luxC completely abolished light production, despite
supplementation with AcK (Table 1). This implies that the
second amber codon brings translation of luxC to a halt. We
therefore undertook further engineering to enable suppression
to compete with termination.41,42
It is known that the context of an internal stop codon can
have a huge impact on translational readthrough.43,44 This led
us to analyze the influence of sequence motifs known to have
significant effects on amber suppression. AcK incorporation
into the nascent chain competes with translational termination
mediated by the release factor RF1. This competition is
reflected by the fact that even at saturating AcK concentrations
the luminescence of LuxAm cells does not reach the level
observed in the Lux+ E. coli strain (Figure 2C). However, the
efficiency of recognition of the amber stop codon by RF1 is
modulated by the base that follows it. While in E. coli a 3′ uracil
best ensures termination, amber suppression is favored by a
neighboring adenine.45,46 The threonine sense codon ACU that
follows the UAG in the LuxAm reporter should therefore
promote suppression and was left intact. Accordingly, we
focused on the sequence context 5′ to the amber codon.
Although the codon directly upstream of the stop site is of
importance,47 in 1994 Mottagui-Tabar and co-workers found
that the penultimate codon has a major influence on
termination in E. coli.43 In that study, the authors described a
hierarchy of suppression, with arginine codons in this position
showing the lowest and aspartate codons stimulating the
highest suppression efficiency when UGA was the stop codon.
On the basis of these findings, we decided to investigate the
influence of R−2 A−1 and D−2 A−1 on amber suppression. We
also included H−2 H−1, a context motif that was identified in a
screen for efficient incorporation of ncAAs.44 Moreover, we
chose K−3 D−2 P−1 and P−2 P−1, as well as a combination of the
two (K−4 D−3 P−2 P1), to precede the stop site. These sequence
contexts are known to cause ribosome stalling and should thus
interfere with translation termination.48−50
All LuxAm variants were constructed essentially as depicted in
Figure 2B, by insertion of the motif after Gly2 in the luxC gene.
Luminescence was measured under PBAD-inducing conditions as
described above, and in the presence and absence of 1 mM
AcK, respectively (Table 1).
As before (Figure 2C), the strain containing the LuxAm
reporter construct produced a maximal level of luminescence
of about 2.4 × 106 RLU upon supplementation with AcK. This
is a 3.5-fold increase relative to cells that were grown without
AcK. In comparison, the maximal light intensities emitted by
Lux-RA(Am) and Lux-DA(Am) cells grown in the presence of
AcK were 3.4 × 106 and 5.0 × 105 RLU, respectively, and
differed significantly from each other. This might be explained
by altered luxC expression, as regulatory elements are located
within the first 50 codons.51 Regardless of these differences, the
relative increases in luminescence in the presence of AcK were
comparable, at 3.7-fold for LuxRA(Am) and 2.6-fold for
LuxDA(Am). Mottagui-Tabar et al. showed that, in principle,
arginine and aspartate in the second last position to UAG
follow the same rules as when UGA is the stop codon, but that
the effect with UAG was less pronounced.43 This latter factor
may account for the small differences in light production seen
between amber-suppressed LuxRA(Am) and LuxDA(Am).
In agreement with the findings of Pott et al., we observed
increased luminescence for LuxHH(Am) compared to the original
LuxAm bioreporter.44 However, this is largely attributable to
increased translational read-through, as indicated by the
increase in light production seen in the absence of AcK
(Table 1). The analysis of amber context motifs that promote
ribosome stallingKDP, PP and KDPPrevealed a strong
decrease in luminescence, which was unaffected by the presence
of AcK. This decrease is presumably the result of the
recruitment of ribosome rescue systems, such as tmRNA,
which ultimately lead to abortion of translation.49 Of the three
arrest motifs tested, only the PP motif present in the LuxPP(Am)
reporter had a significant effect on amber suppression. In this
case, the addition of AcK to the growth medium was correlated
with an increase of >6-fold in luminescencethe highest
relative change observed with any of the motifs tested. Thus, a
diprolyl amber context would appear to be especially beneficial
in experiments where coupling with transcriptional regulation
must be avoided.
A Diproline Amber Context Allows Tight Regulation
of β-Galactosidase Protein Levels. We next tested whether
the integration of an amber stop codon into the bacterial
chromosome might allow for tighter regulation of protein
production in E. coli. For these experiments, we chose the β-
galactosidase LacZ, which cleaves the disaccharide lactose into
D-galactose and D-glucose. This enzyme is essential for growth
of E. coli cells on lactose as sole carbon source. We constructed
two E. coli strains, bearing either an Am (TAG) or a PP(Am)
(CCG CCG TAG) insertion after the ninth codon in the lacZ
Table 1. Influence of the 5′ Amber Context on
Luminescence Productiona
motif AcK (1 mM) mean × 103/SD × 103 (RLU)
Lux+ − 7165 ± 392
Lux+ + 7252 ± 486
LuxAm − 689 ± 26
LuxAm + 2406 ± 77
Lux2Am − 0
Lux2Am + 0
LuxRA(Am) − 919 ± 68
LuxRA(Am) + 3400 ± 22
LuxDA(Am) − 194 ± 33
LuxDA(Am) + 496 ± 51
LuxHH(Am) − 1434 ± 21
LuxHH(Am) + 3717 ± 633
LuxKDP(Am) − 20 ± 5
LuxKDP(Am) + 35 ± 26
LuxPP(Am) − 112 ± 35
LuxPP(Am) + 691 ± 72
LuxKDPP(Am) − 3 ± 3
LuxKDPP(Am) + 78 ± 7
aCells harboring the corresponding Lux reporter plasmid in
combination with pACYCDuet-AcKRST were grown in LB
supplemented with 0.2% L-arabinose overnight and luminescence
production was monitored in response to AcK and is given in relative
light units (RLU).
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coding sequence (Figure 3A). Similar to LuxC, our decision for
the insertion position was based on a lack of structural elements
as well as comparatively low sequence conservation in the first
ten N-terminal amino acids of LacZ.54 In addition to the
resulting strains LF1-LacZ(Am) and LF1-LacZ-PP(Am) and to
further exclude any effects on protein activity we engineered
two strains containing a lysine codon instead of TAG for use as
positive controls (LF1-LacZ-K and LF1-LacZ-PPK). These two
strains were compared with wildtype MG1655 cells and found
to be phenotypically indistinguishable with respect to both
growth on lactose and β-galactosidase activity (data not
shown). By contrast, both LF1-LacZ(Am) and LF1-LacZ-
PP(Am) exhibited strongly diminished LacZ production
(Figure 3B). Moreover, whereas β-galactosidase activity was
still detectable in LF1-LacZ(Am) in the absence of AcK (141
MU; MU = Miller Units), only background levels (55 MU)
were measured in strain LF1-LacZ-PP(Am). As expected,
addition of 1 mM AcK to the medium increased LacZ
production in both cases, to 468 MU (LF1-LacZ(Am)) and
111 MU (LF1-LacZ-PP(Am)), respectively. In agreement with
our previous finding for the luminescence reporter LuxPP(Am),
the PP(Am) context resulted in a more pronounced decrease in
translational output, confirming that it further reduces leakiness
in the system. The virtually complete abrogation of LacZ
production is further illustrated by the fact that the color
change from white to blue of E. coli colonies encoding LacZ-
PP(Am) is strictly dependent on AcK (Figure 3C). In contrast,
the LF1-LacZ(Am) strain turns blue when grown on LB/X-Gal
agar plates containing the lacZ inducer IPTG (Figure 3C).
Furthermore, LF1-LacZ-PP(Am) containing AcKRST was only
able to grow on lactose when AcK was concomitantly supplied,
while the residual β-galactosidase activity in LF1-LacZ(Am)
cells (Figure 3B) was sufficient to promote growth even in the
absence of AcK (Figure 3D). Thus, these data further
corroborate our findings with the Lux reporters (Figure 2C,
D; Table 1).
The ability to tightly control LacZ synthesis in this way
demonstrates the potential of our system for AcK-dependent
translational regulation of essential genes with a specific amber
context.
Chromosomal Integration of AcKRS Enhances Regu-
lated Amber Suppression. Having shown that amber
suppression is a potent molecular tool for the regulation of
translational output, we set out to engineer E. coli in such a way
that it can serve as a host for investigation of the function of
essential genes in an AcK-dependent manner. In a previous
publication we reported the construction of a strain named
LF1, into which we had inserted a kanamycin resistance
cassette and a wildtype copy of rpsL (conferring streptomycin
sensitivity) into the lac locus.55
The two genes are flanked by FRT sites that mediate Red/
ET (Gene Bridges) recombination, which permits scarless
insertion of any DNA sequence of interest within 1 day. We
used this method to integrate pylS*/pylT into the LF1 strain.
While pylS was set under the control of Plac, pylT (tRNACUA)
expression was kept constitutively expressed employing PproK.
The genomic context of the resultant insert in the new strain
LF1-AcKRST is depicted in Figure 4A. To test amber
suppression in E. coli LF1-AcKRST, the cells were transformed
with pBAD/HisA-Lux(Am), and luminescence was monitored
in response to the external supply of IPTG and AcK. As
expected, no luminescence was detectable in the absence of
both substances. Similarly, supplementation with 1 mM AcK
alone did not lead to any measurable light production, while
addition of IPTG to the medium on its own resulted in only
very weak luminescence of approximately 1.0 × 104 RLU. In
stark contrast, the simultaneous presence of AcK and IPTG
Figure 3. Regulation of LacZ levels in E. coli by amber suppression.
(A) Genetic organization of the lacZ gene in E. coli LF1-LacZ strains.
E. coli LF1 strains were constructed by inserting either an amber (LF1-
LacZ(Am)) or PP amber sequence (LF1-LacZ-PP(Am)) after the
ninth codon of the lacZ gene. Corresponding lysine codon insertions
served as positive controlsLF1-LacZ-K and LF1-LacZ-PPK,
respectively. (B) Quantitative analysis of amber suppression of β-
galactosidase LacZ. To measure the β-galactosidase activity, cells were
grown in LB overnight and reporter activity was determined according
to Miller,52 in the presence/absence of the amber suppression
machinery (AcKRST). Cells were incubated with IPTG, AcK or a
combination of both substances. The activity is given in Miller Units
(MU). (C) Qualitative analysis of amber suppression of LacZ. E. coli
LF1 strains described in (A) were grown on LB agar supplemented
with 80 μM X-Gal, 1 mM IPTG and 1 mM AcK as indicated. (D)
Growth analysis of E. coli LF1 strains with lactose as sole carbon
source. LF1 strains with and without AcKRST were grown in M9
minimal medium53 supplemented with 20 mM lactose in the
presence/absence of 1 mM AcK in microtiter plates.
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increased the light intensity to about 3.7 × 105 RLU. Thus, the
E. coli strain LF1-AcKRST provides an on/off switch for the
production of specific proteins. It should be noted that 0.2%
Ara was always added to the medium, so that the luxCDABE
operon was fully induced under all conditions tested. Recall
that when pylS*/pylT was provided in trans (pACYCDuet-
AcKRST) significant luminescence was observed in the absence
of AcK (Figure 2C). Thus, the reduction in pylS*/pylT copy
number from about 20−30 in the plasmid-based system56 to
one in the chromosome almost completely abolishes
mischarging of tRNACUA. Furthermore, the coupling of
chromosomal integration of the amber suppression machinery
(AcKRST) with IPTG-inducible expression of pylS* eliminates
the physiological burden that goes along with the constitutive
expression of orthogonal tRNAs and aminoacyl tRNA
synthetases57 (Supplementary Figure S4).
To proof functionality of the parental strain E. coli LF1-
AcKRST in regulating the expression of essential gene
products, we aimed to generate a mutant with a defect in cell
wall biosynthesis. For this purpose, we chose the gene encoding
dihydrodipicolinate synthase DapA, being crucial for the
generation of meso diaminopimelic acid (DAP).58 Accordingly,
a dapA deletion causes DAP auxotrophy. To this end the E. coli
strain LF1-AcKRST/dapA:camr was generated using Red/ET
(Gene Bridges) recombination. As expected LF1-AcKRST/
dapA:camr (DAP−) can only grow in LB supplemented with as
little as 75 μM DAP (Supplementary Figure S5).
To trace the observed auxotrophy back to the deletion of
dapA we constructed a plasmid pBAD/HisA-dapA coding for
an N-terminal His6-tagged copy of DapA. Ectopic expression of
His6-DapA in LF1-AcKRST/dapA:cam
r permitted growth in
the absence of DAP after induction with 0.2% Ara (Figure 5A).
Beside the fact, that this result clearly links the observed
phenotype to the gene deletion, it also demonstrates that the
N-terminal extension of the protein sequence does not interfere
with the enzymatic activity of DapA. Consequently, a plasmid
pBAD/HisA-dapA(Am) was derived from pBAD/HisA-dapA.
This daughter plasmid deviates from the parental only by an
amber motif as a third codon in the original dapA ORF which
in turn follows a 39 amino acids (aa) long N-terminal extension
encoded in the pBAD/HisA backbone.
We investigated the power of coupled transcriptional and
translational regulation by controlling the growth of the DAP−
Figure 4. E. coli LF1-AcKRST. (A) Genetic organization of the E. coli
strain LF1-AcKRST. Nε-acetyl lysyl-tRNA-synthetase (pylS*) was
cloned under the control of the IPTG-inducible lac promoter (Plac),
while the cognate tRNACUA (pylT) was placed under the control of the
constitutive promoter PproK. (B) AcK-dependent amber suppression in
E. coli LF1-AcKRST. Cells were transformed with the Lux-amber
reporter (LuxAm). The resulting strains were then grown overnight in
LB, and luminescence development was recorded in response to IPTG
and AcK. The maximal luminescence normalized to the OD600 from a
16 h time course experiment is depicted. Error bars represent the
standard deviation of data from three different experiments.
Figure 5. Transcriptional and translational control of DAP auxotrophy. Growth analysis of the LF1-AcKRST/dapA:camr strain harboring the pBAD/
HisA-dapA or pBAD/HisA-dapA(Am) plasmid. Cells were grown in a microtiter plate over a time course of 22h in LB with the indicated
supplements. Afterwards pictures of the bacterial cultures were taken. (A) Growth curve and picture of the LF1-AcKRST/dapA:camr strain harboring
a plasmid borne copy of dapA (pBAD/HisA-dapA), or the empty vector e.v. (pBAD/HisA) as negative control, in response to 0.2% (w/v) L-
arabinose (Ara), 0.2% (w/v) D-glucose (Gluc) or 75 μM diaminopimelic acid (DAP). Ara and DAP growth curves are depicted as triplicates, Gluc
growth curves are depicted as single measurements. (B) Growth curve and picture of the LF1-AcKRST/dapA:camr strain harboring the empty vector
(e.v.) as negative control or pBAD/HisA-dapA(Am) (DapAAm) containing a plasmid borne copy of DapA with an inserted amber codon, in response
to Ara, DAP, Gluc, Nε-acetyl-L-lysine (AcK) and isopropyl β-D-1-thiogalactopyranoside (IPTG) as indicated. Error bars in the growth curve represent
the standard deviation of data from three different experiments.
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strain in the presence of a plasmid borne gene copy. Therefore,
the E. coli DAP− strain LF1-AcKRST/dapA:camr was trans-
formed with pBAD/HisA-dapA and pBAD/HisA-dapA(Am),
respectively and cells were initially cultivated overnight in LB
supplemented with 75 μM DAP. The next day cells were
inoculated into LB + 0.2% D-glucose (Gluc) (to catabolically
repress PBAD induction), LB + 75 μM DAP and LB + 0.2% Ara
(to induce PBAD induction). Growth of the strain harboring the
pBAD/HisA-dapA(Am) was additionally monitored in LB + 1
mM IPTG (to induce expression of Plac regulated AckRS), in
LB + 1 mM IPTG + 1 mM AcK (to allow Amber suppression)
and ultimately in LB containing a combination of all three
components (0.2% Ara, 1 mM IPTG and 1 mM AcK) (Figure
5B). As expected, this coupling of AcK dependent amber
suppression with Ara induced transcriptional activation
permitted growth in the absence of DAP. Notably, growth
behavior of cells cultivated with 0.2% L-Ara, 1 mM IPTG and 1
mM AcK was beside a short lag-phase almost identical to what
we observed for cells that were supplemented with 75 μM of
DAP (Figure 5B). On the other hand, we could not detect an
increase in OD600 in the cultures lacking either DAP or 0.2%
Ara. However, the sole addition of Ara was sufficient to
promote overnight growth of LF1-AcKRST/dapA:camr with
pBAD/HisA-dapA(Am). Compared to cultures containing all
three supplements (Ara, IPTG and AcK) we observed an
extended lag phase and even an initial drop in the starting
OD600 (Figure 5B). The latter might be explained by cell lysis
due to instability of the bacterial cell wall, whereas the first 10 h
without any significant change in OD600 indicates the
development of a suppressor mutation that promotes growth
even under translationally repressing conditions. Similar results
were observed when monitoring the growth of cells containing
pBAD/HisA-dapA in which PBAD dependent gene expression
was catabolically repressed59 (+0.2% Gluc) (Figure 5A).
Thus, the coupling of transcriptional and translational
regulation does not only allow a tunable protein output over
several orders of magnitude but also prevents a fast develop-
ment of suppressor mutation in cases where prolonged
incubation is necessary.
Four Broad-Host-Range Cloning Vectors Allow Amber
Suppression in Diverse Bacterial Species. The demon-
stration that amber suppression permits tight regulation of
protein output in E. coli raised the question of the system’s
transferability to other bacteria. To answer this question, we
made use of the various pBBR1MCS-X derivatives available,60
bearing resistance cassettes for kanamycin, tetracycline,
ampicillin and gentamycin, respectively.61 The pBBR1 origin
of replication present in these plasmids is recognized in a wide
range of bacterial hosts, and they are also mobilizable for
conjugational transfer.60
Moreover, the vectors do not belong to the Inc.P, Inc.Q or
Inc.W incompatibility group, and can therefore be coinherited
with p15A- or ColE1-dependent replicons.61 Consequently, we
cloned the genes of the amber suppression machinery into
pBBR1MCS-2 to 5, keeping the original multiple cloning sites
intact, and retaining the potential for blue/white screening
Figure 6. A set of broad-host-range cloning vectors for amber suppression in diverse bacteria. (A) Maps of pBBR1MCS-X AcKRST derivatives. The
pylS*/pylT cassette was integrated adjacent to the multiple cloning site in the available broad-host-range plasmids pBBR1MCS-2 to 5. (B) Analysis
of amber suppression in cells bearing the pBBR1MCS-X AcKRST derivatives. pBBR1MCS-X AcKRST vectors were transferred into E. coli BW25113
together with the Lux-amber reporter (LuxAm) or Lux reporter (Lux+), as positive control. The resulting strains were grown overnight in LB and
luminescence development was recorded in response to Ara and AcK. The maximal luminescence normalized to the OD600 from a 16 h time course
experiment is depicted. Error bars represent the standard deviation of data from three different experiments.
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.7b00048
ACS Synth. Biol. 2017, 6, 1892−1902
1898
(Figure 6A). The function of the resulting derivatives was
validated by transformation of E. coli with the LuxAm reporter
and subsequent analysis of AcK-dependent amber suppression
(Figure 6B).
Next we cloned a copy of the NanoLuc luciferase (Nluc) into
pBBR1MCS-2 AcKRST (Figure 7A) under the control of the
PBAD promoter. The plasmids generated in this way
(pBBR1MCS-2 AcKRST Nluc, pBBR1MCS-2 AcKRST Nluc-
(Am), pBBR1MCS-2 AcKRST Nluc PP(Am)) were then
transferred into Salmonella enterica LT2 and Vibrio cholerae El
Tor C6706 cells, and the wildtype NanoLuc was used as the
positive control (Nluc). AcK-dependent amber suppression was
analyzed with a NanoLuc variant, containing a UAG as third
codon (NlucAm). Again, a position close to the protein start was
selected because the enzyme reportedly tolerates N-terminal
fusions.62 In addition, we constructed a variant with PP amber
context (NlucPP(Am)) (Figure 7A). The dependence of
luminescence production in S. enterica and V. cholerae cells
on supplementation with Ara and/or AcK was then analyzed.
As expected, cells encoding a NanoLuc without any amber
insertion emit luminescence when grown in the presence of Ara
(Figure 7B, C). In contrast, significant luminescence
production by cells harboring the NlucAm or NlucPP(Am)
reporter required the simultaneous addition of Ara and AcK.
As in E. coli, the PP(Am) context further diminished the low
level of light production seen in the absence of AcK. Thus, our
results are 1:1 transferable from E. coli to S. enterica and
V. cholerae and with this, amber suppression is applicable to
diverse bacteria.
■ CONCLUDING REMARKS
In the present study we investigated the application of AcK-
dependent amber suppression for the regulation of translational
outputs. We showed that coupling of transcriptional and
translational regulation is an effective way to fully switch off the
synthesis of specific proteins. Manipulation of the concen-
trations of both the transcriptional inducer and AcK permits
gradual adjustment of the protein output. Furthermore, and in
line with previous reports, we observed that the incorporation
of an amber stop codon into a plasmid-borne gene copy
resulted in a measurable level of protein synthesis by
translational read-through (Figure 2C), which can be
modulated by changing the amber context43,46,49 (Table 1).
Such read-through might be beneficial when reduced levels of
an essential gene product are needed to maintain viability, but
nevertheless cause a mutant phenotype. If necessary, the
translational output can be further increased by ectopic
expression of the pylS*/pylT amber suppression system. It
should be noted that in our system mischarging becomes
virtually irrelevant when pylS*/pylT was integrated in the
chromosome and combined with inducible expression. This is
exemplified by the fact that E. coli LF1-AcKRST cells encoding
a LuxAm reporter remain completely dark in the absence of
IPTG (Figure 4). Only the concomitant presence of IPTG and
AcK allowed efficient amber suppression. Thus, chromosomal
incorporation of the amber suppression machinery might
generally increase specificity for ncAAs.
Altogether, our analyses of AcK-dependent amber suppres-
sion as a means of regulating protein production provide the
basis for use of the system as a versatile translational control
mechanism for investigation of the function of essential genes.
Thus, the components available in this molecular toolbox
enable fine-tuning of protein synthesis, not only in E. coli but
also in other Gram-negative bacteria such as S. enterica or
V. cholerae.
■ MATERIALS AND METHODS
Bacterial Stains, Oligonucleotides and Plasmids.
Strains, primers and plasmids used in this study are listed in
Supplementary Tables S1−S3. All oligonucleotides used for
PCR amplification and sequencing were synthesized by Sigma-
Aldrich. The sequences of all constructed plasmids were
verified by Sanger sequencing.
Molecular Biological Methods. E. coli, S. enterica and
V. cholerae cells were routinely grown in LB and where
indicated in M9 minimal medium.63 Solidification of the
medium was achieved by adding 1.5% (w/v) Agar−Agar (Carl
Roth). If necessary, media were supplemented with antibiotics
at the following concentrations: ampicillin sodium salt (100
μg/mL), chloramphenicol (30 μg/mL), kanamycin sulfate (50
μg/mL), tetracycline hydrochloride (15 μg/mL), gentamycin
sulfate (15 μg/mL), and streptomycin sulfate (50 μg/mL). For
blue-white selection, LB-agar plates were additionally supple-
mented with 80 μM 5-bromo-4-chloro-3-indolyl β-D-galacto-
Figure 7. Amber suppression in Salmonella enterica and Vibrio cholerae.
(A) An amber (NlucAm) or PP amber motif (NlucPP(Am)) was inserted
after codon 2 of the NanoLuc gene and cloned into the pBBR1MCS-2
AcKRST backbone. A vector bearing the wildtype NanoLuc gene
served as the positive control (Nluc). pBBR1MCS-2 AcKRST Nluc,
pBBR1MCS-2 AcKRST Nluc(Am) and pBBR1MCS-2 AcKRST Nluc
PP(Am) were transferred into Vibrio cholerae (B) and Salmonella
enterica (C). Luminescence was measured from overnight cultures
using the Nano-Glo luciferase assay system. Error bars represent the
standard deviation of data from three different experiments.
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pyranoside (X-Gal) (Sigma-Aldrich) and 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) (Sigma-Aldrich) to induce the
lac promoter Plac. Unless indicated otherwise, 0.2% (w/v) L-
arabinose was added to induce the PBAD promoter.
All enzymes and kits were used according to the
manufacturers’ directions. DNA fragments were purified from
agarose gels using a high-yield PCR cleanup and gel extraction
kit (Sued-Laborbedarf). Restriction endonucleases were
purchased from New England Biolabs. Sequence amplifications
were performed by PCR using Phusion high-fidelity DNA
polymerase (Finnzymes) or Taq DNA polymerase (New
England Biolabs). All mutants were constructed by one- or
two-step PCR using mismatched primer pairs.64
β-Galactosidase activity assays were performed as essentially
described previously.55
Plasmid and Strain Construction. pACYCDuet-AcKRST
was constructed as follows: A PCR fragment containing the
respective mutations in the pylS gene was generated as
described previously by Umehara et al. 20127 and cloned into
pACYCDuet-PylRST using the internal XhoI and NotI
restriction sites (Supplementary Table S2, Supplementary
Table S3).
LuxCDABE-containing pBAD/HisA constructs were gener-
ated as follows: The luxCDABE operon from Photorhabdus
luminescens was amplified from pBBR1MCS-5 TT-RBS-lux,65
and then cloned into pBAD/HisA (Invitrogen) using NcoI and
KpnI as restriction sites. The resulting vector pBAD/HisA-Lux
served as a template for all other luxCDABE-bearing plasmids
used in this study. To construct luxC amber versions we used
mismatched primer pairs (Supplementary Table S3) for
overlap-extension PCR and cloned the resulting fragments
into pBAD/HisA-Lux using NcoI and BsrGI, thereby replacing
the parental luxC fragment. The resulting plasmids, pBAD/
HisA-Lux(Am), pBAD/HisA-Lux(2Am), pBAD/HisA-Lux-RA-
(Am), pBAD/HisA-Lux-DA(Am), pBAD/HisA-Lux-HH(Am),
pBAD/HisA-Lux-KDP(Am), pBAD/HisA-Lux-PP(Am) and
pBAD/HisA-Lux-KDPP(Am) are listed and described in
Supplementary Table S2.
The constructs pBAD/HisA-dapA and pBAD/HisA-dapA-
(Am) were generated as follows: From genomic E. coli DNA,
dapA was amplified and the amber motif was introduced using a
mismatched primer (Supplementary Table S3). The resulting
fragments were than cloned into the pBAD/HisA backbone
using XhoI and EcoRI as restriction sites. The resulting plasmids
are listed in Supplementary Table S2.
To generate pBAD/HisA-Kan and plasmid derivatives
(Supplementary Table S2) the ampicillin resistance cassette
was replaced by nptI, which was amplified from pBBR1MCS-2
(Supplementary Table S3). The PCR fragment was introduced
restriction-free into pBAD/HisA as described.66
The broad-host-range cloning vectors containing pylS*/pylT
were constructed as follows: pylS*/pylT was amplified from
pACYCDuet-AcKRST and the resulting PCR fragment was
cloned into pBBR1MCS-2 to 5 plasmids using either the NsiI
or the AgeI restriction site (Supplementary Table S2,
Supplementary Table S3).
The Nluc reporter plasmids were generated by amplifying
the sequence encoding NanoLuc luciferase from pNL1.1
(Promega). The respective amber motifs were introduced
using mismatched primer pairs in a standard PCR (Supple-
mentary Table S3). The fragments obtained were each
combined with the arabinose-inducible PBAD promoter frag-
ment (amplified from pBAD/HisA, via overlap-extension
PCR), and cloned into pBBR1MCS-2 AcKRST using XbaI
and KpnI restriction sites. The resulting plasmids, pBBR1MCS-
2 AcKRST Nluc, pBBR1MCS-2 AcKRST Nluc(Am), and
pBBR1MCS-2 AcKRST Nluc PP(Am) are listed in Supple-
mentary Table S2.
E. coli LF1-LacZ-K, LF1-LacZ(Am), LF1-LacZ-PPK, and
LF1-LacZ-PP(Am) strains, as well as LF1-AcKRST, were
constructed essentially as described previously by Fried et al.55
and are listed in Supplementary Table S1.
E. coli LF1-AcKRST/dapA:camr was generated by using the
pRed/ET recombination technology in accordance to the
technical protocol of the Quick & Easy E. coli Gene Deletion
Kit (Gene Bridges) and is listed in Supplementary Table S1.
Lux-Based Luminescence Activity Assay. Single colo-
nies were transferred into LB supplemented with the
appropriate antibiotics, and grown aerobically overnight at 37
°C. On the next day, cells were inoculated at an OD600 of 0.01
into fresh LB supplemented with the corresponding antibiotics.
Cells were then grown aerobically at 37 °C in a microtiter plate
in a Tecan Infinite F500 system (TECAN) and luminescence
development in response to AcK and Ara was monitored at 10
min intervals over the course of 16 h. Light units were
normalized to OD600 and are thus expressed in relative light
units (RLU). Subsequently RLUs were background corrected
by subtracting the luminescence level detected in cells
containing a vector without a luxCDABE operon. Each
measurement was performed in triplicate.
The luminescence assay for the E. coli LF1-AcKRST strain
was performed as described above but with the difference that
the cells on the second day were inoculated in LB, containing
besides the antibiotic additionally 0.2% Ara (w/v). Sub-
sequently, luminescence development in response to 1 mM
AcK and 1 mM IPTG was detected as described before.
NanoLuc Luciferase Assay in S. enterica and V. chol-
erae. Single colonies of S. enterica and V. cholerae were
transferred into LB supplemented with kanamycin sulfate (50
μg/mL) and grown overnight aerobically at 37 °C. On the next
day, these cultures were used to inoculate the main cultures to
an OD600 of 0.01. To determine AcK- and Ara-dependent
luminescence development, all main cultures were grown
aerobically overnight at 37 °C in LB supplemented with
kanamycin sulfate (50 μg/mL) and containing either 1 mM
AcK, 0.2% Ara (w/v), or a combination of both compounds. A
culture grown in the absence of both served as negative control.
OD600 was determined from overnight cultures and the Nano-
Glo luciferase assay reagent (Promega) was prepared according
to manufacturer’s instructions. Then, the experimental cultures
were mixed 1:1 with Nano-Glo luciferase assay reagent,
transferred into a 96-well microtiter plate, and luminescence
was determined 5 min later with a Tecan Infinite F500 system
(TECAN). Light units were normalized to OD600 and
expressed in relative light units (RLU). Each measurement
was performed in triplicate.
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Supplementary Tables 
Supplementary Table S1. Strains used in this study. 
Stain Relevant genotype or description Reference or source 
E. coli DH5αλpir F
- 
80lacZΦM15 (lacZYA-argF)U196 recA1 hsdR17 deoR 
thi-1 supE44 gyrA96 relA1/pir 
1 
E. coli BW25113 
F
-
 λ - ∆(araD-araB)567 ∆lacZ4787(::rrnB-3) rph-1 ∆(rhaD-
rhaB)568 hsdR514 
2 
E. coli MG1655 wild-type; F- lambda- ilvG rfb50 rph-1 
3 
Salmonella enterica Serovar Typhimurium LT2 ATCC 19585 
Vibrio cholera C6706 
O1 El Tor isolate from Peru Centers for Disease Control and 
Prevention (CDC) 
E. coli LF1 
F
-
 - ilvG rfb50 rph-1 rpsL150 Plac::rpsL-neo-kan::lacZ
∆1-
100bp
, Kan
r
, Strp
s
 
4
 
E. coli LF1-LacZ-K 
Derivative from E. coli LF1, contains an insertion of a 
lysine codon (AAA) after position 9 of the lacZ gene, 
Kan
s
 Str
r
 
this study 
E. coli LF1-LacZ(Am) 
Derivative from E. coli LF-1, contains an insertion of an 
amber codon (TAG) after position 9 of the lacZ gene, 
Kan
s
, Str
r
 
this study 
E. coli LF1-LacZ-PPK 
Derivative from E. coli LF1, contains an insertion of a 
proline-proline-lysine motif (CCG CCG AAA) after 
position 9 of the lacZ gene, Kan
s
, Str
r
 
this study 
E. coli LF1-LacZ-PP(Am) 
Derivative from E. coli LF1, contains an insertion of a 
proline-proline-amber motif (CCG CCG TAG) after 
position 9 of the lacZ gene, Kan
s
, Str
r
 
this study 
E. coli LF1-AcKRST 
Derivative from E. coli LF1, contains the acetyl lysyl-
tRNA-synthetase (AcKRS), a mutated version of the 
PylRS from Methanosarcina mazei towards N
ε
-acetyl 
lysine specificity, according to Umehara et al.
5
 and the 
cognate amber suppressor tRNACUA (pylT), Kan
s
, Str
r
 
this study 
E. coli LF1-AcKRST/dapA:cam
r
 
Derivative from E. coli LF1-AcKRST were the dapA gene 
was replaced by a chloramphenicol resistance cassette 
using λ-RED recombinase, Camr 
this study 
 
  
Supplementary Table S2. Plasmids used in this study. 
Plasmid Features References 
pBBR1MCS-2 Broad-host-range cloning vector, 5.1 kb, ND
a
; Kan
r
 
6
 
pBBR1MCS-3 Broad-host-range cloning vector, 5.2 kb, ND
a
; Tet
r
 
6
 
pBBR1MCS-4 Broad-host-range cloning vector, 5.0 kb, ND
a
; Amp
r
 
6
 
pBBR1MCS-5 Broad-host-range cloning vector, 4.9 kb, ND
a
; Gm
r
 
6
 
pBBR1MCS-2 AcKRST 
Broad-host-range cloning vector, Contains the acetyl lysyl-
tRNA synthetase (pylS*) under control of PglnS and the 
suppressor tRNACUA (pylT) under the control of PproK, inserted 
into the NsiI restriction site, 6.8 kb, ND
a
; Kan
r
 
this study 
pBBR1MCS-3 AcKRST 
Broad-host-range cloning vector. Contains the acetyl lysyl-
tRNA synthetase (pylS*) under control of PglnS and the 
suppressor tRNACUA (pylT) under the control of PproK, inserted 
into the AgeI restriction site, 6.9 kb, ND
a
; Tet
r
  
this study 
pBBR1MCS-4 AcKRST 
Broad-host-range cloning vector. Contains the acetyl lysyl-
tRNA synthetase (pylS*) under control of PglnS and the 
suppressor tRNACUA (pylT) under the control of PproK, inserted 
into the NsiI restriction site, 6.6 kb, ND
a
; Amp
r
 
this study 
pBBR1MCS-5 AcKRST 
Broad-host-range cloning vector. Contains the acetyl lysyl-
tRNA synthetase (pylS*) under control of PglnS and the 
suppressor tRNACUA (pylT) under the control of PproK, inserted 
into the NsiI restriction site, 6.5 kb, ND
a
; Gm
r
 
this study 
pBBR1MCS-5 TT-RBS-lux 
PCR template for the amplification of the lux operon 
luxCDABE from Photorhabdus luminescens, ND
a
; Gm
r
 
7
 
pBAD/HisA 
pBR322-derived expression vector, contains the promotor 
PBAD of the arabinose operon araBAD from E. coli and its 
regulatory gene araC, 4.1 kb, Amp
r
 
Invitrogen 
pBAD/HisA-Lux 
Contains the lux operon inserted into the NcoI / KpnI restriction 
sites, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux(Am) 
Contains the lux operon with an amber codon (TAG) in luxC at 
position 3, inserted into the NcoI / BsrGI restriction sites of 
pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux(2Am) 
Contains the lux operon with two amber codons (TAG) in luxC 
at position 3, inserted into the NcoI / BsrGI restriction sites of 
pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux-RA(Am) 
Contains the lux operon with an arginine alanine amber motif 
(CGG GCT TAG) in luxC at position 3, inserted into the NcoI / 
BsrGI restriction sites of pBAD/HisA-Lux, 9.8 kb, Amp
r
  
this study 
pBAD/HisA-Lux-DA(Am) 
Contains the lux operon with an aspartic-acid alanine amber 
motif (GAT GCT TAG) in luxC at position 3, inserted into the 
NcoI / BsrGI restriction sites of pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux-HH(Am) 
Contains the lux operon with an histidine histidine amber motif 
(CAC CAC TAG) in luxC at position 3, inserted into the NcoI / 
BsrGI restriction sites of pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux-KDP(Am) 
Contains the lux operon with an lysine aspartic-acid proline 
amber motif (AAA GAT CCG TAG) in luxC at position 3, 
inserted into the NcoI / BsrGI restriction sites of pBAD/HisA-
Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux-PP(Am) 
Contains the lux operon with an proline amber motif (CCG 
TAG) in luxC at position 3, inserted into the NcoI / BsrGI 
restriction sites of pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pBAD/HisA-Lux-KDPP(Am) 
Contains the lux operon with an lysine aspartic acid proline 
proline amber motif (AAA GAT CCG CCG TAG) 
in luxC at position 3, inserted into the NcoI / BsrGI restriction 
sites of pBAD/HisA-Lux, 9.8 kb, Amp
r
 
this study 
pNL1.1 
PCR template for amplification of NanoLuc® (Nluc), 3.1 kb, 
Amp
r
 
Promega 
pBBR1MCS-2 AcKRST Nluc 
Derived from pBBR1MCS-2 AcKRST, contains Nluc under 
control of PBAD inserted into the XbaI / KpnI restriction sites, 
8.7 kb, Kan
r
 
this study 
pBBR1MCS-2 AcKRST 
Nluc(Am) 
Derived from pBBR1MCS-2 AcKRST, contains Nluc under 
control of PBAD inserted into the XbaI / KpnI restriction sites, 
insertion of an amber codon in Nluc at position 3, 8.7 kb, Kan
r
 
this study 
pBBR1MCS-2 AcKRST Nluc 
PP(Am) 
Derived from pBBR1MCS-2 AcKRST, contains Nluc under 
control of PBAD inserted into the XbaI / KpnI restriction sites, 
insertion of an proline proline amber motif in Nluc at position 3, 
8.7 kb, Kan
r
 
this study 
pBAD/HisA-Kan 
pBAD/HisA (Invitrogen) derived expression vector, the 
ampicillin resistance cassette (bla) was replaced with a 
this study 
kanamycin resistance cassette from pBBR1MCS-2, 4.2 kb, 
Kan
r
 
pBAD/HisA-Kan Lux 
Derived from pBAD/HisA (Kan), contains the lux operon 
inserted restriction free, 9.8 kb, Kan
r
 
this study 
pBAD/HisA-Kan-Lux(Am) 
Derived from pBAD/HisA (Kan), contains the lux operon 
inserted restriction free, insertion of an amber codon (TAG) in 
luxC at position 3, 9.8 kb, Kan
r
 
this study 
pBAD/HisA-dapA 
Contains dapA inserted between the XhoI / EcoRI restriction 
sites, 5.0 kb, Amp
r
 
this study 
pBAD/HisA-dapA(Am) 
Derived from pBAD/HisA-dapA, contains dapA with an amber 
codon on position 3 of the dapA open reading frame, inserted 
between the XhoI / EcoRI restriction sites, 5.0 kb, Amp
r
 
this study 
pACYCDuet
TM
-1 Standard expression vector, ORI P15A, 4 kb, Cam
r
 Novagen 
pACYCDuet-PylRST 
Contains the pyrrolysyl-tRNA-synthetase (PylRS) / cognate 
amber suppressor tRNACUA (pylT) 
 
pair from Methanosarcina 
mazei, 5.5 kb, Cam
r
 
8
 
pACYCDuet-AcKRST 
Contains the acetyl lysyl-tRNA-synthetase (AcKRS), a mutated 
version of the PylRS from Methanosarcina mazei towards N
ε
-
acetyl lysine specificity, according to Umehara et al.
5
 and the 
cognate amber suppressor tRNACUA (pylT), 5.5 kb, Cam
r 
this study 
pRed/ET λ-RED recombinase in pBAD24; Ampr Gene Bridges 
a
 ND, the incompatibility group of pBBR1 MCS plasmids has not been defined 
9
; compatible with IncP, IncQ and IncW group 
plasmids, as well as ColE1- and P15a-based replicons 
6
. Amp
r
, Cam
r
, Kan
r
, Tet
r
, Gm
r
 and Str
r
 are ampicillin, chloramphenicol, 
kanamycin, tetracycline, gentamycin, and streptomycin resistance, respectively. 
 
  
Supplementary Table S3. Primers used in this study. 
Primer name Sequence Restriction site  Reference 
Sequencing and control primers 
AcKRS chk fw AAT AAG TTC CTC ACA AAG GCA AAC GAA GAC  this study 
pBBR1MCS245 NsiI chk rev CAA GGC GAC AAG GTG CTG ATG  this study 
pBBR1MCS3 AgeI chk rev TGC GAT GAG TGG CAG GGC GGG GC  this study 
Seq33 fw-100 GGC GTC ACA CTT TGC TAT GC  
10
 
AraC chk fw CCT GAC CGC GAA TGG TGA GAT TGA GA  this study 
Ara Prom chk fw CTG ACG CTT TTT ATC GCA ACT CTC TAC TG  this study 
dapA chk fw CAT GAA GCT CCG CAA GCG GT  this study 
dapA chk rev CAC CAG ATA ATG TTG CGA TGA CAGT  this study 
Primers to generate a mutated version of the PylRS from Methanosarcina mazei towards Nε-acetyl lysine specificity 
(AcKRS). Described primers a directly derived from the library primers described by Umehara et al.
5
 
AcKRS L301M Y306L L309A OL fw 
AGA ACT TCT GCC TGA GAC CCA TGA TGG CTC 
CAA ACC TTC TGA ACT ACG CGC GCA AGC TTG 
ACA GGG CCC 
 
this study 
AcKRS L301M Y306L L309A OL rev 
GGG CCC TGT CAA GCT TGC GCG CGT AGT TCA 
GAA GGT TTG GAG CCA TCA TGG GTC TCA GGC 
AGA AGT TCT 
 
this study 
AcKRS C348F OL fw CAT GCT GAA CTT CTT TCA GAT GGG ATC G  this study 
AcKRS C348F OL rev CGA TCC CAT CTG AAA GAA GTT CAG CAT G  this study 
MPYSf TTT CCC TGA ATT CCG GCA AGC  
5
 
AcKRS rev 
ATC GGC GAG AAA GTC AGC AGG CCG CGC GGC 
CGC TTA CAG GTT GGT AGA AAT CCC GTT ATA 
GTA AGA CTC 
 
this study 
Primers for Lux reporter constructs 
KpnI LuxE rev 
GCT TCG AAT TCC CAT ATG GTA CCT TAT CAA 
ACG CTT CGG TTA AGC TCA A 
KpnI this study 
NcoI LuxC-wt fw 
CTA ACA GGA GGA ATT AAC CAT GGG CAC TAA 
AAA AAT TTC ATT CAT TAT TAA CGG CCA G 
NcoI this study 
NcoI LuxC:Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CTA GAC 
TAA AAA AAT TTC ATT CAT TAT TAA CGG CCA 
G 
NcoI this study 
NcoI LuxC:2Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CTA GTA 
GAC TAA AAA AAT TTC ATT CAT TAT TAA CGG 
CCA G 
NcoI this study 
NcoI LuxC:RA Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CCG GGC 
TTA GAC TAA AAA AAT TTC ATT CAT TAT TAA 
CGG CCA G 
NcoI this study 
NcoI LuxC:DA Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CGA TGC 
TTA GAC TAA AAA AAT TTC ATT CAT TAT TAA 
CGG CCA G 
NcoI this study 
NcoI LuxC:HH Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CCA CCA 
CTA GAC TAA AAA AAT TTC ATT CAT TAT TAA 
CGG CCA G 
NcoI this study 
NcoI LuxC:KDP Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CAA AGA 
TCC GTA GAC TAA AAA AAT TTC ATT CAT TAT 
TAA CGG CCA G 
NcoI this study 
NcoI LuxC:PP Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CCC GCC 
GTA GAC TAA AAA AAT TTC ATT CAT TAT TAA 
CGG CCA G 
NcoI this study 
NcoI LuxC:KDPP Am fw 
CTA ACA GGA GGA ATT AAC CAT GGG CAA AGA 
TCC GCC GTA GAC TAA AAA AAT TTC ATT CAT 
TAT TAA CGG CCA G 
NcoI this study 
LuxC rev TCA AAA TCT TTT TTG GCA TTC GGT  this study 
Primers for E. coli LF1 LacZ XXX strain construction and verification 
lacI 583bp sense GTC TGC GTC TGG CTG GCT GGC ATA  
4
 
lacZ 500bp anti CGA CTG TCC TGG CCG TAA CCG ACC  
4
 
lacZ 220bp anti AGC TTT CCG GCA CCG CTT CTG  
4
 
LacZ-K-OL-fw TCA CTG GCC AAA GTC GTT TTA C  this study 
LacZ-K-OL-rev GTA AAA CGA CTT TGG CCA GTG A  this study 
LacZ-PPK-OL-fw TCA CTG GCC CCG CCG AAA GTC GTT TTA C  this study 
LacZ-PPK-OL-rev GTA AAA CGA CTT TCG GCG GGG CCA GTG A  this study 
LacZ-Am-OL-fw TCA CTG GCC TAG GTC GTT TTA C  this study 
LacZ-Am-OL-rev GTA AAA CGA CCT AGG CCA GTG A  this study 
LacZ-PPAm-OL-fw TCA CTG GCC CCG CCG TAG GTC GTT TTA C  this study 
LacZ-PPAm-OL-rev GTA AAA CGA CCT ACG GCG GGG CCA GTG A  this study 
Primers for E. coli LF1-AcKRST strain construction 
Plac-AcKRST-OL-fw GGA AAC AGC TAT GGA TAA AAA ACC ACT AAA  this study 
CAC TCT GAT A 
Plac-AcKRST-OL-rev 
GGT TTT TTA TCC ATA GCT GTT TCC TGT GTG 
AAA TTG TTA TCC 
 
this study 
Plac-OL-sRBS-lacZ-fw 
ACA AAT ACA ATA AAT AAA GTA AGG AGG TAC 
ATT ATG ACC ATG ATT ACG GAT TCA CTG GCC 
G 
 
this study 
Plac-AcKRST-OL-sRBS-lacZ-rev 
AAT GTA CCT CCT TAC TTT ATT TAT TGT ATT 
TGT GCA AAA AAG CCT GCT CGT TGA GC 
 
this study 
Primer for E. coli LF1-AcKRST/dapA:cam
r
 strain construction 
FRT dapA fw 
CCA GGC GCG ACT TTT GAA CAG AGT AAG CCA 
TCA AAT CTC CCT AAA CTT TAA ATT AAC CCT 
CAC TAA AGG GCG 
 
this study 
FRT dapA rev 
CAT ACC AAA CGT ACC ATT GAG ACA CTT GTT 
TGC ACA GAG GAT GGC CCA TGT AAT ACG ACT 
CAC TAT AGG GCT C 
 
this study 
Primers for dapA constructs    
dapA EcoRI fw 
CCG GAA TTC TTA CAG CAA ACC GGC ATG CTT 
AAG 
EcoRI 
this study 
dapA XhoI rev 
CCG CTC GAG ATG TTC ACG GGA AGT ATT GTC 
GCG 
XhoI 
this study 
Amber dapA XhoI rev 
CCG CTC GAG ATG TTC TAG GGA AGT ATT GTC 
GCG 
XhoI 
this study 
Primers for broad-host-range cloning vectors 
AcKRST NsiI fw 
TGC ATG CAT TCA TCA ATC ATC CCC ATA ATC 
CTTG 
NsiI this study 
AcKRST NsiI rev 
TGC ATG CAT GCA AAA AAG CCT GCT CGT TGA 
GCA G 
NsiI this study 
AcKRST BspEI fw 
GGC ATT CTC CGG ATC ATC AAT CAT CCC CAT 
AAT CCT TG 
BspEI this study 
AcKRST BspEI rev 
GGC ATT CTC CGG AGC AAA AAA GCC TGC TCG 
TTG AGC AG 
BspEI this study 
Primers for resistance cassette exchange in pBAD/HisA 
pBAD/HisA amp kan ex fw 
TAT ATG AGT AAA CTT GGT CTG ACA GTC AGA 
AGA ACT CGT CAA GAA GGC GA 
 
this study 
pBAD/HisA amp kan ex rev 
CTT TTT GTT TAT TTT TCT AAA TAC ATA GCT 
TGC AGT GGG CTT ACA TGG CG 
 
this study 
Primers for NanoLuc
®
 reporter constructs 
Ara XbaI fw TGC TCT AGA TTA TGA CAA CTT GAC GGC TAC XbaI this study 
Ara Nluc OL rev CAT GGT TAA TTC CTC CTG TTA GC  this study 
Ara Nluc OL fw 
GCT AAC AGG AGG AAT TAA CCA TGG TCT TCA 
CAC TC 
 this study 
Ara Nluc am OL fw 
GCT AAC AGG AGG AAT TAA CCA TGG GCT AGG 
TCT TCA CAC TCG AAG AT 
 this study 
Ara Nluc am PP OL fw 
GCT AAC AGG AGG AAT TAA CCA TGG GCC CGC 
CGT AGG TCT TCA CAC TCG AAG AT 
 this study 
Nluc KpnI rev CGG GGT ACC TTA CGC CAG AAT GCG TTC KpnI this study 
 
  
Supplementary Table S4. Amber suppression in Salmonella enterica LT2 (A) and Vibrio 
cholerae El Tor C6706 (B). Cells were grown aerobically overnight at 37 °C in LB and on the 
next day, luminescence production in response to Nε-acetyl-L-lysine (AcK) and L-arabinose 
(Ara) was measured for the reporter pBBR1MCS-2 AcKRST Nluc, pBBR1MCS-2 AcKRST 
NlucAm and pBBR1MCS-2 AcKRST NlucPP(Am), using the Nano-Glo® luciferase assay system. 
 
  
Supplementary Figures 
 
Supplementary Figure S1. Influence of Nε-acetyl-L-lysine (AcK) on the doubling time of E. coli 
BW25113 during exponential growth. Cells were grown in LB in the absence (- AcK) and in the 
presence of 1 mM AcK (+ 1 mM AcK). Error bars represent the standard deviation of data from 
three different experiments. 
 
Supplementary Figure S2. Luminescence production of Lux+ (A) and LuxAm (B) in E. coli 
BW25113 in response to L-arabinose (Ara) and of Nε-acetyl-L-lysine (AcK). The maximal 
luminescence normalized to the OD600 from a 16 h time course experiment is depicted in 
response to Ara and AcK for Lux+ (A) and LuxAm (B). Error bars represent the standard deviation 
of data from three different experiments. 
 
 
Supplementary Figure S3. Comparison of PylRS and AcKRS based amber suppression. E. coli 
BW25113 cells were transformed with the Lux-amber reporter (LuxAm) in combination with either 
pACYCDuet-AcKRST (encoding the acetyl lysyl-tRNA synthetase/tRNACUA pair, AcKRST), 
pACYCDuet-PylRST (encoding the pyrrolysyl-tRNA synthase/tRNACUA pair, PylRST) or the 
empty vector (e.v.) as negative control. These cells were grown aerobically in LB supplemented 
with 0.2% (w/v) L-arabinose (Ara) at 37°C in a microtiter plate within a Tecan Infinite® F500 
system (TECAN). The maximal luminescence production in response to Nε-acetyl-L-lysine (AcK) 
and Nε-tert-butoxycarbonyl-L-lysine (BocK) normalized to the OD600 from a 16 h time course 
experiment is depicted. Error bars represent the standard deviation of data from three different 
experiments. 
 
 
Supplementary Figure S4. Influence of the chromosomal integration of the acetyl lysyl-tRNA 
synthetase/tRNACUA pair (AcKRST) on cell growth. E. coli MG1655, LF1 and LF1-AcKRST were 
grown aerobically at 37°C in a microtiter plate within a Tecan Infinite® F500 system (TECAN) in 
LB. Error bars represent the standard deviation of data from three different experiments. 
 
Supplementary Figure S5. Determination of the minimal diaminopimelic acid (DAP) 
concentration required for the growth of the dapA deficient LF1-AcKRST/dapA:camr strain. 
Depicted are cells grown for 16h at 37 °C aerobically in a microtiter plate in LB, supplemented 
with varying DAP concentrations ranging from 600 µM to 0 µM. 
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Tripeptides with two consecutive prolines are the shortest and most frequent sequences
causing ribosome stalling. The bacterial translation elongation factor P (EF-P) relieves
this arrest, allowing protein biosynthesis to continue. A seven amino acids long loop
between beta-strands β3/β4 is crucial for EF-P function and modified at its tip by
lysylation of lysine or rhamnosylation of arginine. Phylogenetic analyses unveiled an
invariant proline in the -2 position of the modification site in EF-Ps that utilize lysine
modifications such as Escherichia coli. Bacteria with the arginine modification like
Pseudomonas putida on the contrary have selected against it. Focusing on the EF-
Ps from these two model organisms we demonstrate the importance of the β3/β4
loop composition for functionalization by chemically distinct modifications. Ultimately,
we show that only two amino acid changes in E. coli EF-P are needed for switching the
modification strategy from lysylation to rhamnosylation.
Keywords: IF5A, EarP, EpmA, bacterial two-hybrid, glycosylation, TDP-rhamnose, Pseudomonas aeruginosa,
NleB
INTRODUCTION
Protein biosynthesis is a universally conserved three-step process that occurs on ribosomes
and provides a platform for tRNA mediated amino acid delivery. During translation elongation
aminoacyl-tRNAs bind to the ribosomal A-site and peptide bond formation is mediated by a
peptidyl-tRNA located in the P-site. Relocation of the P-site tRNA to the E-site enables its exiting
from the ribosome. The speed of incorporating amino acids into the growing polypeptide chain
varies and strongly depends on their chemical nature (Pavlov et al., 2009). Due to its rigid structure,
proline in particular delays the peptidyl transfer reaction, being both a poor A-site donor and
P-site acceptor substrate (Muto and Ito, 2008; Wohlgemuth et al., 2008; Pavlov et al., 2009;
Johansson et al., 2011; Doerfel et al., 2013, 2015). When translating stretches of two or more
prolines, ribosomes become arrested (Tanner et al., 2009; Doerfel et al., 2013; Gutierrez et al.,
2013; Hersch et al., 2013; Peil et al., 2013; Ude et al., 2013; Woolstenhulme et al., 2013, 2015;
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Elgamal et al., 2014; Starosta et al., 2014a). Thus consecutive
prolines are disfavored in evolution (Qi et al., 2018). However,
the structural benefits of polyproline sequences in proteins
(Adzhubei et al., 2013; Starosta et al., 2014b) seem to outweigh the
translational drawback and favored the evolution of a specialized
universal elongation factor termed e/aIF5A in eukaryotes/archaea
and EF-P in bacteria (Doerfel et al., 2013; Gutierrez et al., 2013;
Ude et al., 2013). Upon polyproline mediated stalling e/aIF5A
and EF-P are recruited to the ribosome to a location between the
P- and E-tRNA binding sites (Blaha et al., 2009; Saini et al., 2009;
Melnikov et al., 2016a,b; Schmidt et al., 2016; Huter et al., 2017).
With its three domains (Figures 1A,B), EF-P spans both
ribosomal subunits and forms an L-shaped, tRNA mimicking
structure (Hanawa-Suetsugu et al., 2004; Katz et al., 2014).
Whereas the two OB-Folding domains (Oligonucleotide
Binding) II and III are likely to be involved in P-site tRNAPro
(Katoh et al., 2016) and E-site codon (Huter et al., 2017)
recognition, the EF-P KOW-like N-domain I is crucial for the
catalytic activity. Specifically, a seven amino acid long apical loop
region between beta-strands three and four (β3β4) protrudes
toward the peptidyl transferase center (Blaha et al., 2009; Huter
et al., 2017). A conserved positively charged residue at the loop
tip mediates stabilization and positioning of the CCA-end of the
P-site tRNAPro in a way favorable for peptide bond formation
(Doerfel et al., 2013, 2015; Lassak et al., 2015). EF-P activity
is further enhanced by post-translational extensions of this
specific tip residue (Doerfel et al., 2013; Lassak et al., 2015).
Interestingly the underlying bacterial modifications appear to
be chemically diverse (Lassak et al., 2016; Figure 1A). In a
subset of bacteria including the Gram-negative model organism
Escherichia coli, a lysine residue K34 is β-lysylated (Bailly and
de Crecy-Lagard, 2010; Navarre et al., 2010; Yanagisawa et al.,
2010) with (R)-β-lysine (Behshad et al., 2006) at the ε-amino
group, employing the catalytic activity of the EF-P specific
ligase EpmA (YjeA, PoxA, GenX) (Roy et al., 2011). Subsequent
hydroxylation by EpmC (YfcM) (Peil et al., 2012; Kobayashi et al.,
2014) presumably at the (R)-β-lysyl-lysine C5 atom (Huter et al.,
2017) completes the modification, but is negligible for function
(Bullwinkle et al., 2013). A chemically related amino acid –
5-amino-pentanolyl-lysine – was found on Bacillus subtilis EF-P
(Rajkovic et al., 2016). By contrast, activity of a distinct EF-P
subset encoded in the β-proteobacterial subdivision and certain
γ-proteobacteria such as Pseudomonas putida and Shewanella
oneidensis depends on α-rhamnosylation of arginine at the
equivalent position (Lassak et al., 2015; Rajkovic et al., 2015;
Yanagisawa et al., 2016). This glycosylation is mediated by the
GT-B folding glycosyltransferase EarP (Krafczyk et al., 2017;
Sengoku et al., 2018) belonging to the enzyme family GT104
according to the CAZy database (Coutinho et al., 2003).
Despite their distinct chemical nature both lysine as well
as arginine modifications of EF-P promote proline-proline
peptide bond formation at the ribosome. We therefore asked
whether there is a specific conservation pattern around the
modified residue of diverse EF-Ps and if so how such a specific
context contributes to modification efficiency and ribosome
rescue. Using bioinformatics and site directed mutagenesis,
we were able to show that EarP mediated modification of
E. coli EF-P requires only the substitution of the protruding
lysine by arginine. However, this protein derivative remained
translationally inactive. Notably, we recognized a selective
pressure on the amino acid located at the second position
N-terminal of the modification site. While bacteria encoding
EF-P with protruding lysine contain an invariant proline, those
with arginine instead strictly select against it. Strikingly, the
additional substitution of this residue in this context in E. coli
EF-P led to a variant that even promotes peptide bond formation
in polyproline arrested ribosome upon arginine rhamnosylation.
We therefore reason that the presence or absence of this specific
proline orients β3β4 in a way that results in translationally
active EF-Ps with modifications similar to either (R)-β-lysylation
or α-rhamnosylation.
MATERIALS AND METHODS
Plasmid and Strain Construction
All strains, plasmids and oligonucleotides used in this
study are listed and described in the Supplementary
Tables S1–S3. All kits and enzymes were used according to
manufacturer’s instructions. Plasmid DNA was isolated using
the Hi Yield R© Plasmid Mini Kit from Süd Laborbedarf.
DNA fragments were purified from agarose gels using
the Hi Yield R© Gel/PCR DNA fragment extraction kit
from Süd Laborbedarf. All restriction enzymes, DNA
modifying enzymes and the Q5 R© high fidelity DNA
polymerase for PCR amplification were purchased from
New England BioLabs.
Escherichia coli strain KV1 for bacterial two-hybrid analysis
was constructed as follows: The luxCDABE operon from
Photorhabdus luminescens was amplified from pBAD/HisA-
Lux (Volkwein et al., 2017) and integrated into E. coli LF1
as essentially described previously by Fried et al. (2012).
To keep the ability of blue/white screening, a synthetic
ribosomal binding site predicted by RBS calculator (Salis et al.,
2009; Espah Borujeni et al., 2014) was introduced upstream
of the lacZ start site. Afterward cyaA was deleted using
Red R©/ET R© recombination technology and the kanamycin cassette
was removed using the 709-FLPe/amp expression vector in
accordance to the Quick and Easy E. coli Gene Deletion Kit
(Gene Bridges, Germany). In the same way, epmAEco was deleted
in the E. coli 1efp reporter strain MG-CR-efp-KanS, resulting
in the 1efpEco/1epmAEco reporter strain MG-CR-efp-epmA-
KanR. The 1efpEco reporter strain MG-CR-efp-KanS itself was
generated by removing the kanamycin resistance cassette from
MG-CR-efp (Lassak et al., 2015) using also the Quick and Easy
E. coli Gene Deletion Kit of Gene Bridges according to the
manufacturer’s instructions.
Growth Conditions
Escherichia coli cells were routinely grown in Miller modified
Lysogeny Broth (LB) (Bertani, 1951; Miller, 1972; Bertani, 2004)
at 37◦C aerobically under agitation, if not indicated otherwise.
When required, media were solidified by using 1.5% (w/v) agar.
The medium was supplemented with antibiotics at the following
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concentrations when indicated: 100 µg/ml ampicillin sodium
salt, 50 µg/ml kanamycin sulfate, 30 µg/ml chloramphenicol, or
15 µg/ml tetracycline hydrochloride. Plasmids carrying the PBAD
promoter (Guzman et al., 1995) were induced with L-arabinose at
a final concentration of 0.2% (w/v).
SDS-PAGE and Western Blotting
For protein analyses cells were subjected to 12% (w/v) sodium
dodecyl sulfate (SDS) polyacrylamide gel electrophoresis
(PAGE) as described by Laemmli (1970). To visualize
and confirm protein separation, 2,2,2-trichloroethanol was
incorporated into the polyacrylamide gels (Ladner et al., 2004)
and detected within a Gel DocTM EZ gel documentation
system (Bio-Rad). Afterward the proteins were transferred
onto nitrocellulose membranes (Whatman) which were then
subjected to immunoblotting. In a first step the membranes
were incubated either with 0.1 µg/mL Anti-6×His R© antibody
(Abcam, Inc.) to detect EF-P, or with 0.25 µg/ml Anti-
ArgRha antibody (Li et al., 2016; Krafczyk et al., 2017) to
visualize rhamnosylation. These primary antibodies (rabbit)
were then targeted with 0.2 µg/ml Anti-rabbit alkaline
phosphatase-conjugated secondary antibody (Rockland).
Localization was visualized by adding development solution
[50 mM sodium carbonate buffer, pH 9.5, 0.01% (w/v)
p-nitro blue tetrazolium chloride (NBT) and 0.045% (w/v)
5-bromo-4-chloro-3-indolyl-phosphate (BCIP)].
β-Galactosidase Activity Assay
Escherichia coli 1efp (MG-CR-efp-KanS) or 1efp/1epmA
(MG-CR-efp-epmA-KanR) reporter strain cells, in which lacZ
expression is controlled by the cadBA promoter, were grown
overnight (o/n) in 100 mM sodium-phosphate buffered Miller
modified LB (pH 5.8) under microaerobic conditions and with
agitation at 37◦C. On the next day, cells were harvested by
centrifugation, and the β-galactosidase activities were determined
as described (Tetsch et al., 2008) and are given in relative Miller
units (MU) (Miller, 1992).
Whenever the plasmid based reporter system pBBR1MCS-
3 XPPX lacZ (Peil et al., 2013) was used, cells were grown
o/n in 100 mM sodium-phosphate buffered Miller modified
LB (pH 5.8), microaerobically under agitation at 37◦C.
Whenever the E. coli 1epmA reporter strain (MG-CL-12-
yjeA) (Ude, 2013) was used, cells were grown in potassium
buffered KE minimal medium (Epstein and Kim, 1971) pH
5.8, supplemented with 10 mM lysine, 0.2% glycerol and
antibiotics in the appropriate concentrations. Whenever efpPpu
and earPPpu were co-expressed from pBBR1MCS2 (Kovach
et al., 1995) and pBAD33, respectively, cells were grown
in 100 mM sodium-phosphate buffered Miller modified LB
(pH 5.8), microaerobically under agitation at 30◦C. Whenever
efpPpu and earPPpu were co-overexpressed from pBAD24
and pBAD33, respectively, cells were grown in 100 mM
sodium-phosphate buffered Miller modified LB (pH 5.8) and
20 mM arabinose, aerobically under agitation at 30◦C. In
all cases, the cells were harvested by centrifugation on the
next day, and the β-galactosidase activities were determined
as described (Tetsch et al., 2008) and are given in MU
(Miller, 1992).
NMR Experiments
To obtain labeled proteins for NMR studies, bacterial
overproductions were performed in M9 glucose minimal
medium (Miller, 1972) containing either 15N-labeled ammonium
chloride alone (pET-SUMO-efpEcoK34R, pET-SUMO-efpEco
P32S, pET-SUMO-efpEco P32S K34R, pET-SUMO-efpPpu), or
15N-labeled ammonium chloride in combination with 13C
labeled glucose (pET-SUMO-efpEco, pET-SUMO-efpEco loopPpu).
Overproduction of these N-terminally His6-SUMO tagged
hybrid EF-P variants was induced in E. coli BL21 (DE3) by
the addition of 1 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG; Sigma Aldrich) during exponential growth. Until the
induction point the cells were grown at 37◦C, after IPTG
induction the temperature was shifted to 18◦C and the cells
were grown o/n. On the next day, the cells were harvested by
centrifugation. The resulting pellet was resuspended on ice
in dialysis buffer 1 (100 mM Na2HPO4/NaH2PO4, pH 6.5,
1 mM DTT). Cells were lysed using a continuous-flow cabinet
from Constant Systems Ltd., at 1.35 kbar, in combination with
sonication. The resulting lysate was centrifuged for 40 min
at 4◦C at 39,810 × g. The His6-SUMO tagged proteins were
purified in a first step with nickel-nitrilotriacetic acid (Ni-NTA;
Qiagen) according to the manufacturer’s instructions, using
20 mM imidazole for washing and 250 mM imidazole for elution.
Subsequently, imidazole was removed by dialysis o/n at 4◦C in
dialysis buffer 1. Afterward, the His6-SUMO tag was cleaved off
using His6-Ulp1 protease (Starosta et al., 2014b), followed by
a second Ni-NTA purification step to remove the His6-SUMO
tag itself as well as the His6 tagged Ulp1 protease. As a final
step, the purified protein was dialyzed again o/n at 4◦C in
dialysis buffer 1.
C-terminally His6-tagged EarPPpu for NMR interaction
studies was overproduced in E. coli LMG194 cells harboring a
pBAD33-earPPpu plasmid in Miller modified LB at 37
◦C. During
exponential growth, 0.2% (w/v) L-arabinose was added. After
induction, the temperature was shifted to 18◦C, and the cells
were grown o/n. On the next day, the cells were harvested
by centrifugation. The resulting pellet was resuspended on ice
in dialysis buffer 2 (100 mM Na2HPO4/NaH2PO4, pH 7.5,
50 mM NaCl, 5 mM DTT). Cell lysis, centrifugation of the
lysate and the first Ni-NTA purification step was performed
as described above. In a final step, the purified protein was
dialyzed o/n in dialysis buffer 2 to remove imidazole from the
purification step.
All 15NNMR relaxation experiments for EF-P and its variants
were performed in 100 mM Na2HPO4/NaH2PO4, pH 6.5 and
1 mM DTT. NMR data were recorded at 298 K for ∼ 0.15–
0.18 mM of EF-PEco and its variants except for EF-PEco P32S
for which the data were recorded at 0.09 mM due to low
yields of expression. Pulse experiments were performed on an
800 MHz Bruker Avance III NMR spectrometer equipped with
a TXI cryogenic probehead. Amide 15N relaxation data of R1,
R2, and steady-state heteronuclear {
1H}–15N-NOE experiments
were performed as described before (Farrow et al., 1994;
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Korzhnev et al., 2002). T1 data were measured with 11 different
relaxation delays: 20, 50, 100, 150, 250, 400, 500, 650, 800, 1000,
and 1300ms, whereby 150ms was used as duplicate. T2 data were
determined by using eight different relaxation delays: 16, 32, 48,
64, 80. 96, 112, and 128 ms using 16 ms as duplicate. Duplicate
time points were used for error estimation. The correlation
time (τc) of the protein molecule was estimated using the ratio
of averaged T2/T1 values (Farrow et al., 1994). Steady-state
heteronuclear {1H}–15N-NOE experiments were recorded with
and without 3 s of 1H saturation. All relaxation experiments were
acquired as pseudo-3D experiments. The spectra were processed
with NMRPipe (Delaglio et al., 1995) and peak integration and
relaxation parameter calculation was performed using PINT
(Niklasson et al., 2017).
For the titration of EF-PEco and its variants with 2×
EarPPpu, both the proteins were dialyzed against 100 mM
Na2HPO4/NaH2PO4, pH 7.5, 50 mM NaCl, and 1 mM DTT.
Experiments were recorded on an 800 MHz Bruker NMR
spectrometer equipped with a TXI cryogenic probehead at 298 K.
Protein backbone assignments for EF-PEco and EF-PEco loopPpu
were obtained from HNCACB, CBCA(CO)NH, and HNCA
experiments (Sattler et al., 1999). Data analysis was performed
in CcpNmr Analysis software (Vranken et al., 2005). Resonance
assignments of EF-P variants have been deposited at the BMRB
with the following accession codes: 27811.
In vitro Rhamnosylation Studies
To obtain EF-P variants for in vitro rhamnosylation
studies, protein overproductions were performed in E. coli
LMG194 cells, grown in Miller modified LB, harboring the
following C-terminally His6-tagged EF-P constructs (see also
Supplementary Table S2):
• EF-PPpu: pBAD24-efpPpu, pBAD24-efpPpu S30P, pBAD24-
efpPpu G31A, pBAD24-efpPpu R32K, pBAD24-efpPpu N33G,
pBAD24-efpPpu S34Q
• EF-PEco: pBAD24-efpEco K34R, pBAD24-efpEco P32S K34R,
pBAD24-efpEco K34R G35N, pBAD24-efpEco K34R Q36S,
pBAD24-efpEco P32S K34R G35N, pBAD24-efpEco P32S
K34R Q36S, pBAD24-efpEco K34R G35N Q36S, pBAD24-
EF-PEco loopPpu, pBAD24-EF-PEco domainIPpu
Furthermore, C-terminally His6 tagged EarPPpu was
overproduced in E. coli LMG194 harboring pBAD33-earPPpu.
To overproduce proteins, cells harboring corresponding
plasmids were grown at 37◦C, and during exponential growth,
0.2% (w/v) L-arabinose was added to induce protein production.
After induction, the temperature was shifted to 18◦C, and the
cells were grown o/n. On the next day, the cells were harvested
by centrifugation and the resulting pellet was resuspended in
buffer 3 (100 mM Na2HPO4/NaH2PO4, pH 7.5, 50 mM NaCl).
Cells were then lysed by sonication and the resulting cell lysate
was clarified by centrifugation for 40 min at 4◦C at 39,810 × g.
The His6 tagged proteins were then purified using Ni-NTA beads
(Qiagen) according to the manufacturer’s instructions, whereby
20 mM imidazole was used for washing and 250 mM imidazole
for elution of the His6 tagged proteins. Subsequently, imidazole
was removed by dialysis o/n at 4◦C in buffer 3, followed by
a second dialysis step at the next morning for 5 h, again in
buffer 3. The resulting proteins were then used for in vitro
rhamnosylation assays.
Kinetic parameters were determined by varying TDP-
β-L-rhamnose (TDP-Rha) concentrations while keeping
concentrations of EarPPpu (0.1 µM) and unmodified EF-PPpu
(2.5 µM) constant. A mixture of EarPPpu and unmodified EF-
PPpu was equilibrated to 30
◦C in 100 mM Na2HPO4/NaH2PO4,
pH 7.6. The reaction was started by the addition of TDP-
Rha and was stopped after 20 s of incubation at 30◦C by the
addition of one volume twofold Laemmli buffer (Laemmli,
1970) and incubation at 95◦C for 5 min. Samples were
subjected to SDS-PAGE and rhamnosylated EF-PPpu was
detected using an Anti-ArgRha antibody (Krafczyk et al., 2017).
A secondary FITC coupled Anti-rabbit antibody (Abcam,
United Kingdom) was used to visualize rhamnosylation in a
LI-COR Odyssey CLx. Band intensities were quantified using
ImageJ (Schneider et al., 2012). Km values were determined
by fitting relative band intensities to the Michaelis–Menten
equation using SigmaPlot. The Km of 5 µM TDP-Rha was
determined using commercially available substrate (Carbosynth,
United Kingdom). Previously, we determined a Km of 50 µM
using biochemically synthesized TDP-Rha (Krafczyk et al.,
2017). After rigorous assessment of this discrepancy we
found that contaminations with ammonium acetate were
responsible for a miscalculation of the TDP-Rha concentration
in stock solutions.
In vitro rhamnosylation of EF-PEco and EF-PPpu variants was
conducted in 100 mM Na2HPO4/NaH2PO4, pH 7.5 containing
50 mM NaCl. A master mix containing 25 µM of the
corresponding EF-P variant and 100 µM TDP-Rha was prepared
in a reaction tube and divided into 10 µl aliquots. The reaction
was started by addition of 10 µl of 0.5 µM EarP solution and
stopped after distinct time intervals by addition of 20 µl twofold
Laemmli buffer and immediate heating to 95◦C in an Eppendorf
ThermoMixer for 2 min. All samples were diluted by a factor
of 10 in onefold Laemmli buffer and 20 µl (corresponding to
0.5 µg of EF-P) were subjected to SDS-PAGE and Western
blotting. Rhamnosylated EF-P was detected and visualized using
a polyclonal rabbit Anti-ArgRha and a fluorescence labeled Anti-
rabbit antibody, respectively. Band intensities were determined
using ImageJ (Schneider et al., 2012). Relative rhamnosylation
rates were calculated by plotting the normalized linear range
(intensity tx/intensitymax) of the time course and determining the
slope of the resulting graphs.
Isoelectric Focusing
To investigate lysylation of E. coli EF-P C-terminally His6-
tagged EF-PEco was overproduced in E. coli BW25113 and
E. coli BW25113 1epmA cells, harboring the pBAD33-efp-
His6 plasmid, and were grown in Miller modified LB at 37
◦C.
Furthermore, E. coli BW25113 was transformed with pBAD33-
efp-His6-epmAB to produce post-translationally modified EF-P.
During exponential growth, 0.2% (w/v) L-arabinose was added to
induce protein production and cells were grown o/n at 18◦C. On
the next day, cells were harvested by centrifugation. The resulting
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pellet was resuspended on ice in HEPES buffer (50 mM HEPES,
100 mM NaCl, 50 mM KCl, 10 mM MgCl2, 5% (w/v) glycerol,
pH 7.0). Cells were lysed using a continuous-flow cabinet from
Constant Systems Ltd., at 1.35 kb. The resulting lysates were
clarified by centrifugation for 1.5 h at 4◦C at 234,998 × g. The
His6-tagged proteins were purified with Ni-NTA according to the
manufacturer’s instructions, using 20 mM imidazole for washing
and 400 mM imidazole for elution. In a final step, the purified
protein was dialyzed o/n in HEPES buffer to remove imidazole
from the purification step.
For isoelectric focusing 0.5 µg of protein per lane was
loaded on a native vertical isoelectric focusing gel with a pH
gradient range of 4–7 (SERVAGelTM) containing approximately
3% (v/v) SERVALYTTM. Prior to loading, samples were mixed
with twofold IEF sample buffer according to the manufacturer’s
instructions and wells were rinsed with SERVA IEF Cathode
buffer. Focusing was conducted for 1 h at 50 V, 1 h at 300 V
and finally bands were sharpened for 30 min at 500 V. Western
blotting was conducted as described above using 0.1 µg/ml Anti-
EF-PEco (Eurogentec).
Bacterial Two-Hybrid Analysis
Protein-protein interactions were detected using the bacterial
adenylate cyclase two-hybrid system kit (Euromedex) according
to the manufacturer’s instructions. This system is based on
functional reconstitution of split Bordetella pertussis adenylate
cyclase CyaA, which in turn activates the lac promoter
Plac being dependent on the cAMP receptor protein CAP
(Supplementary Figure S1A). The E. coli KV1 strain used
in this study was generated by start to stop deletion of
the cyaA gene from E. coli LF1 (Fried et al., 2012) and
subsequent incorporation of the lux operon at the lac locus
by using described methods. Applicability of this strain was
tested by assessing the self-interaction of the GCN4 leucine
zipper in E. coli KV1 and the commercially available bacterial
two-hybrid strains E. coli BTH101 (Euromedex) and E. coli
DHM1 (Euromedex) on X-Gal containing screening plates.
For this purpose, the reporter strains were co-transformed
with the plasmids pKT25-zip (Euromedex) and pUT18C-zip
(Euromedex) that encode for protein hybrids of the leucine
zipper and the corresponding CyaA fragment. While all reporter
strains respond with comparable β-galactosidase mediated
color formation, KV1 exhibits an additional light output
(Supplementary Figure S1B). Liquid cultures of transformants
containing 50 µg/ml kanamycin sulfate, 100 µg/ml carbenicillin
and 0.5 mM IPTG were inoculated from single colonies and
incubated at 30◦C for 8 h. 2 µl of liquid culture were spotted on
LB plates containing 40 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-Gal) and 0.5 mM IPTG as well as 50 µg/ml
kanamycin sulfate and 100 µg/ml carbenicillin. Pictures were
taken after 32 h of incubation at 30◦C.
For measuring interaction strength between EarPPpu and
EF-PPpu or EF-PEco, chemically competent E. coli KV1 cells
were co-transformed with pKT25-EarPPpu and either pUT18C-
EF-PPpu or pUT18C-EF-PEco. Transformants carrying leucine-
zipper-reporter hybrids (pUT18-zip and pKT25-zip) were used
as positive controls, whereas transformants containing pUT18C
and pKT25 vector backbones served as negative controls. Single
colonies were picked and used to inoculate 96-well plates, with
each well containing 200 µl of LB medium supplemented with
0.5 mM IPTG as well as 50 µg/ml kanamycin sulfate and
100 µg/ml carbenicillin. Plates were incubated at 30◦C and
under moderate agitation (550 rpm in Eppendorf ThermoMixer)
for 16 h. On the next morning, Costar 96 Well White plates
containing 200 µl of LB medium (0.5 mM IPTG, 50 µg/ml
kanamycin sulfate, 100µg/ml carbenicillin) were inoculated with
2 µl of o/n culture and luminescence output was monitored in
10-min intervals for 40 h in a Tecan Spark with 240 rpm at 30◦C.
Bioinformatic Analyses
Fold Recognition and Comparison of EF-P Structures
The EF-PPpu fold recognition model was generated using the
online user interface of the I-TASSER server (Zhang, 2008; Roy
et al., 2010; Yang et al., 2015). Chain B of the Pseudomonas
aeruginosa EF-P crystal structure (3OYY:B) (Choi and Choe,
2011) was used as “template without alignment.” The resulting
model exhibits a C-score (confidence score for estimating the
quality of fold recognitionmodels predicted by I-TASSER. Range:
(−5; 2); high values signify a model with a high confidence and
vice-versa) of 1.27 and an estimated TM-score [measure for the
similarity between the predicted model and the native structures.
Range: (0,1), with 1 indicating a perfect match] of 0.89 ± 0.07,
indicating high confidence and correct topology. The structural
alignment of the N-terminal KOW-like EF-P N-domains of
the EF-PPpu fold recognition model and E. coli EF-P (3A5Z:H)
(Katz et al., 2014) was generated using the UCSF Chimera
(Pettersen et al., 2004) MatchMaker function (Chain pairing:
Best-aligning pair of chains; Alignment algorithm: Needleman–
Wunsch; Matrix: Blosum-62; Gap extension penalty: 1; Matching
to 2.0 angstroms) and resulted in an RMSD of 1.005 angstroms
between 51 pruned atom pairs. Only amino acids 1–63 of each
EF-P structure were used for the alignment.
Sequence Data and Domain Analysis
Using the search query “Bacteria”[Organism] AND [“reference
genome”(refseq category) OR “representative genome ”(refseq
category)] AND “complete genome”[filter] we obtained from
the RefSeq database (O’Leary et al., 2016) a collection of 1644
proteomes corresponding to complete and/or representative
genomes. HMMER searches (Finn et al., 2015) against the locally
installed Pfam database (Finn et al., 2016) was used to identify
domains in proteins using the hmmscan e-value cut-off of 0.001.
We created an initial dataset of EF-P proteins by considering
only those gene products that exclusively contain the three
domains of interest – “EFP_N” (KOW-like domain), “EFP”
(OB domain), “Elong-fact-P_C” (C-terminal). Subsequently
we excluded from the dataset the proteins annotated in
the UniProt database (UniProt Consortium, 2018) as YeiP,
which are EF-P’s paralogs and possess the same domain
architecture. Additional sequence comparisons did not yield any
misannotated YeiP proteins.
Sequences of predicted KOW-like domains, in which
the β3β4 loop is located, were aligned using the
“E-INS-i” algorithm from the MAFFT software suite
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(Katoh and Standley, 2013). According to the trimAl tool
(Capella-Gutierrez et al., 2009) the MSA of KOW-like domain
sequences does not contain any sequences particularly prone
to introduce poorly aligned regions. Eleven sequences were
manually deleted from the set as they introduce gaps in the
multiple alignment of the β3β4 region (alignment positions
31–37) and the alignment was re-computed. MSA file is available
in the Supplementary Materials.
The final EF-P set contains 1166 sequences from 1137
genomes, including 29 genomes containing two EF-P
paralogs. Sequence logos were built using ggseqlogo R package
(Wagih, 2017).
The EF-P-containing genomes were scanned for the EpmA,
EpmC, EarP, DHS, and YmfI proteins. We identified 358,
143, 100, and 128 EpmA, EpmC, EarP, and DHS proteins
based, which are single-domain proteins containing the “tRNA-
synt_2,” “EpmC,” “EarP” (Lassak et al., 2015) and “DS”
(Brochier et al., 2004) domains, respectively. Orthologs of
the YmfI protein (Uniprot ID: O31767) from Bacillus subtilis
(Hummels et al., 2017; Rajkovic and Ibba, 2017) were obtained
from the orthologous group 508579 of the OMA database
(Altenhoff et al., 2018).
Phylogenetic Analysis
IQ-Tree 1.6.10 (Nguyen et al., 2015) was used to infer a
phylogenetic tree of KOW-like domains by the maximum
likelihood method, with the LG substitution matrix and the
number of standard non-parametric bootstrap replicates set to
100. The tree file in PDF format and its visualization including
bootstrap support values are available as Supplementary
Dataset S2. Using the ete3 python package (Huerta-Cepas
et al., 2016) the tree was rooted to the midpoint outgroup
and converted to ultrametric. The evolutionary reconstruction
of ancestral states was performed using the ace function from
the phytools R package (Revell, 2012), which implements the
maximum likelihood estimation. We used the ggtree R package
(Yu et al., 2017) to visualize the evolutionary reconstruction
of ancestral states on the tree of KOW-like domains and
annotate it with the amino acid located at the 34th position,
the presence or absence of a certain modification enzyme, and
the taxonomy for Proteobacteria, Firmicutes and Actinobacteria.
A tree with a more detailed taxonomic annotation is available in
Supplementary Materials.
RESULTS AND DISCUSSION
K34R Substitution of E. coli EF-P Is
Sufficient for Non-cognate
Rhamnosylation by EarP
Canonically, N-linked protein glycosylation occurs at a consensus
sequence motif (Helenius and Aebi, 2004). By contrast, the
glycosyltransferase EarP seems to recognize rather the overall
shape of domain I of its target EF-P (Krafczyk et al., 2017;
Sengoku et al., 2018; Figure 1B). Notably, and despite large
sequence diversity all EF-Ps are structurally similar (Yanagisawa
et al., 2010; Choi and Choe, 2011; Lassak et al., 2016). In
this regard the EF-Ps of the two model organisms E. coli
(EF-PEco) and P. putida (EF-PPpu) are highly superimposable
(Figure 1B) although they share a sequence identity below 30%.
We were therefore curious whether cross-interaction between
the non-cognate partners EF-PEco and EarPPpu is possible.
To this end we constructed a highly sensitive bacterial two-
hybrid E. coli reporter strain KV1 to combine it with the
plasmid system which was reported previously (Karimova et al.,
1998) (Supplementary Figure S1A). Distinct from the original
strains we used bioluminescence as a readout (see section
“Materials and Methods”) and generated C-terminal fusions of
the two complementary fragments T25 and T18 of the Bordetella
pertussis adenylate cyclase with EarPPpu and the EF-Ps of
E. coli and P. putida (T25-EarPPpu, T18-EF-PPpu, T18-EF-PEco).
Interaction strength of protein pairs was assessed by determining
the maximal light output in a 40 h time course experiment
(Supplementary Figure S1B). Cells co-expressing the cognate
interaction partners EarPPpu and EF-PPpu emitted a maximum
of 7,000 RLU (Figure 1C). When EarPPpu and the non-cognate
EF-PEco were co-produced, a maximal light emission of 255
RLU was observed. Although this is substantially lower, the
measured value is significantly above background levels (maximal
RLU of <100) and thus clearly demonstrates cross-interaction of
EarPPpu and EF-PEco.
Knowing that EF-PEco and EarPPpu do cross-interact, we next
assessed whether cross-rhamnosylation also occurs. Therefore we
took advantage of a previously introduced rhamnosylarginine
specific antibody (Li et al., 2016; Krafczyk et al., 2017)
and used it to test in vitro rhamnosylation over time. The
rhamnosylation efficiency of EarPPpu with its cognate partner
EF-PPpu was determined with 50 µM TDP-β-L-rhamnose (TDP-
Rha) (=10-fold Km; Supplementary Figure S2A) and set to
100%. Next we tested an EF-PEco variant in which solely
the modification site K34 was changed to arginine (K34REco).
However, we did not observe any rhamnosylation in vitro
(Figure 1D and Supplementary Figure S2B) presumably as
a result of suboptimal contacts between EF-PEco and EarPPpu
(Sengoku et al., 2018; Figure 1C). As important interaction
sites between EF-P and its corresponding modification system
are predominantly located within the first 65 amino acids
(Navarre et al., 2010; Yanagisawa et al., 2010; Krafczyk et al.,
2017; Sengoku et al., 2018) we now swapped the N-domain
of EF-PEco with the one from EF-PPpu (EF-PEco domainIPpu).
In line with our expectations EF-PEco domainIPpu was readily
modified (Figure 1D). For this reason, in a subsequent step
we tested an EF-PEco variant with swapped β3β4 – EF-PEco
loopPpu, containing in total four amino acid substitutions P32S,
K34R, G35N, and Q36S. Although the efficiency was strongly
reduced (1% compared to EF-PPpu) this variant could still be
rhamnosylated (Figure 1D).
We previously observed that impairments of EarP variants
with largely reduced in vitro rhamnosylation rates could be
compensated in vivo (EF-P modification and functionality) when
EF-P and the variants were co-overproduced (Krafczyk et al.,
2017; Supplementary Figure S3). This could be explained by an
increase of the local protein concentrations within the cells.
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FIGURE 1 | Cross-interaction, -modification and -functionalization studies on E. coli EF-P, and EarP of P. putida (A) Post-translational modifications (PTM) present
either in E. coli EF-P ((R)-β-lysylation) or P. putida EF-P (α-rhamnosylation). The modifying enzymes EpmA and EarP are indicated. (B) Structural comparison of EF-P
from P. putida (fold recognition model; see section “Materials and Methods,” left) and E. coli (3A5Z:H, right) (Katz et al., 2014). The KOW-like EF-P N-domains are
depicted in blue and gray, the OB-folding domains are depicted in orange and green, respectively. Middle: Structural alignment of the KOW-like EF-P N-domains.
(C) In vivo interaction analysis of a T25-EarPPpu fusion with T18 fusions of EF-PPpu (cognate EarP interaction partner) and EF-PEco (non-cognate EarP interaction
partner). The maximal light emission from a 40 h time course experiment is given in RLU. 95% confidence intervals of at least six replicates are shown. Asterisks
indicate significant (P < 0.05) differences in the maximal light emission between cells expressing only one or none of the interaction partners and those co-expressing
the corresponding interaction partners. (D) Top: In vitro rhamnosylation rates (yellow) and in vivo ribosome rescue activity (gray) of EF-PEco/Ppu variants. In yellow
depicted are the relative in vitro rhamnosylation rates of EF-PPpu (set to 100%) and EF-PEco/Ppu variants. Yellow underscoring indicates that these variants were
tested in vitro. Yellow asterisks indicate significant (P < 0.05) differences in the rhamnosylation rate of corresponding variants to the wildtype. In vivo measurements
were performed in the E. coli reporter strain (MG-CR-efp-KanS). E. coli1efp cells were complemented either with plasmid encoded His6-tagged EF-PEco variants
solely (earP−Ppu, dark gray bars) or in combination with EarPPpu (earP
+
Ppu, light gray bars). β-galactosidase activities are given in relative MU with the wild-type
EF-PPpu in earP
+ cells set to 100%. Rhamnosylation of EF-PEco was confirmed by Western blot analysis using Anti-rhamnosylarginine specific antibodies
(Anti-ArgRha). EF-PEco domainIPpu was generated by replacing the EF-P KOW-like N-domain I of E. coli with the one from P. putida. EF-PEco loopPpu was generated
by replacing β3β4 from E. coli with the corresponding β3β4 from P. putida. Black asterisks indicate significant (P < 0.05; P > 0.001) differences in the ribosome
rescue activity in the presence (dark gray) and absence (light gray) of EarP. Bottom: In vivo EF-P rhamnosylation levels were visualized using Anti-ArgRha specific
(Continued)
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FIGURE 1 | Continued
antibodies. Corresponding EF-P protein levels were detected with Anti-6×His R© (E) Effect of the EF-PEco loopPpu variant on different polyproline containing stalling
motifs. Measurements were performed in E. coli1efp cells (JW4107), harboring plasmid encoded the EF-PEco loopPpu variant in combination with the lacZ reporter
preceded by different stalling motifs (pBBR1MCS-3 XPPX lacZ) in the presence/absence of EarPPpu.
Consequently, we reinvestigated rhamnosylation of K34REco,
EF-PEco loopPpu, and EF-PEco domainIPpu by EarPPpu in E. coli.
Following this approach, even the single substituted EF-PEco
variant reached modification levels comparable to wildtype EF-
PPpu (Figure 1D, bottom). Thus, we were ultimately able to test
these EF-PEco variants on their ability to rescue ribosome stalling
in an EarP dependent manner. EF-P functionality was measured
using a previously established β-galactosidase dependent reporter
system (Ude et al., 2013; Figure 1D, top). The assay is based
on the effective translation of the polyproline motif containing
acid stress responsive transcriptional regulator CadC (Buchner
et al., 2015; Schlundt et al., 2017) and activation of its cognate
promoter PcadBA fused to lacZ (Ude et al., 2013): β-galactosidase
activity is low in E. coli cells lacking efp but becomes elevated
when complementing with both a copy of earPPpu and efpPpu
provided in trans (Figure 1D). Similarly, EF-PEco domainIPpu
rescues ribosome stalling upon rhamnosylation, indicating that
binding of the two distinct EF-Ps from E. coli and P. putida to
the ribosome occurs presumably at the same position. Hence the
structural determinants for proper orientation of the respective
protruding residue (lysine or arginine) and accordingly the
correspondingmodificationmay predominantly lay in the β3β4
composition. In line with this assumption rhamnosylated EF-PEco
loopPpu also alleviates the translational arrest occurring at the
CadC nascent chain. We note that this rescue activity is not
restricted to three consecutive prolines, but encompasses also
other diprolyl arrest motifs as demonstrated for APP, DPP, PPD,
PPG, and PPN (Figure 1E). In contrast to EF-PEco loopPpu we
measured an unexpected increase in relative β-galactosidase level
to about 20% of wildtype activity after introducing K34REco into
1efpEco cells pointing toward a partial complementation of the
mutant phenotype. However, this activity was lowered in the
concomitant presence of earPPpu, which suggests an inhibitory
effect of the modification. Presumably, the otherwise preserved
EF-PEco loop composition inK34REco precludes proper alignment
of rhamnosylarginine with the CCA-end of the P-site tRNAPro.
Collectively, these data demonstrate that EarP-mediated
rhamnosylation can tolerate substantial changes in the primary
sequence of the target protein EF-P. The capability of EF-P to
alleviate polyproline dependent translational stalling is, however,
strongly affected by changes in β3β4 sequence. This in turn
suggests that both of the modifications rely on a certain acceptor
loop architecture that orients the protruding residues in a way
favorable for promoting ribosome rescue.
The Sequence Composition of the EF-P
β3β4 Determines Ribosome Rescue
With Distinct Modifications
Having shown that the EF-PEco β3β4 composition is crucial
for rhamnosylation dependent rescue of polyproline arrested
ribosomes, we next examined the role of the specific loop amino
acids on protein function. Therefore, we initially constructed
a phylogenetic tree based on 1166 EF-P sequences. To define
modification-specific protein subsets, EpmA and EarP orthologs
were collected as described previously (Lassak et al., 2015;
Supplementary Dataset S1). The EF-P modification system
present in B. subtilis was excluded in this study, as the full
pathway is still poorly understood (Rajkovic et al., 2016; Witzky
et al., 2018). A first sequence logo of β3β4 numbered according
to the E. coli protein (amino acids 31 to 37) was generated based
on the complete EF-P dataset (Figure 2A and Supplementary
Dataset S1). In line with earlier reports (Bailly and de Crecy-
Lagard, 2010), the vast majority (81.11%) of EF-Ps have a
lysine at the β3β4 tip (K34), whereas arginine is the second
most frequent amino acid occurring in 14.75% of the proteins
(Supplementary Dataset S1). The remaining 4.11% contain A
(0.51%), M (0.77%), N (2.23%), and Q (0.6%) in this position. We
next extracted two subsets of proteins with either a protruding
lysine (lysine-type) or arginine (arginine-type) (Figure 2B). This
analysis revealed a highly conserved proline in the second
position N-terminal of the modification site (P32) in the lysine
type subset being almost absent in the arginine-type EF-Ps.
Consistently, bacteria with EpmA pathway have this proline in
the EF-P sequence whereas those with EarP do not (Figure 2C).
With few exceptions the two modification systems thus appear
to be mutually exclusive (Lassak et al., 2015; Supplementary
Dataset S1). Based on these observations, EF-P sequences were
grouped according to the presence or absence of P32 (Figure 2D).
Besides lysine (98.73%), we also found that alanine (100%) and
asparagine in the protruding position strongly co-occur with
proline (100%), whereas other types of amino acids co-occur with
P32 extremely rarely or not at all: arginine (2.33%), methionine
(0%), and glutamine (0%) (Supplementary Dataset S1).
Subsequent to and based on our bioinformatic analysis we
mutated β3β4 of the EF-Ps of both E. coli and P. putida.
EF-P functionality was measured in vivo, again using the CadC
dependent β-galactosidase reporter system (Ude et al., 2013;
Figure 3). The partial PcadBA activation with plasmid-based
K34REco (Figure 1D) intrigued us to first investigate the effect
of overproduced unmodified wildtype EF-PEco. Therefore, we
ectopically expressed efpEco in a reporter strain lacking the
E. coli lysyl ligase EpmA and measured the β-galactosidase
outcome (Supplementary Figure S4). Intriguingly, PcadBA was
50% reactivated compared to a trans complementation with
epmAEco. Presumably, the lysine K34 side chain forms important
stabilizing contacts with the CCA-end of the P-site tRNAPro
(Huter et al., 2017), which can in part compensate for a
lack of modification. We were therefore next curious whether
unmodified amino acids other than lysine and arginine can
promote EF-PEco functionality without modification. Hence, we
substituted K34 by any other amino acid (A, M, N, Q) to
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FIGURE 2 | Composition of β3β4 of the EFP_N superfamily (A) Domain architecture of EF-P: The first magnification illustrates β3β4 of the KOW-like
EF-P_N-domain I including the post-translational modification (PTM) site. The second magnification depicts the general amino acid composition of the seven amino
acid long loop between the strands β3 and β4 based on 1166 sequences. (B) Weblogo of β3β4 for the EF-Ps with lysine (lysine-type EF-P, upper logo) or an
arginine (arginine-type EF-P, lower logo) at position 34 according to the numbering of the E. coli ortholog. (C) Weblogo of β3β4 for the EF-Ps of bacteria
co-occurring with EpmA (upper logo) or EarP (lower logo). (D) Weblogo of β3β4 for the EF-Ps containing (upper logo) or not containing (lower logo) a proline at
position 32 according to the numbering of the E. coli ortholog.
be found in the protruding position of β3β4 of the various
EF-Ps (Figure 3A and Supplementary Dataset S1). However,
none of the resultant protein variants was translationally active,
indicating on the one hand that side chain similarities only
between arginine and lysine seems to be high enough to
preserve certain of the above-mentioned interactions. On the
other hand, the significantly lower activity with K34REco (20%)
compared to unmodified EF-PEco (50%) points toward a non-
stimulating or even negative effect, possibly caused by the
guanidino group.
Having demonstrated that substitution of K34 in E. coli
EF-P is hardly tolerated, we went on to analyze the impact
of its context residues. Coherent with its high degree of
conservation in lysine-type EF-Ps (Figures 2B,D) an exchange
of P32 (P32SEco, P32GEco) analogous to the arginine-type EF-P
sequence logo (Figure 2C) abolishes β-galactosidase activity
(Figure 3A). Similarly, a substitution of G33 (G33AEco, G33SEco)
is not tolerated and leads to a loss of function of EF-PEco. In
comparison, whenmutating G35 (G35NEco) and Q36 (Q36SEco) a
residual rescue activity of 3.8 and 21.1%, respectively, is retained.
Altogether our analysis of EF-PEco β3β4 unveils important
determinants for protein function and thus explains their high
degree of conservation.
In our complementary analysis with the EF-P of P. putida
KT2440 we generated the substitution variants K29RPpu,
S30PPpu, R32KPpu, N33GPpu, and S34QPpu according to amino
acids predominantly found in the lysine-type sequence logo
(Figure 2B). We also constructed K29APpu, S30APpu, S30GPpu,
G31APpu, G31SPpu, N33DPpu, S34APpu, and A35SPpu to further
study the impact of the corresponding positions on EF-P
activity and rhamnosylation efficiency. An in vitro time course
analysis was performed (Figure 3B) with wild-type EF-PPpu
as well as its variants S30PPpu, G31APpu, R32KPpu, N33GPpu,
and S34QPpu. This revealed relative rhamnosylation rates with
S30PPpu and G31APpu (<1% of wild-type activity) being slowest,
while N33GPpu and S34QPpu reach 62 and 12% compared to
wild-type EF-PPpu, respectively (Figure 3B). Corresponding to
the E. coli EF-P variants we also assessed the capability of
EF-PPpu in alleviating the translational arrest on consecutive
prolines in vivo. As for the cross-modified K34REco (Figure 1D),
we found that overproduction of EarP compensates for
reduced rhamnosylation efficiency and accordingly all EF-PPpu
substitutions – except changes of R32 – were fully modified
in vivo (Figure 3B). Regardless, S30PPpu reaches only 4% of wild-
type β-galactosidase activity and hence remains almost inactive
even upon rhamnosylation (Figure 3B). This result is notably
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FIGURE 3 | Activity of E. coli and P. putida EF-P variants with single amino acid substitutions in β3β4 (A) Top: In vivo activity measurements of E. coli EF-P β3β4
variants using the described E. coli reporter strain. In this strain, either efp (E. coli MG-CR-efp-KanS, epmA+ Eco, dark gray bars) or both, efp as well as epmA were
deleted (E. coli MG-CR-efp-epmA-KanR, epmA−Eco, light gray bars) and complemented with a plasmid encoded E. coli His6-tagged EF-P variant. β-galactosidase
activities are given in relative MU with the wild-type EF-PEco in the epmA
+ background set to 100%. Asterisks indicate significant (P < 0.05) differences in the
ribosome rescue activity of a given EF-PEco variant in the presence of EpmA compared to the same variant in the absence of EpmA. Bottom: Production of EF-PEco
variants was confirmed by Western blot analysis using Anti-6×His R© (B) Top: In vitro rhamnosylation rates (yellow) and ribosome rescue activity (gray) of EF-PEco/Ppu
variants. Shown in yellow are the relative in vitro rhamnosylation rates of EF-PPpu wild type (set to 100%) and EF-PPpu amino acid substitution variants. Yellow
underscoring depicts that these variants were tested in vitro. Yellow asterisks indicate significant (P < 0.05) differences in the rhamnosylation rate of corresponding
variants to the wildtype. In vivo activity measurements of P. putida EF-P β3β4 using the E. coli reporter strain (E. coli MG-CR-efp-KanS). E. coli 1efp cells were
complemented either with a plasmid-encoded P. putida His6-tagged EF-P variant solely (earP
−
Ppu, dark gray bars) or in combination with EarPPpu (earP
+
Ppu, light
gray bars). β-galactosidase activities are given in relative MU with the wild-type EF-PPpu in earP
+ cells set to 100%. Black asterisks indicate significant (P < 0.05;
P > 0.0001) differences in the ribosome rescue activity of a given EF-PPpu variant in the presence of EarP compared to the same variant in the absence of EarP.
Bottom: Rhamnosylation levels of EF-PPpu variants were detected by Western blot analysis using Anti-Arg
Rha.
reminiscent of what we saw with the corresponding E. coli EF-P
converse exchange P32S. Contrary to S30PPpu, the alanine and
glycine substitutions S30APpu and S30GPpu reached 39 and 96%
of wild-type β-galactosidase activity, respectively. These data
support our observation of a strong selection against proline in
the arginine-type EF-Ps, but at the same time allowing for a
certain degree of freedom in the -2 position of the modification
site. Substitutions of EF-PPpu in positions N33, S34, and A35
as well as K29 are also tolerated without significant activity
loss (Figure 3B). Similar to G33 in EF-PEco (Yanagisawa et al.,
2010; Figure 3A), the position equivalent G31 in EF-PPpu is
crucial for both modification efficiency and protein function
(Figure 3B), which might be explained by sterically-hindering
interactions with either the ribosome or EarP caused by longer
side chains. Interestingly and in contrast to K34REco, R32KPpu
is not only inactive but the β-galactosidase activity measured
with this variant is even below the level of an 1efpEco deletion
strain. This drastic phenotype indicates an inhibitory effect on
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FIGURE 4 | In vivo and in vitro characterization of EF-P hybrids (A) Top: In vivo rhamnosylation and functionality analysis of EF-P hybrids co-expressed with EarP
from P. putida or S. oneidensis. Measurements were performed in the E. coli reporter strain (MG-CR-efp-KanS). E. coli1efp cells were complemented either with
plasmid encoded His6-tagged EF-PEco/Ppu variants solely (earP
−, dark gray bars) or in combination with either EarP from P. putida (earP+Ppu, light gray bars) or
EarP from S. oneidensis (earP+So, blue bars). β-galactosidase activities are given in relative MU with the wild-type EF-PPpu in earP
+
Ppu cells set to 100%. Asterisks
indicate significant (P < 0.05) differences in the ribosome rescue activity of a given EF-PEco variant in the presence of EarPPpu or EarPSo compared to the same
variant in the absence of EarP. Bottom: In vivo rhamnosylation levels were detected and visualized using Anti-ArgRha. Production of EF-PPpu and EF-PEco variants
was detected and visualized using Anti-6×His R©. (B) NMR-single titration experiment: Average change in the intensity ratio of EF-PEco and its variants upon titration
with twofold EarPPpu. Error bars represent standard deviation of the intensity ratios over all signals within each titration.
polyproline translation. Notably, we saw the same when testing
unmodified EF-P of both P. putida (Figure 1D) or S. oneidensis
(Lassak et al., 2015). A similar phenomenon was also observed
by others when analyzing the growth of P. aeruginosa harboring
the EF-P R32K variant (Rajkovic et al., 2015). The most plausible
explanation is a distinct orientation of the protruding residue that
depends on the β3β4 composition.
The Essential Proline P32 in E. coli EF-P
Prevents Activation With
Rhamnosylarginine
Our mutational analysis clearly shows that the presence of
P32 is crucial for the activity of EF-PEco on the one hand
and prevents ribosome rescue by EF-PPpu on the other hand.
Accordingly, we were curious whether a double substitution
P32S/K34REco is sufficient to become translationally active upon
modification by EarP (Figure 4A). Unfortunately, this EF-P
variant was unable to promote CadC translation as seen by
the low β-galactosidase activities in the 1efpEco PcadBA::lacZ
reporter strain. However, at the same time we noticed a
reduced in vivo rhamnosylation efficiency, which might mask a
potential rescue effect. Therefore, we tested whether the EarP
ortholog from S. oneidensis MR–1 might be a more efficient
modifier. Indeed, upon co-expression of earPSo, rhamnosylation
of P32S/K34REco reached significantly higher levels, which
concomitantly resulted in a partial ribosome rescue (Figure 4A).
To understand the effect of substituting E. coli EF-P P32 especially
on rhamnosylation efficiency by EarPPpu we determined its
interactions with wildtype EF-PEco and variants at a molecular
level by performing NMR titration experiments (Figure 4B and
Supplementary Figures S5A,B). EF-PEco interacts with EarPPpu
as shown by the decrease in total amount of peak intensities
in the EF-PEco
15N-HSQC spectrum upon EarPPpu titration.
Physical interaction leads to an increased molecular tumbling
time, which in turn decreases transverse relaxation times and
peak intensities. The interaction was substantially enhanced in
the K34REco variant, resulting in even lower peak intensities.
This was expected, as R34 makes important contacts with
EarP and its cognate EF-P in Neisseria meningitidis (Sengoku
et al., 2018). In contrast to K34REco, we observed reduced
interaction strength in the P32S variant as peak intensities
were stronger than for EF-PEco wild type. This result might
be counterintuitive, however, only if one ignores that EF-P
must not only be efficiently rhamnosylated by EarP, but at
the same time has to interact optimally with the P-site tRNA
on the ribosome. In this light, the substitution of proline
might be regarded as an evolutionary consequence to maintain
functionality at the expense of rhamnosylation efficiency. In line
with the findings for K34REco and P32SEco, the K34R/P32SEco
double substitution variant showed intermediate interaction with
EarPPpu compared to K34REco and increased further with the
EF-PEco loopPpu variant. In addition to K34REco and P32SEco,
the EF-PEco loopPpu construct bears two additional substitutions
at positions 35 and 36, which seem to be important for EF-
P/EarP interaction. Thus, we can interpret our finding as an
adjustment to compensate for the negative interaction effect that
we saw with P32SEco.
It is possible that substitution of proline P32 causes substantial
changes in the loop dynamics due to its rigid nature. To test this,
we performed 15N R1, R2, and steady-state heteronuclear {
1H}–
15N-NOE relaxation experiments on EF-PEco and its variants and
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FIGURE 5 | EF-P phylogeny and β3β4 sequence evolution (A) Phylogenetic tree reconstruction of the 32nd position (–2 relative to the β3β4 tip) of the EF-P
KOW-like N-domain I. The colored circle areas correspond to the likelihood of the 32nd position to contain a proline (state “P”) or another amino acid residue (“not
P”). (B) Bar colors indicate, from left to right, the amino acid located at the 34th position (β3β4 tip), the presence/absence of certain modification enzymes, and the
taxonomy annotation for Proteobacteria, Firmicutes and Actinobacteria. Each colored line corresponds to one bacterial species in the EF-P
data set (Supplementary Dataset S1).
compared it with EF-PPpu. Our analysis suggests that substitution
of single EF-PEco β3β4-loop residues with residues from EF-
PPpu or even with the complete β3β4 does not significantly alter
the NMR relaxation properties of β3β4 and hence its dynamics
(Supplementary Figures S5C–F). Thus, differences observed in
the interaction of EF-PEco and its variants with EarPPpu can be
attributed to the molecular nature of resulting interactions rather
than changes in the loop dynamics.
Our observation that substitution of P32 weakens the
interaction strength between EF-PEco and EarPPpu explains
the differences in cross-complementing the 1efp PcadBA::lacZ
mutant phenotype with K34R/P32SEco in combination with
the rhamnosyltransferase ortholog either from S. oneidensis
or P. putida (Figure 4A). It is also indicative that further
sequence determinants in the β3β4 are contributing to EF-P
recognition by EarP and accordingly being in line with our
in vitro rhamnosylation studies on EF-PPpu substitution variants
(Figure 3B). Consequently, we additionally substituted G35
and Q36 for asparagine and serine, respectively. Both resultant
EF-PEco variants P32S/K34R/G35NEco and P32S/K34R/Q36SEco
alleviated CadC translation when co-producing EarPPpu,
exhibited by a twofold and threefold increase in β-galactosidase
activities, respectively (Figure 4A). However, neither the
double substitution K34R/G35NEco, K34R/Q36SEco nor
the triple exchange K34R/G35N/Q36Eco had an alleviating
effect on the translational arrest (Figure 4A). In summary,
our analysis clearly shows that cross-activation of EF-PEco
by EarPPpu is strictly prohibited in the presence of P32,
whereas on the contrary cross-modification solely depends
on the protruding residue to be arginine. Combined with
our in vitro interaction analysis we conclude that specifically
the selection against that proline is an adaptation to rescue
polyproline stalled ribosomes with α-rhamnosylarginine
rather than for efficient modification (Supplementary
Figure S2B). On the other hand, our data also implies that
additional adjustments in the β3β4 sequence composition
have been made to compensate for the negative effect of
rhamnosylation (Figure 1D).
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The Phylogeny of the β3β4 Composition
Unveils the Functional Relationship
Between P32 and the Modification Site
Our findings prompted us to investigate the evolutionary order of
events resulting in the observed co-occurrence patterns between
the residues occupying either the modification site (position 34
according to the numbering of E. coli EF-P) or the respective
position two amino acids upstream. To this end, we performed a
phylogenetic tree reconstruction using the maximum likelihood
method from the phytools R package (Revell, 2012). We note
that, according to the given bootstrap values, especially the
deep branches of the tree might be rather randomly placed
and thus the obtained results should be handled with caution
(Supplementary Datasets S2, S3). Nevertheless, in combination
with our biochemical and biophysical data these bioinformatics
analyses might provide a plausible rationale for the β3β4
composition and EF-P modification strategies.
As the lysine at the β3β4 tip was found in more than three
quarters of all EF-P sequences and is also conserved in the
eukaryotic and archaeal orthologs e/aIF5A (Dever et al., 2014),
we hypothesized that this amino acid is evolutionary ancient.
Indeed, we found EF-P with a protruding lysine to be most
likely at the root of our tree with subsequent emergence of the
first arginine, followed by asparagine, glutamine, and methionine
(Supplementary Figure S6A).
When reconstructing evolutionary scenarios for position
32 (Figure 5A), proline is the most likely amino acid in
an EF-P progenitor. The subsequent selection against it in
certain EF-P subpopulations strongly correlates with arginine
in the protruding position (Supplementary Figure S6A) and
in turn strengthens our observations that this specific residue
is crucial for optimal orientation of β3β4 (Figures 3, 4).
This scenario is further corroborated by the fact that the
structural restrictions caused by proline in position 32 have
favored the evolution of lysine β-lysylation and lysine 5-
aminopentanolylation. Whereas P32 seems to be incompatible
with rhamnosylation. Our data further implies that the
modification system for the latter emerged subsequent to
the phylogenetic recruitment of R34/noP32 (Figure 5B and
Supplementary Figure S6B).
CONCLUSION
In this study, we provide a comprehensive analysis of
EF-P β3β4 and how its sequence composition allows
functionalization by chemically and structurally distinct
modifications. It might also help to predict the type of novel,
yet undiscovered EF-P post-translational functionalization
strategies in the >50% of bacteria which do not encode any
known modification enzyme. Our assumption is supported
by the recent identification of lysine 5-amino-pentanolylation
which takes place in B. subtilis and presumably a few other
firmicutes (Hummels et al., 2017). This EF-P activation
strategy chemically resembles β-lysylation and also occurs
on a β3/β4 loop with an invariant proline two amino
acids upstream of the modification site. Further, in certain
prokaryotes that have a β3β4 similar to EF-PEco with lysine
at the loop tip or alternatively an asparagine (Figure 2D),
one can identify a deoxyhypusine synthase (DHS) like
protein (Figure 5B; Brochier et al., 2004). In eukaryotes
and archaea, DHS elongates a lysine in the EF-P ortholog
IF5A by an amino-butyryl moiety (Wolff et al., 1990; Prunetti
et al., 2016). Accordingly, it is plausible that the bacterial
ortholog might attach an analogous modification onto
the respective EF-Ps although the experimental connection
remains elusive.
The evolutionary flexibility in modification systems and
β3β4 sequence composition is not fully understood yet.
However, one could speculate that besides the universally
conserved role in alleviating ribosome stalling at polyproline
stretches (Gutierrez et al., 2013; Ude et al., 2013) diverse
EF-Ps might have extended functionality. In this regard it was
reported (Pelechano and Alepuz, 2017; Schuller et al., 2017)
that IF5A also acts on non-polyproline arrest motifs and even
facilitates termination. Although EF-P activity seems to be
restricted to the alleviation of translational arrest situations at
consecutive prolines (Ude et al., 2013; Woolstenhulme et al.,
2015) it should be noted that all global analyses thus far were
performed solely in E. coli (Peil et al., 2013; Woolstenhulme
et al., 2015) and Salmonella enterica (Hersch et al., 2013), both of
which depend on (R)-β-lysylation of lysine. One might therefore
speculate whether other EF-Ps with distinct modifications and
β3β4 sequence composition might have expanded functions
similar to eIF5A. EarP-dependent EF-Ps might therefore be of
particular interest. First evolved in β-proteobacteria, this EF-P
type seems to have spread into certain γ-proteobacterial orders
and other phyla (Lassak et al., 2015). Conversely, however,
horizontal gene transfer events of EpmABC-dependent EF-Ps
into the β-proteobacterial subdivision hardly occur. This in
turn could indicate a selection in favor of EF-P arginine
rhamnosylation caused either by an expanded target spectrum or
improved functionality.
The results of this study also demonstrate the possibility of
switching the EarP acceptor substrate specificity. The interaction
of EarP with its cognate EF-P has been shown to be both
sequence- and structure dependent (Krafczyk et al., 2017;
Sengoku et al., 2018). Our data show that a substitution of lysine
to arginine in the EF-P of E. coli K34REco is already sufficient to
allow for rhamnosylation in an EarP dependent manner. As the
EF-Ps of E. coli and P. putida share only 30% identity in the EarP-
interacting EF-P_N domain, sequence-specific contacts between
EF-P and EarP (Krafczyk et al., 2017; Sengoku et al., 2018) might
only enhance interaction strength between the two proteins. This
is further supported by our corresponding bacterial two-hybrid
and in vitro NMR analyses. The recognition motif for the AIDA-
associated heptosyltransferase Aah has been described as a “short
β-strand–short acceptor loop–short β-strand” (Charbonneau
et al., 2012). Analogously the two beta-strands bracketing
β3β4 might constitute a structural recognition motif for
EarP dependent rhamnosylation. Determining the minimal
recognition motif is of particular interest as this information
allows for targeted rhamnosylation even for proteins other than
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EF-P. Thus, our study also lays the foundation to evolve EarP
into a glycosynthase that can ultimately be used in heterologous
production of eukaryotic glycoproteins.
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1 Supplementary Figures and Tables 
1.1 Supplementary Figures 
 
 
Figure S1. (A) Molecular principle of the Euromedex bacterial two-hybrid system with E. coli KV1 
(adjusted from the Euromedex KIT Manual): The Bordetella pertussis adenylate cyclase CyaA 
apoprotein catalyzes the formation of cyclic AMP from ATP. Splitting the enzyme into two parts – 
T18 and T25 – renders CyaA inactive even upon co-expression. Fusing T18 and T25 to interacting 
proteins brings the fragments into close proximity and thus allows reconstitution of the Apo-CyaA. In 
E. coli KV1, the cyclic AMP dependent lac promoter precedes a translational fusion of the lux-operon 
and lacZ, allowing the indirect measurement of protein-protein interactions by light emission and 
colorimetric detection. (B) Proof of principle of E. coli KV1 as an in vivo reporter for protein-protein 
interaction using the self-interacting leucine zipper of GCN4. The colorimetric detection in E. coli KV1 
cells was assessed semi quantitatively based on the formation of blue colonies on LB (Miller)-plates 
containing 40 µg/mL X-Gal. E. coli KV1 light emission was measured in a time course experiment 
recording relative luminescence (RLU) and optical density at 600 nm (OD600) in time intervals of 10 
minutes. 
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Figure S2. (A) Left: Analysis of EarPPpu kinetic parameters. 0.5 µg of EF-PPpu and 0.05 µg of EarPPpu 
were subjected to SDS-PAGE after in vitro rhamnosylation (see Material and Methods) for 20 seconds 
at varying TDP-rhamnose concentrations. Proteins were transferred to nitrocellulose membrane by 
horizontal Western blotting. Rhamnosylated EF-PPpu was detected using 0.25 µg/ml of Anti-Arg
Rha. 
Right: TDP-rhamnose saturation curve of EarPPpu. Band intensities on nitrocellulose membrane were 
quantified using ImageJ and relative band intensities were plotted against TDP-rhamnose 
concentration. (B) Timecourse analysis of various EF-PPpu and EF-PEco variants. 0.5 µg of EF-PPpu and 
0.05 µg of EarPPpu were subjected to SDS-PAGE after in vitro rhamnosylation at a TDP-rhamnose 
concentration of 50 µM for varying timespans. Band intensities on nitrocellulose membrane were 
quantified using ImageJ and relative band intensities were plotted against time.  
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Figure S3. β-galactosidase activity in E. coli MG-CR-efp-KanS upon expression (dark grey) or co-
overexpression (light grey) of EF-PPpu and EarPPpu and single-amino-acid substitution variants. Cells 
were incubated under cadBA-inducing conditions (LB, pH 5.8) at 30°C o/n. 
 
Figure S4. (A) β-galactosidase activity in the ∆epmA reporter strain (E. coli MG-CL-12-yjeA) 
harboring either a plasmid borne copy of epmA (pBAD33-epmA) or efp (pBAD24-efpEco). (B) 
Isoelectric focusing of E. coli EF-P, either overproduced in E. coli epmA- (BW25113-epmA), in which 
epmA was chromosomally deleted, or in E. coli wild type cells (BW25113). Furthermore, EF-P was 
overproduced in combination with its PTM proteins EpmA and EpmB in E. coli wild type (BW25113). 
Production of EF-P was verified by Western blot analysis.  
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Figure S5. (A)1H-15N HSQC titrations of EF-PEco and EF-PEco loopPpu with EarPPpu is shown along 
with the backbone assignments. Both proteins show a decrease in intensity upon titration with EarPPpu 
indicating their interaction with EarPPpu. (B) Intensity ratio of all the EF-PEco mutants on titration with 
EarPPpu is shown. (C) The correlation time (c) for EF-PEco and its variants along with (D) R1, (E) R2 
rates and (F) hetNOE are shown.  
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Figure S6. (A) Phylogenetic trees of the EF-P KOW-like N-domain I, with reconstructed state of the 
34th position (A, left), presence of known modification systems and taxonomy (A, right colored bars). 
(B) Phylogenetic reconstruction of emergence of EF-P modification systems.  
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1.2 Supplementary Tables 
Table S1. Strains used in this study 
Strain Genotype Reference 
DH5αλpir recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 ∆lacZYA-argF U169 ɸ80dlacZ∆M15 λpir (Macinga et al., 1995) 
LMG194 
F- ΔlacX74 galE galK thi rpsL ΔphoA (PvuII) 
Δara714 leu::Tn10 (Guzman et al., 1995) 
BL21(DE3) F- ompT gal dcm lon hsdSB(rB
- mB-) λ(DE3) (Studier and Moffatt, 
1986) 
DHM1 
F- cya-854 recA1 endA1 gyrA96 (NalR) thi1 
hsdR17 spoT1 rfbD1 glnV44(AS) 
(Karimova et al., 
2005) 
BTH101 
F- cya-99 araD139 galE15 galK16 rpsL1 (StrR) 
hsdR2 mcrA1 mcrB1 additional relA1 mutation 
reported by (Battesti and Bouveret, 2012) 
Euromedex 
JW4107 
Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-
1, Δ(rhaD-rhaB)568, Δefp-772::kan, hsdR514 (Baba et al., 2006) 
KV1 MG1655 rpsL150 ΔcyaA Plac::luxCDABE-lacZ This study 
LF1 
MG1655 rpsL150 Plac::rpsL-neo-kan::lacZ
Δ1–100 
bp;KanR StrpS 
(Fried et al., 2012) 
MG-CR-efp 
MG1655 ΔlacZ::tet rpsL150 efp::npt ΔcadBA 
PcadBA::lacZ 
(Lassak et al., 2015) 
MG-CR-efp-KanS 
MG1655 ΔlacZ::tet rpsL150 Δefp ΔcadBA 
PcadBA::lacZ 
This study 
MG-CR-efp-epmA-
KanR 
MG1655 ΔlacZ::tet rpsL150 Δefp ΔcadBA 
epmA::npt PcadBA::lacZ 
This study 
MG-CL-12-yjeA 
MG1655 ∆lacZ::tet rpsL150 yjeA::npt ∆cadBA 
cadBA::lacZ 
(Ude, 2013) 
BW25113 
∆(araD-araB)567, ∆lacZ4787(::rrnB-3),  
λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514 
(Datsenko and 
Wanner, 2000) 
BW25113-epmA 
∆(araD-araB)567, ∆lacZ4787(::rrnB-3),  
λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514, ΔepmA This study 
JW4116 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, 
rph-1, Δ(rhaD-rhaB)568, ΔpoxA782::kan, 
hsdR514 
(Baba et al., 2006) 
KanR: kanamycin resistance, SrepS: streptomycin sensitive 
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Table S2. Plasmids used in this study 
Plasmid Features Reference 
Plasmids for strain construction 
pRED/ET® Amp λ-RED recombinase in pBAD24; AmpR GeneBridges,  
Germany 
FRT-PGK-gb2-
neo-FRT  
template DNA 
PCR-template (plasmid DNA) for generating a 
FRT-flanked  
PGK-gb2-neo cassette, KanR 
GeneBridges,  
Germany 
709-FLPe, amp 
Plasmid for removal of FRT flanked resistance 
cassette, Supplier ID: A106 
GeneBridges,  
Germany 
pBAD/HisA-Lux 
Contains the luxCDABE operon from 
Photorhabdus luminescens 
(Volkwein et al., 
2017) 
Plasmids for mutational analysis of the E. coli loop and for overproduction 
pBAD24 
AmpR-cassette, pBBR322 origin, araC coding 
sequence, ara operator 
(Guzman et al., 
1995) 
pBAD24-efpEco 
C-terminal His6-tagged E. coli efp amplified from 
pBAD33-efpE.c.-His6 (Lassak et al., 2015) using 
P1/P2 
this study 
pBAD24-efpEco 
P32G 
C-terminal His6-tagged E. coli efp substitution 
variant P32G. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P16 and 
P2/P15 
this study 
pBAD24-efpEco 
P32S 
C-terminal His6-tagged E. coli efp substitution 
variant P32S. Overlap PCR fragment was amplified 
from pBAD24-efpEco using P1/P18 and P2/P17 
this study 
pBAD24-efpEco 
G33A 
C-terminal His6-tagged E. coli efp substitution 
variant G33A. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P20 and 
P2/P19 
this study 
pBAD24-efpEco 
G33S 
C-terminal His6-tagged E. coli efp substitution 
variant G33S. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P22 and 
P2/P21 
this study 
pBAD24-efpEco 
K34A 
C-terminal His6-tagged E. coli efp substitution 
variant K34A. Amplified from pBAD33-efpE.c.-
His6-K34A (Lassak et al., 2015) using P1/P2 
this study 
pBAD24-efpEco 
K34M 
C-terminal His6-tagged E. coli efp substitution 
variant K34M. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P24 and 
P2/P23 
this study 
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pBAD24-efpEco 
K34N 
C-terminal His6-tagged E. coli efp substitution 
variant K34N. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P26 and 
P2/P25 
this study 
pBAD24-efpEco 
K34Q 
C-terminal His6-tagged E. coli efp substitution 
variant K34Q. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P28 and 
P2/P27 
this study 
pBAD24-efpEco 
K34R 
C-terminal His6-tagged E. coli efp substitution 
variant K34R. Amplified from pBAD33-efpE.c.-
His6-K34R (Lassak et al., 2015) using P1/P2 
this study 
pBAD24-efpEco 
G35N 
C-terminal His6-tagged E. coli efp substitution 
variant G35N. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P30 and 
P2/P29 
this study 
pBAD24-efpEco 
Q36S 
C-terminal His6-tagged E. coli efp substitution 
variant Q36S. Overlap PCR fragment was 
amplified from pBAD24-efpEco using P1/P32 and 
P2/P31 
this study 
Plasmids for mutational analysis of the P. putida loop and for overproduction 
pBAD24-efpPpu 
C-terminal His6-tagged P. putida efp amplified 
from Pseudomonas putida KT2440 using P1/P2 
this study 
pBAD24-efpPpu 
K29A 
C-terminal His6-tagged efp P. putida substitution 
variant K29A. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P36 and 
P2/P35 
this study 
pBAD24-efpPpu 
K29R 
C-terminal His6-tagged P. putida efp substitution 
variant K29R. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P37 and 
P2/P35 
this study 
pBAD24-efpPpu 
S30A 
C-terminal His6-tagged P. putida efp substitution 
variant S30A. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P38 and 
P2/P35 
this study 
pBAD24-efpPpu 
S30G 
C-terminal His6-tagged P. putida efp substitution 
variant S30G. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P39 and 
P2/P35 
this study 
pBAD24-efpPpu 
S30P 
C-terminal His6-tagged P. putida efp substitution 
variant S30P. Overlap PCR fragment was amplified 
from pBAD24-efpPpu using P1/P40 and P2/P35 
this study 
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pBAD24-efpPpu 
G31A 
C-terminal His6-tagged P. putida efp substitution 
variant G31A. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P41 and 
P2/P35 
this study 
pBAD24-efpPpu 
G31S 
C-terminal His6-tagged P. putida efp substitution 
variant G31S. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P42 and 
P2/P35 
this study 
pBAD24-efpPpu 
R32K 
C-terminal His6-tagged P. putida efp substitution 
variant R32K. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P44 and 
P2/P43 
this study 
pBAD24-efpPpu 
N33D 
C-terminal His6-tagged P. putida efp substitution 
variant N33D. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P46 and 
P2/P45 
this study 
pBAD24-efpPpu 
N33G 
C-terminal His6-tagged P. putida efp substitution 
variant N33G. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P47 and 
P2/P45 
this study 
pBAD24-efpPpu 
S34A 
C-terminal His6-tagged P. putida efp substitution 
variant S34A. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P48 and 
P2/P45 
this study 
pBAD24-efpPpu 
S34Q 
C-terminal His6-tagged P. putida efp substitution 
variant S34Q. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P49 and 
P2/P45 
this study 
pBAD24-efpPpu 
A35S 
C-terminal His6-tagged P. putida efp substitution 
variant A35S. Overlap PCR fragment was 
amplified from pBAD24-efpPpu using P1/P50 and 
P2/P45 
this study 
pBAD33 
CmR-cassette, p15A origin, araC coding sequence, 
ara operator 
(Guzman et al., 
1995) 
pBAD33 PP1857-
His6 
C-terminal His6-Tag earP version from P. putida 
KT2440 
(Krafczyk et al., 
2017) 
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Plasmids for cross modification/actication and overproduction 
pBBRMCS2 pBBR origin of replication, oriT, KanR 
(Kovach et al., 
1995) 
pBAD24-efpEco  
domainI-efpPpu 
C-terminal His6-tagged E. coli efp where the first 
65 amino acids (domainI) were substituted by the 
first 65 amino acids from P. putida efp. Overlap 
PCR fragment was amplified from pBAD24-efpPpu 
using P1/P52 and pBAD24-efpEco P2/P51 
this study 
pBAD24-efpEco  
loop-efpPpu 
C-terminal His6-tagged E. coli efp P32S K34R 
G35N Q36S multiple amino acid substitution 
variant, corresponding to EF-P of E. coli carrying 
the acceptor loop of EF-P from P. putida. Overlap 
PCR fragment was amplified from pBAD24-efpEco 
using P1/P54 and P2/P53 
this study 
pBAD24-efpEco  
P32S K34R 
C-terminal His6-tagged E. coli efp substitution 
variant P32S K34R. Overlap PCR fragment was 
amplified from pBAD24-efpEco K34R using P1/P56 
and P2/P55 
this study 
pBAD24-efpEco  
K34R G35N 
C-terminal His6-tagged E. coli efp substitution 
variant K34R G35N. Overlap PCR fragment was 
amplified from pBAD24-efpEco K34R using P1/P58 
and P2/P57 
this study 
pBAD24-efpEco  
K34R Q36S 
C-terminal His6-tagged E. coli efp substitution 
variant K34R Q36S. Overlap PCR fragment was 
amplified from pBAD24-efpEco K34R using P1/P60 
and P2/P59 
this study 
pBAD24-efpEco  
P32S K34R G35N 
C-terminal His6-tagged E. coli efp substitution 
variant P32S K34R G35N. Overlap PCR fragment 
was amplified from pBAD24-efpEco P32S K34R 
using P1/P62 and P2/P61 
this study 
pBAD24 -efpEco  
P32S K34R Q36S 
C-terminal His6-tagged E. coli efp substitution 
variant P32S K34R Q36S. Overlap PCR fragment 
was amplified from pBAD24-efpEco P32S K34R 
using P1/P64 and P2/P63 
this study 
pBAD24-efpEco  
K34R G35N Q36S 
C-terminal His6-tagged E. coli efp substitution 
variant K34R G35N Q36S. Overlap PCR fragment 
was amplified from pBAD24-efpEco K34R using 
P1/P66 and P2/P65 
this study 
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pBAD33-earPSo 
earP from Shewanella oneidensis MR-1 amplified 
from pBAD24-earPS.o.-His6 (Lassak et al., 2015) 
using P1/P67 
this study 
Plasmids for XPPX assay 
p3LC-TL30-APP p3LC-TL30 + sequence encoding Ala-Pro-Pro (Peil et al., 2013) 
p3LC-TL30-PPD p3LC-TL30 + sequence encoding Pro-Pro-Asp (Peil et al., 2013) 
p3LC-TL30-PPP p3LC-TL30 + sequence encoding Pro-Pro-Pro (Ude et al., 2013) 
p3LC-TL30-DPP p3LC-TL30 + sequence encoding Asp-Pro-Pro (Peil et al., 2013) 
p3LC-TL30-PPG p3LC-TL30 + sequence encoding Pro-Pro-Gly (Peil et al., 2013) 
p3LC-TL30-PPN p3LC-TL30 + sequence encoding Pro-Pro-Asn (Peil et al., 2013) 
Plasmids used in the reporter strain MG-CL-12-yjeA 
pBAD33-epmA epmA from E. coli, amplified using P72/P75 this study 
Plasmids for protein overproduction (NMR) 
pET SUMO 
pBR322 origin, lacI, T7 lac promoter, N-terminal 
His6 tag, SUMO coding sequence, Kan
R, Supplier 
ID: K300-01 
Invitrogen 
pET SUMO-efpEco 
C-terminal genetic fusion of efp from E. coli to 
His6-SUMO-tag. Amplified from pBAD24-efpEco 
using P68/P69 
this study 
pET SUMO-efpPpu 
C-terminal genetic fusion of efp from P. putida 
KT2440 to His6-SUMO-tag 
(Krafczyk et al., 
2017) 
pET SUMO-efpEco 
P32S 
C-terminal genetic fusion of efp from E. coli 
substitution variant P32S to His6-SUMO-tag. 
Overlap PCR fragment was amplified from pET 
SUMO-efpEco using P5/P18 and P6/P17 
this study 
pET SUMO-efpEco 
K34R 
C-terminal genetic fusion of efp from E. coli 
substitution variant K34R to His6-SUMO-tag. 
Overlap PCR fragment was amplified from pET 
SUMO-efpEco using P5/P71 and P6/P70 
this study 
pET SUMO-efpEco 
P32S K34R 
C-terminal genetic fusion of efp from E. coli 
substitution variant P32S K34R to His6-SUMO-tag. 
Overlap PCR fragment was amplified from pET 
SUMO-efpEco using P5/P56 and P6/P55 
this study 
pET SUMO-efpEco 
loopPpu 
C-terminal genetic fusion of efp from E. coli 
substitution variant P32S K34R G35N Q36S to 
His6-SUMO-tag. Overlap PCR fragment was 
amplified from pET SUMO-efpEco using P5/P54 
and P6/P53 
this study 
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Plasmids for bacterial two-hybrid (BTH) 
pUT18-zip 
N-terminal genetic fusion of the leucine zipper 
from GCN4 to the T18 fragment of CyaA 
Euromedex 
pKT25-zip 
C-terminal genetic fusion of the leucine zipper 
from GCN4 to the T25 fragment of CyaA 
Euromedex 
pUT18C-PP1858 
C-terminal genetic fusion of efp from 
Pseudomonas putida to the T18 fragment of CyaA 
(Krafczyk et al., 
2017) 
pKT25-PP1857 
C-terminal genetic fusion of earP from 
Pseudomonas putida to the T25 fragment of CyaA 
(Krafczyk et al., 
2017) 
pUT18C-efpEco 
C-terminal genetic fusion of efp from Escherichia 
coli to the T18 fragment of CyaA. PCR fragment 
was amplified from pBAD24-efpEco using P80/P81 
this study 
pUT18C-efpEco 
K34R 
C-terminal genetic fusion of efp from Escherichia 
coli to the T18 fragment of CyaA. K34R single 
amino acid exchange variant. PCR fragment was 
amplified from pBAD24-efpEco K34R using 
P80/P81 
this study 
pUT18C-efpEco 
P32S K34R 
C-terminal genetic fusion of efp from Escherichia 
coli to the T18 fragment of CyaA. P32S K34R 
double amino acid exchange variant. PCR fragment 
was amplified from pBAD24-efpEco P32S K34R 
using P80/P81 
this study 
pUT18C-efpEco 
loopPpu 
C-terminal genetic fusion of efp from E. coli to the 
T18 fragment of CyaA. P32S K34R G35N Q36S 
multiple amino acid exchange variant, 
corresponding to EF-P of E. coli carrying the 
acceptor loop of EF-P from P. putida. PCR 
fragment was amplified from pBAD24-efpEco 
loopPpu using P80/P81 
this study 
Plasmids for isoelectric focusing 
pBAD33-efp-His6 
C-terminal His6-Tag efp version from E. coli into 
pBAD33 
(Lassak et al., 2015) 
pBAD33-efp-His6-
epmAB 
C-terminal His6-tagged efp and epmAB from E. 
coli. Overlap PCR fragment was amplified using 
P73/P76, P72/P75 and P74/P77  
this study 
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Plasmids for EarP mutant test  
pBBR1-MCS2 
NP_SO_PP1858- 
His6 
C-terminal His6-Tag efp from Pseudomonas putida 
under control of the Shewanella oneidensis native 
efp promoter in pBBR1-MCS2 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
D13A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Asp13 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
D17A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Asp17 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
F191A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Phe191 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
Y193A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Tyr193 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
Q255A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Gln255 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
F258A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Phe258 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
R271A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Arg271 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
D274A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Asp274 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
S275A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Ser275 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
R278A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Arg278 
exchanged to Ala 
(Krafczyk et al., 
2017) 
pBAD33 PP1857 
Y291A-His6 
C-terminal His6-Tag earP from Pseudomonas 
putida in pBAD33. Mutant version; Tyr291 
exchanged to Ala 
(Krafczyk et al., 
2017) 
AmpR, CmR, KanR: ampicillin, chloramphenicol, kanamycin resistance. 
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Table S3. Primers used in this study 
Identifier Oligonucleotide Sequence (5' - 3') Restriction  
site 
Reference 
Primers for sequencing and cloning     
P1 Seq33 fw 
GGC GTC CAC ACT TTG CTA 
TGC 
  
(Lassak et al., 
2010) 
P2 pBAD HisA rev 
CAG TTC CCT ACT CTC GCA 
TG 
  
(Lassak et al., 
2010) 
P3 epmA chk fw 
TAG GTA CAA CAG TAT AGT 
CTG ATG GAT AA 
  this study 
P4 epmA chk rev 
TGA GGC ATG AAA CCA TCC 
TTC ATT TC 
  this study 
P5 T7 Prom TAA TAC GAC TCA CTA TAG G     
P6 T7 Term TAT GCT AGT TAT TGC TCA G     
Primers for strain construction of KV1 
P7 lacI-583-fw 
GTC TGC GTC TGG CTG GCT 
GGC ATA 
  
(Fried et al., 
2012) 
P8 luxC-OL-rev 
TAG TGC CCA TAG CTG TTT 
CCT GTG TGA AAT TGT TAT 
CC 
  this study 
P9 luxC-OL-fw 
GGA AAC AGC TAT GGG CAC 
TAA AAA AAT TTC ATT CAT 
TAT TAA CGG 
  this study 
P10 
luxE-OL-sRBS-
lacZ-rev 
AAT GTA CCT CCT TAC TTT 
ATT TAT TGT ATT TGT TTA 
GCT ATC AAA CGC TTC GGT 
TAA GCT C 
  this study 
P11 
OL-sRBS-lacZ-
fw 
ACA AAT ACA ATA AAT AAA 
GTA AGG AGG TAC ATT ATG 
ACC ATG ATT ACG GAT TCA 
CTG GCC G 
  this study 
P12 lacZ 500bp anti 
CGA CTG TCC TGG CCG TAA 
CCG ACC 
  
(Fried et al., 
2012) 
P13 delta cyaA fw 
GTT GGC GGA ATC ACA GTC 
ATG ACG GGT AGC AAA TCA 
GGC GAT ACG TCT TGA ATT 
AAC CCT CAC TAA AGG GCG 
  this study 
  Supplementary Material 
 
15 
P14 delta cyaA rev 
TCC GCT AAG ATT GCA TGC 
CGG ATA AGC CTC GCT TTC 
CGG CAC GTT CAT CAT AAT 
ACG ACT CAC TAT AGG GCT C 
  this study 
Primers E. coli loop mutation and overproduction constructs 
P15 
efp Eco P32G 
fw 
GTA AAA GGC GGT AAA GGC 
CAG G 
  this study 
P16 
efp Eco P32G 
rev 
CCT GGC CTT TAC CGC CTT 
TTA C 
  this study 
P17 efp Eco P32S fw 
CGT AAA ATC GGG TAA AGG 
CCA GG 
  this study 
P18 
efp Eco P32S 
rev 
CCT GGC CTT TAC CCG ATT 
TTA CG 
  this study 
P19 
efp Eco G33A 
fw 
TAA AAC CGG CGA AAG GCC 
AGG 
  this study 
P20 
efp Eco G33A 
rev 
CCT GGC CTT TCG CCG GTT 
TTA 
  this study 
P21 
efp Eco G33S 
fw 
GTA AAA CCG TCG AAA GGC 
CAG G 
  this study 
P22 
efp Eco G33S 
rev 
CCT GGC CTT TCG ACG GTT 
TTA C   
this study 
P23 
efp Eco K34M 
fw 
GTA AAA CCG GGT ATG GGC 
CAG GCA TTT 
  this study 
P24 
efp Eco K34M 
rev 
AAA TGC CTG GCC CAT ACC 
CGG TTT TAC 
  this study 
P25 
efp Eco K34N 
fw 
GTA AAA CCG GGT AAC GGC 
CAG GCA TTT 
  this study 
P26 
efp Eco K34N 
rev 
AAA TGC CTG GCC GTT ACC 
CGG TTT TAC 
  this study 
P27 
efp Eco K34Q 
fw 
GTA AAA CCG GGT CAG GGC 
CAG GCA TTT 
  this study 
P28 
efp Eco K34Q 
rev 
AAA TGC CTG GCC CTG ACC 
CGG TTT TAC 
  this study 
P29 
efp Eco G35N 
fw 
CCG GGT AAA AAC CAG GCA 
TTT GC 
  this study 
P30 
efp Eco G35N 
rev 
GCA AAT GCC TGG TTT TTA 
CCC GG   
this study 
P31 
efp Eco Q36S 
fw 
GGG TAA AGG CAG CGC ATT 
TGC 
  this study 
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P32 
efp Eco Q36S 
rev 
GCA AAT GCG CTG CCT TTA 
CCC 
 
this study 
Primers P. putida loop mutation and overproduction constructs 
P33 
NheI-NRBS-
PP_1858-fw 
GCA CTA GCT AGC CGC GGC 
CTC GAT TTT TAT AAA TCC 
NheI this study 
P34 
XbaI-PP_1858-
GS-His6-rev 
CGT CTA GAT TAG TGA TGG 
TGA TGG TGA TGC GAG CCC 
TTC TTG GAG CGG CCT TTG 
AA 
XbaI this study 
P35 
efp Ppu 29 30 31 
OL fw 
CGT AAC AGC GCG ATC ATG 
AAG ACC 
  this study 
P36 efp Ppu K29A 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCC CGA CGC GGT GAA CTC 
AGC   
this study 
P37 
efp Ppu K29R 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCC CGA GCG GGT GAA CTC 
AGC 
  this study 
P38 efp Ppu S30A 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCC CGC CTT GGT GAA CTC 
AGC   
this study 
P39 
efp Ppu S30G 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCC GCC CTT GGT GAA CTC 
AGC 
  this study 
P40 
efp Ppu S30P 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCC CGG CTT GGT GAA CTC 
AGC   
this study 
P41 
efp Ppu G31A 
OL rev 
CAT GAT CGC GCT GTT ACG 
CGC CGA CTT GGT GAA CTC 
  this study 
P42 
efp Ppu G31S 
OL rev 
CAT GAT CGC GCT GTT ACG 
GCT CGA CTT GGT GAA CTC   
this study 
P43 
efp Ppu R32K 
fw 
ACC AAG TCG GGC AAG AAC 
AGC GCG ATC 
  this study 
P44 
efp Ppu R32K 
rev 
GAT CGC GCT GTT CTT GCC 
CGA CTT GGT   
this study 
P45 
efp Ppu 33 34 35 
OL fw 
ATC ATG AAG ACC AAG CTG 
AAG AAC CTG 
  this study 
P46 
efp Ppu N33D 
OL rev 
CTT CAG CTT GGT CTT CAT 
GAT CGC GCT ATC ACG GCC 
CGA CTT   
this study 
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P47 
efp Ppu N33G 
OL rev 
CTT CAG CTT GGT CTT CAT 
GAT CGC GCT GCC ACG GCC 
CGA CTT 
  this study 
P48 
efp Ppu S34A 
OL rev 
CTT CAG CTT GGT CTT CAT 
GAT CGC CGC GTT ACG GCC 
CGA   
this study 
P49 
efp Ppu S34Q 
OL rev 
CTT CAG CTT GGT CTT CAT 
GAT CGC CTG GTT ACG GCC 
CGA 
  this study 
P50 
efp Ppu A35S 
OL rev 
CTT CAG CTT GGT CTT CAT 
GAT GCT GCT GTT ACG GCC   
this study 
Primers cross modification/activation and overproduction 
P51 
efp Eco domainI 
Ppu OL fw 
AAG CTG GAC GAC GTG ATC 
CTG GAT ATG AAC CTG ACT 
TAC CTG 
  this study 
P52 
efp Eco domainI 
Ppu OL rev 
CAG GTA AGT CAG GTT CAT 
ATC CAG GAT CAC GTC GTC 
CAG CTT   
this study 
P53 
efp Eco loop 
Ppu OL fw 
AAG TCG GGC CGT AAC AGC 
GCG TTT GCT CGC GTT AAA 
CTG CGT 
  this study 
P54 
efp Eco loop 
Ppu OL rev 
CGC GCT GTT ACG GCC CGA 
CTT TAC GAA TTC ACT CGC 
TTC AAC   
this study 
P55 
efp Eco P32S 
K34R OL fw 
GAA TTC GTA AAA AGC GGT 
CGC GGC CAG GCA TTT 
  this study 
P56 
EF-P Eco P32S 
K34R OL rev 
AAA TGC CTG GCC GCG ACC 
GCT TTT TAC GAA TTC   
this study 
P57 
efp Eco K34R 
G35N OL fw 
CCG GGT CGC AAC CAG GCA 
TTT GCT CG 
  this study 
P58 
efp Eco K34R 
G35N OL rev 
CGA GCA AAT GCC TGG TTG 
CGA CCC GG   
this study 
P59 
efp Eco K34R 
Q36S OL fw 
CGC GGC AGC GCA TTT GCT 
CGC GTT A 
  this study 
P60 
efp Eco K34R 
Q36S OL rev 
TAA CGC GAG CAA ATG CGC 
TGC CGC G   
this study 
P61 
efp Eco P32S 
K34R G35N OL 
fw 
AGC GGT CGC AAC CAG GCA 
TTT GCT CG 
  this study 
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P62 
efp Eco P32S 
K34R G35N OL 
rev 
CGA GCA AAT GCC TGG TTG 
CGA CCG CT 
  
this study 
P63 
efp Eco P32S 
K34R Q36S OL 
fw 
AGC GGT CGC GGC AGC GCA 
TTT GCT CG 
  this study 
P64 
efp Eco P32S 
K34R Q36S OL 
rev 
CGA GCA AAT GCG CTG CCG 
CGA CCG CT 
  
this study 
P65 
efp Eco K34R 
G35N Q36S OL 
fw 
GGG TCG CAA CAG CGC ATT 
TG 
  this study 
P66 
efp Eco K34R 
G35N Q36S OL 
rev 
CAA ATG CGC TGT TGC GAC 
CC 
  
this study 
P67 earP So rev 
GCG GTA CCC GAT TTT CTA 
TTT CAG CGC AGC AT 
KpnI this study 
Primers pET SUMO constructs 
P68 
efp Eco-SUMO-
fw 
ATG GCA ACG TAC TAT AGC 
AAC GAT TTT 
  this study 
P69 
efp Eco-SUMO-
rev 
TTA GTG ATG GTG ATG GTG 
ATG GCT 
  this study 
P70 
efp Eco K34R 
OL fw 
GTA AAA CCG GGT CGC GGC 
CAG GCA TTT 
 this study 
P71 
efp Eco K34R 
OL rev 
AAA TGC CTG GCC GCG ACC 
CGG TTT TAC 
 this study 
Primers isoelectric focusing and pBAD33-epmA  
P72 
efp-yjeA-OL-
XbaI-fw 
CGT GAA GTA ATC TAG ATT 
GTC AAA AAC TGG AGA TTT 
AAC TAT GAG C 
XbaI this study 
P73 
efp-yjeA-OL-
XbaI-rev 
TTT TTG ACA ATC TAG ATT 
ACT TCA CGC GAG AGA CGT 
ATT CA 
XbaI this study 
P74 
yjeA-yjeK-OL-
PstI-fw 
GCA TAA CTG CAG GGT AGC 
TAA GCC ACA AAA TGG CG 
PstI this study 
P75 
yjeA-yjeK-OL-
PstI-rev 
GCT ACC CTG CAG TTA TGC 
CCG GTC AAC GCT AAA G 
PstI this study 
P76 
SacI-RBS-efp-
fw 
GCG ATG AGC TCA ATT AAC 
AAA TTT CAG AGG GCC TTA 
TGG 
SacI this study 
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P77 SphI-yjeK-rev 
GCA TCG CAT GCT TAC TGC 
TGG CGT AGC TGG AG 
SphI this study 
Primer for strain construction of MG-CR-efp-epmA-KanR 
P78 epmA fw 
CAC 
CGC TGT TTG ATT CCT GCG T 
  this study 
P79 epmA rev 
GCT ACA GAA TGG CGC TTA T
CA CG 
  this study 
Primer for for bacterial two-hybrid (BTH) 
P80 
XbaI-efp-Eco 
FW 
GTA TCG TCT AGA GGC AAC 
GTA CTA TAG CAA CGA TTT 
TCG TG 
XbaI this study 
P81 
XmaI-efp-Eco 
Rev 
GTA TCG CCC GGG ACT TCA 
CGC GAG AGA CGT ATT CAC C 
XmaI this study 
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6 Concluding Discussion and Outlook 
 
Polyproline motifs are indispensable to endow proteins with important structural 
functionalities, and EF-P is needed to translate these motifs efficiently on the ribosome 
and thus present in all domains of life (Starosta et al., 2014b). In order to fulfill its 
molecular function, EF-P has to be post-translationally modified. Here different 
strategies have evolved which differ strongly in their chemical outcome. However, so 
far it remains unclear how these strategies have evolved and which requirements EF-P 
has to fulfil in order to be functional with chemical and structural distinct modifications. 
The biochemical and bioinformatic data of this thesis now contribute substantially to 
the understanding of the evolution of the different PTM, and shows how the amino acid 
composition of the β3/β4 loop (β3Ωβ4) influences the functionality of the chemically 
divergent modifications. Furthermore, it determines prerequisites for rhamnosylation 
by the rhamnosyltransferase EarP, and based on this knowledge it demonstrates the 
possibility of switching the EarP acceptor substrate specificity (Chapter 4). Together 
this lays the foundation to evolve EarP into a general glycosyltransferase which would 
then allow the glycosylation of diverse proteins in the future.  
In addition to that, a tool for the incorporation of diverse ncAAs into EF-P was 
established to further investigate the effect of chemical divergent PTMs on EF-Ps 
functionality. This tool allows to replace the natural PTM of EF-P with synthetic 
modifications (Chapter 2). Based on this approach, a toolbox was developed to control 
bacterial protein levels even of essential genes in diverse Gram-negative bacteria 
(Chapter 3). In addition, the here presented work has also begun to establish a 
screening system which will ultimately enable the identification of PylRS mutants 
capable of incorporation new, previously unknown ncAAs into proteins like EF-P 
(Chapter 2). Finally, this thesis also establishes and provides an improved bacterial 
two-hybrid (BTH) system for the detection of even transient protein-protein interaction 
in a time dependent manner by using luminescence as readout possibility (Chapter 4). 
6.1 Strategy one: Translational activation of EF-P using the amber 
suppression system 
By incorporating (R)-β-lysyl-lysine directly in a single translational step using the amber 
suppression system we aimed to synthetically activate E. coli EF-P. However, in the 
course of this work it turned out that the wt PylRS, which already accepts more than 
20 lysine derivatives without active site engineering (Polycarpo et al., 2006; Wan et al., 
2014; Crnkovic et al., 2016), does not accept (R)-β-lysyl-lysine as a substrate (Chapter 
2). As a consequence, direct incorporation of (R)-β-lysyl-lysine was not possible. 
However, since the discovery of the amber suppression system and its use for the 
incorporation of ncAAs, also numerous mutants of the PylRS have been generated 
and described. Hence there is the possibility that one of these mutants accepts 
(R)-β-lysyl-lysine as a substrate. Considering this possibility, a cooperation with Kathrin 
Lang from the Technical University of Munich has been initiated. Her lab is in 
possession of several PylRS mutants described in literature and is currently screening 
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for potential candidates that accept (R)-β-lysyl-lysine as substrate. Furthermore, PylRS 
libraries will be generated in our lab in the future and screened using the FliC-based 
screening system developed in Chapter 2.  
These PylRS libraries will be generated based on rational design since crystal 
structures of wild-type PylRS (Kavran et al., 2007; Yanagisawa et al., 2008a) and its 
mutants in complex with numerous substrates are nowadays available (Yanagisawa et 
al., 2008b; Takimoto et al., 2011; Schneider et al., 2013; Yanagisawa et al., 2013; 
Flugel et al., 2014; Guo et al., 2014; Schmidt et al., 2014; Englert et al., 2015; Lee et 
al., 2016; Yanagisawa et al., 2019). This information allows in silico docking of new 
ncAAs into the catalytic fragment (residues 185-454 (Kavran et al., 2007) according to 
the M. mazei numbering) of the PylRS. These in silico experiments are essential to 
generate focused libraries, since the catalytic fragment contains up to 30 active site 
residues (Baumann et al., 2019), a number which cannot be covered by conventional 
library design. Furthermore, existing information on PylRS mutants can be integrated 
in the library design. For example, it is known that the replacement of tyrosine at 
position 384 with phenylalanine (Y384F) increases in vivo suppression activity and in 
vitro aminoacylation (Yanagisawa et al., 2008b). This effect can even be enhanced for 
certain ncAAs by replacing tyrosine at position 306 with alanine (Y306A). This allows 
the PylRS binding pocket to accommodate even large lysine derivatives and by that 
further broadens the substrate spectrum (Yanagisawa et al., 2019). 
Regarding the development of the FliC based screening system, it should be 
mentioned that it is based on a totally different screening principle than the already 
existing ones. The development was driven by the following two aspects:  
 First: Screening systems based on fluorescence reporters such as the green 
fluorescent protein (GFP) identify the desired cells/mutants by fluorescence-
activated cell sorting (Santoro et al., 2002; Kuhn et al., 2010; Reichert et al., 
2015). This technology is not available in every lab, elaborate and expensive.  
 
 Second: Other available screening systems different from GFP based ones are 
usually based on antibiotic resistances such as the chloramphenicol 
acetyltransferase (CAT) (Pastrnak et al., 2000; Wang et al., 2001) for positive 
selection, or on toxic gene products such as barnase (Wang et al., 2001; Wang 
and Schultz, 2001), CcdB (Umehara et al., 2012) or TolC (Amiram et al., 2015) 
for negative selection. We and others (Umehara et al., 2012) assume that 
screening systems which are based on different principles, lead in case of 
successful selection to a different pool of positive variants. Therefore, it seems 
reasonable to establish a screening system based on the FliC mediated 
swimming ability of E. coli. 
One might also wonder why it is even possible to introduce the orthogonal amber 
suppression system into E. coli cells, because the system not only incorporates the 
ncAA in the gene product of interest at the previously introduced amber position, but 
also in chromosomally encoded gene products bearing native amber stop codons. The 
rationale behind this is the fact, that the amber stop codon (UAG) is the least used of 
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the three stop codons and rarely terminates essential genes (Korkmaz et al., 2014), 
and if so, is followed either by an ochre (UAA) or an opal (UGA) stop codon at a 
relatively short distance downstream (Johnson et al., 2012). In E. coli MG1655, for 
example, 321 genes are terminated by the amber stop codon of which just 7 are 
essential (Lajoie et al., 2013). However, it has been shown that the conversion of these 
321 amber stop codons to ochre stop codons has the advantage of creating a new 
sense codon exclusively for the ncAA of interest, resulting in improved properties for 
the incorporation of the ncAA by the amber suppression system (Lajoie et al., 2013). 
For this reason, the E. coli strain C321.ΔA.exp, in which all 321 amber stop codons 
are converted to ochre stop codons, was chosen in this work as the chassis to develop 
a screening system based on FliC. 
Should one of the described strategies lead to the identification of a PylRS mutant 
capable of incorporating (R)-β-lysyl-lysine into EF-P from E. coli, the next logical step 
would be to ask which of the chemical groups or structural properties of 
(R)-β-lysyl-lysine (Figure 11) are essential for its functionality. To determine this, the 
potential of chemical substrate synthesis could be used to, for example, shorten the 
chain length of (R)-β-lysyl-lysine or add new functional groups to it.  
 
Figure 11: Chemical structure of (R)-β-lysyl-lysine.  
Moreover, the translational incorporation of (R)-β-lysyl-lysine or derivatives of it in 
E. coli EF-P would not only allow to draw conclusions on functional aspects. It would 
also allow to produce synthetic constitutive active EF-P variants, possibly with even 
enhanced activity. The timescale EF-P needs to find and bind to diprolyl/polyproline 
stalled ribosomes in the cell was determined to be about 16 milliseconds (Mohapatra 
et al., 2017). Increased levels of these synthetic constitutive active EF-Ps could on the 
one hand reduce this time and on the other hand assist to produce diprolyl/polyproline 
containing proteins more efficiently. 
6.1.1 Alternative strategy to activate EF-P synthetically with different 
ncAAs 
An alternative strategy to equip EF-P with different PTMs could be offered by EpmA. 
EpmA is a bacterial class II lysyl-tRNA synthetase homolog lacking the tRNA anticodon 
binding domain (Ambrogelly et al., 2010; Bailly and de Crecy-Lagard, 2010; Navarre 
et al., 2010; Yanagisawa et al., 2010). Hence it specifically modifies EF-P 
post-translationally with (R)-β-lysine and no endogenous tRNAs. Interestingly, it has 
been shown that EpmA can also activate lysine analogs in vitro (Figure 12A) 
(Ambrogelly et al., 2010; Roy et al., 2011). A property which could be further broadened 
by rational design of the active site of EpmA, based on the crystal structure of EpmA 
as well as the co-crystal structure of EpmA in complex with EF-P (Yanagisawa et al., 
2010). 
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The possibility that EpmA can attach the activated lysine analogs to K34 of EF-P from 
E. coli in a subsequent step seems tempting, but remains a speculation so far 
(Figure 12B). Again, and since the interaction sites between EF-P and EpmA are 
known (Yanagisawa et al., 2010; Katz et al., 2014), rational design could enable the 
EpmA mediated transfer of lysine analogs to K34 of EF-P from E. coli. As a result, 
EF-P could be equipped with so far unknown PTMs (Figure 12C) and their influence 
on EF-P functionality could be investigated. 
 
 
Figure 12: EpmA mediated activation of L-lysine analogs. (A) Examples of lysine analogs which can 
be activated in vitro by EpmA (Ambrogelly et al., 2010; Roy et al., 2011). Red framed the natural 
substrate for EpmA. (B) Crystal structure of EF-P from E. coli in complex with EpmA from E. coli (PDB: 
3A5Z) (Sumida et al., 2010). For visualization, UCSF Chimera was used (Pettersen et al., 2004). 
Question marks indicate that it is unknown if the activated lysine derivatives from (A) can be transferred 
onto EF-P or not. (C) Resulting post-translational modifications of EF-P if the transfer of the activated 
amino acids depicted in (A) is possible. Red framed is the natural PTM for EF-P from E. coli. 
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6.2 The amber suppression system as a tool to regulate bacterial 
protein levels 
During the work on the FliC screening system described in Chapter 2, the idea was 
born to use the amber suppression system not only for the incorporation of the ncAA 
of interest into proteins, but also to control bacterial protein levels with it. For this 
purpose, we generated the in Chapter 3 described toolbox based on the amber 
suppression system which is applicable not only in E. coli but also in other Gram-
negative bacteria. 
During the development, the first decision to make was, which of the numerous 
substrates available for the amber suppression system is the most suitable for our 
purpose. In the end, Nε-acetyl-lysine was chosen for the following reasons, which made 
this substrate particularly suitable: It is commercially available, cheap and enables the 
production of unaltered proteins when Nε-acetyl-lysine is incorporated into a protein 
instead of a cognate lysine. This is based on the fact that in bacteria the acetyl group 
is frequently removed by deacetylases (Blander and Guarente, 2004; Yang and Seto, 
2008; Zheng et al., 2018) (Figure 13). 
 
Figure 13: Deacetylation of Nε-acetyl-lysine in bacteria. (Left) Chemical structure of Nε-acetyl-lysine 
which is in bacteria frequently deacetylated, either by sirtuins or metal-dependent enzymes, resulting in 
lysine (right). 
Furthermore, we decided to introduce a transcriptional regulation level in addition to 
the translational regulation level provided by the amber suppression system. This 
coupling of transcriptional and translational regulation is of particular importance if the 
system is applied to essential genes. The reason for this is that a two-level control 
makes it much harder for bacteria to bypass it by introducing spontaneous mutations, 
in comparison to a one level system. Furthermore, the work presented here shows that 
protein production at the translational level can be regulated not only by the amber 
suppression system, but also by the codon context in which the amber stop codon itself 
is embedded. Finally, it shows that only the described combination of transcriptional 
and translational regulation allows a complete shutdown of protein production while 
still being gradually inducible if required, and that the system can be transferred to 
other Gram-negative bacteria like S. enterica and Vibrio cholerae. 
6.2.1 Strategies to improve the uptake of ncAAs into the cell 
The exact mechanism by which the numerous available ncAAs (especially polar ones) 
for the amber suppression system are taken up by the cell has not been clarified yet. 
Hence, the idea developed to further improve our toolbox by optimizing the uptake 
mechanism for Nε-acetyl-lysine into the cell. Usually the medium is supplemented with 
Nε-acetyl-lysine in the millimolar range (Neumann et al., 2008; Umehara et al., 2012; 
Volkwein et al., 2017). Should it be possible to shift this into the nanomolar range, this 
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would reduce the substrate costs at least by a factor of 10. To accomplish this goal, a 
master’s thesis was supervised within the scope of this work in which the mechanism 
for Nε-acetyl-lysine uptake was started to be investigated using the following approach: 
With the help of the database “Transport DB" (Ren et al., 2006), E. coli membrane 
proteins were identified which mediate the uptake of amino acids/peptides or whose 
substrate specificity is not known. Then, the corresponding deletion mutants were 
co-transformed with both, the in Chapter 3 described luxCDABE reporter system in 
which an amber stop codon is inserted into the luxC reductase subunit and the amber 
suppression system for Nε-acetyl-lysine incorporation. As a result, the reductase 
subunit LuxC is produced only in the presence of Nε-acetyl-lysine, leading to a 
luminescence signal (Figure 14A). In contrast, a lack of luminescence indicates that 
Nε-acetyl-lysine is not taken up into the cell and that the deleted gene possibly encodes 
for a putative Nε-acetyl-lysine transporter (Figure 14B).  
 
Figure 14: Schematic illustration of the screening system for the identification of Nε-acetyl-lysine 
transporters in E. coli. (A) In the presence of the corresponding transporter, Nε-acetyl-lysine is taken 
up into the cell which contains on the one hand the acetyl lysyl-tRNA synthetase (AcKRS)/tRNACUA pair 
and on the other hand the luxCDABE reporter system in which an amber stop codon is integrated into 
the luxC subunit. Consequently, the presence of Nε-acetyl-lysine leads to the production of LuxC, which 
finally results in luminescence. (B) The transporter for Nε-acetyl-lysine is deleted, therefore LuxC cannot 
be produced since Nε-acetyl-lysine is absent in the cells and as a result, cells are not emitting light. 
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Worth mentioning here is that that this approach can also be applied to ncAAs different 
than Nε-acetyl-lysine. This is especially of interest for ncAAs which are not 
commercially available and have to be specifically synthesized. A procedure which is 
expensive and, also important, time consuming. Here, the reduction of the required 
substrate quantity would assist the applicability of these substrates in research and 
application. 
The use of the described screening system has already led to the identification of 
several genes that may be involved in the uptake of Nε-acetyl-lysine. In order to make 
a reliable statement whether the identified membrane proteins are involved in the 
uptake, and if so, to what extent it is necessary to perform complementation 
experiments with the identified transport proteins in the corresponding deletion mutant 
background. If the complementation is successful, it would be interesting to see 
whether overproduction of the transporter has a positive effect on the Nε-acetyl-lysine 
import and to what extent the concentration can be reduced while still having a 
functional system to control bacterial protein levels. Furthermore, it would be 
interesting to see if other ncAAs besides Nε-acetyl-lysine are taken up into the cell by 
corresponding transporters. 
 
Additionally, and in the context of the master’s thesis already mentioned, it was also 
possible to isolate bacteria from soil, which were able to grow in the presence of 
Nε-acetyl-lysine as a singular carbon source. This indicates the presence of a high 
affinity transporter for Nε-acetyl-lysine. The successfully isolated bacteria belonging to 
the genera of Enterobacter, Pseudomonas and Xanthomonadaceae. Interestingly, 
laboratory strains from P. putida and Klebsiella aerogenes (formerly named 
Enterobacter aerogenes) were not able to grow with Nε-acetyl-lysine as single carbon 
source. This fact indicates that either the isolated strains from soil evolved specific 
transporters to adapt to the environment, or that the laboratory strains lost their ability 
to do so during ongoing evolution in the lab. However, further research has to be 
conducted to finally identify the membrane proteins responsible for the transport of 
Nε-acetyl-lysine in the identified bacteria. 
 
6.2.2 The Nε-acetyl-lysine metabolism 
Another yet unanswered question is, since the just mentioned bacteria can grow with 
Nε-acetyl-lysine as only carbon source, how Nε-acetyl-lysine is delivered to the cell 
metabolism. Here, we assume that Nε-acetyl-lysine is deacetylated by a yet unknown 
deacetylase, and the resulting lysine is fed into the lysine metabolism of the cell. In this 
case, two scenarios are possible: Either Nε-acetyl-lysine is taken up by a transporter 
and is then deacetylated inside of the cell (Figure 15A) or Nε-acetyl-lysine is 
deacetylated outside of the cell and the resulting lysine is transported in the cell where 
it is fed directly into the lysine metabolism (Figure 15B). To elucidate this, further 
research is needed in this area to identify the responsible enzyme and clarify its 
mechanism of action. 
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Figure 15: Possibilities of Nε-acetyl-lysine metabolism in bacteria. (A) In this scenario, the transport 
of Nε-acetyl-lysine into the cell takes place first and in the following step Nε-acetyl-lysine is deacetylated 
and thus accessible for the lysine metabolism. (B) Another possibility is that Nε-acetyl-lysine is degraded 
first outside of the cell by an exo-deacetylase, and then taken up into the cell as lysine, where it is then 
fed into the lysine metabolism. 
 
6.3 Strategy two: Post-translational activation of EF-P by non-cognate 
rhamnosylation 
In addition to the efforts to synthetically activate EF-P by translational means (Chapter 
2 and 3), a second strategy was pursued in parallel. This strategy took advantage of 
the fact that despite large sequence diversity, all EF-Ps are structurally similar 
(Yanagisawa et al., 2010; Choi and Choe, 2011). This similarity in turn led to the 
hypothesis that cross-activation of EF-P from E. coli with a non-cognate modification 
system might be possible. 
6.3.1 Synthetic rhamnosylation of EF-P 
As interaction is the prerequisite for cross-activation, an E. coli strain that is compatible 
with the commercially available BTH system was developed in order to determine if 
there is interaction between E. coli EF-P and P. putida EarP. The advantage of this 
strain lies in the fact that it offers, compared to the commercial BTH strains, an 
additional luminescence readout possibility. This possibility in turn allows continuous 
monitoring of the luminescence development over a long period of time. Hence, the 
new strain also enables the detection of even transient protein-protein interactions like 
we expected for E. coli EF-P with its non-cognate modification system EarP from 
P. putida. By using this advantage and subsequent biochemical analyses, we could 
show that E. coli EF-P and P. putida EarP do cross-interact, and furthermore, that for 
rhamnosylation of E. coli EF-P by EarP a single amino acid exchange of lysine to 
arginine on the tip of the β3Ωβ4 is sufficient (Chapter 4). 
Despite the fact that this E. coli EF-P variant is rhamnosylated but not functional, this 
result is still of particular interest. It shows that EarP can rhamnosylate a protein which 
shares only about 30% sequence identity compared to the natural substrate (EF-P 
from P. putida) in the EF-P KOW-like N-domain I that mediates interaction with EarP 
(Krafczyk et al., 2017; Sengoku et al., 2018). Furthermore, this fact provides first 
evidence that it could be possible to evolve EarP into a general glycosynthase. In order 
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to accomplish this, however, the next steps would be to identify A) the minimum 
recognition motif, and B) the extent to which the overall structure of EF-P affects the 
recognition by EarP. With this information in hand it should be possible to specifically 
rhamnosylate proteins other than EF-P, enabling to change the carbochemistry of for 
example therapeutic proteins and by that providing them with new, improved properties 
(Sinclair and Elliott, 2005). Here, tools like the first anti-rhamnosyl arginine specific 
antibody (Li et al., 2016) will be useful to support this development.  
6.3.2 Glycoengineering of EarP 
Since detailed information on the structure of EarP in complex with TDP-β-L-rhamnose 
as well as a thorough biochemical characterization of the rhamnosyltransferase 
reaction are available (Krafczyk et al., 2017; Sengoku et al., 2018; He et al., 2019), it 
should be possible to rationally engineer the highly conserved TDP-β-L-rhamnose 
binding pocket in the C-domain of EarP. This could be used to improve the 
rhamnosyltransferase reaction on the one hand or to broaden the substrate spectrum 
from EarP to nucleotide sugars other than TDP-β-L-rhamnose on the other hand. EarP, 
equipped with these characteristics, could help to improve the yield of heterologously 
produced glycoproteins and introduce new carbochemistry into proteins. 
Moreover, the detailed information about EarP residues involved in binding of 
TDP-β-L-rhamnose could also be used to specifically design EarP-targeted inhibitors. 
Since it is known that the post-translational modification of EF-P with 
TDP-β-L-rhamnose is critical for pathogenicity of certain bacteria (Lassak et al., 2015; 
Rajkovic et al., 2015; Yanagisawa et al., 2016; Tollerson et al., 2018), such small 
molecule inhibitors could potentially be used as a new class of antibiotics. 
6.3.3 Synthetic activation of EF-P 
Having shown that E. coli EF-P can be rhamnosylated by its non-cognate modification 
system EarP, we were curious to see if it is also possible to generate an E. coli EF-P 
variant which is not just rhamnosylated but also functional, and by that capable of 
resolving ribosome stalling caused by polyproline stretches. To investigate this, we 
analyzed in a first step the amino acids composition of the seven amino acids long loop 
between β3Ωβ4 of E. coli and P. putida EF-P by biochemical and bioinformatical 
means. The result was that A: the composition of this loop is essential for EF-Ps ability 
to rescue polyproline arrested ribosomes, and B: that the amino acid two positions 
upstream of the modification site is crucial for the functionality of the different chemical 
modifications. With this knowledge we were able to generate E. coli EF-P mutants 
which are both, rhamnosylated and functional, and showed that a minimal change of 
only two amino acids in the E. coli EF-P loop according to the P. putida loop are 
sufficient to achieve this (Figure 16A and B). 
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Figure 16: Overview of the different activation strategies for EF-P. (A) Natural activation of EF-P. 
(Left) Polyproline mediated ribosome stalling. (Middle) Depicted are EF-Ps from E. coli and P. putida in 
its activated/post-translationally modified form. The chemical structures of the PTMs are enlarged. 
Weblogos of the seven amino acids long loop between beta-strands β3/β4 (β3Ωβ4) are shown for lysine 
and arginine type EF-P. Red boxes in the weblogos indicate amino acids enabling, if switched, the 
synthetic activation of EF-PEco. (Right) Resolving of the polyproline mediated ribosome stalling by 
activated (post-translationally modified) EF-Ps from E coli and P putida. (B) Synthetic activation of 
EF-PEco. Here, two amino acids are changed in the β3Ωβ4 of E. coli EF-P according to the weblogo in 
(A), allowing the switch of the modification strategy from lysylation to rhamnosylation while maintaining 
EF-Ps functionality to resolve polyproline mediated ribosome stalling. 
Interestingly, the second amino acid to change (besides the amino acid of the 
modification site itself, K34R) is proline, located two amino acids upstream of the 
modification site, which when exchanged leads to rhamnosylated and additionally 
functional E. coli EF-P. This result led to the hypothesis that the rigidity of proline 
influences the dynamics of the loop of EF-P and thereby its functionality. However, this 
could not be proven experimentally with the in Chapter 4 described methods and the 
exact molecular mechanism by which proline influences functionality therefore remains 
unclear. 
 
After having shown in Chapter 4 that the rhamnosylation of E. coli EF-P by its 
non-cognate modification system is possible and that the exchange of only two amino 
acids within the loop region establishes functionality, it would be interesting to see if 
this approach also works vice versa, resulting in lysylated P. putida EF-P. Similar to 
the work that was presented here, this would help to identify the minimal recognition 
motif of E. coli EpmA and thus lay the foundation for the generation of a general 
lysylase. Furthermore, the generation of a specific antibody against (R)-β-lysyl-lysine 
would allow the identification of further (R)-β-lysylated proteins in divers species. 
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Another interesting issue arising from the results achieved so far in Chapter 4, which 
has not yet been addressed, is why different PTMs have evolved. The data presented 
here and elsewhere (Lassak et al., 2015) clearly show that rhamnosylated 
heterologously produced EF-P is also functional in E. coli, but the rationale behind this 
evolution of a chemically totally different PTM is so far unclear and can only be 
speculative at this point. One possible explanation might be that the different chemical 
modifications offer advantages for a particular set of diprolyl motifs (XPPX) embedded 
in key proteins of the bacteria affected. These advantages could be, on the one hand, 
that the protein production is slowed down to provide time for necessary folding 
processes, or that the production is accelerated to produce more protein in less time.  
 
In this context, another interesting aspect emerges from the bioinformatic data 
presented in Chapter 4. The data indicate that rhamnosylated EF-P most likely 
occurred evolutionarily after (R)-β-lysylated EF-P, and even more importantly that 
rhamnosylated EF-P seems to have spread into other phyla, in some cases replacing 
an already present (R)-β-lysylated EF-P variant. On the contrary, replacement of 
rhamnosylated EF-P by (R)-β-lysylated EF-P variants was not observed. This indicates  
that it might be possible that rhamnosylated EF-P has an extended functionality 
beyond resolving polyproline mediated ribosome stalling. Extended functionality has 
already been reported for the eukaryotic counterpart of EF-P (Pelechano and Alepuz, 
2017; Schuller et al., 2017) but experimental evidence for rhamnosylated EF-P in 
prokaryotes is lacking and needs further investigation. Furthermore, the available 
bioinformatic data show that not all EF-Ps carry an arginine or lysine at the tip of the 
β3Ωβ4 loop (Chapter 4), which raises the question for alternative modification 
strategies in addition to the already known ones. 
However, it should also be taken into consideration that bacteria might have adapted 
their genome in order to reduce EF-P dependence to an amount were basal 
functionality of unmodified EF-P (Volkwein et al., 2019) is sufficient, hence making an 
additional PTM obsolete. The same might also apply for lysine and arginine EF-Ps 
were modification pathways could not be identified experimentally and 
bioinformatically. 
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